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Abstract

By Carim van Beek
University of the Pacific
2020

Natural products have been demonstrated to be of great significance to the
pharmaceutical industry in the development of new drugs and medicine. Unfortunately,
synthetic approaches to obtain these natural products often prove increasingly challenging due
to the complexity of synthesizing the target drug in the proper stereochemistry. The availability
of enantioselective reactions can play a pivotal role in overcoming this challenge, yielding
access to optically pure intermediates and products. Chiral ligands based on a trans-1,2diaminocyclohexane motif are often employed for this purpose and their complexes with
transition metals have been demonstrated to act as efficient chiral catalysts in asymmetric
reactions. In contrast, studies involving cis-1,2-diaminocyclohexane derivatives as chiral
catalysts are strongly underrepresented.
We have designed and performed the synthesis of an axially chiral conformationally
locked cis-1,2-diamine scaffold, conveniently designed for further derivatization into more
complex structures. A key step in this synthesis was the chiral resolution of a racemic
intermediate, realized through both chemical and enzymatic means in a comparative study.
Utilizing the newly gained optically pure primary diamine scaffold, a library of chemically
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diverse secondary diamine ligands has been synthesized and characterized through NMR
spectroscopy, mass spectrometry, and chiral HPLC. Assignment of the absolute configuration
within the cis-1,2-diamine scaffold was realized through single-crystal X-ray crystallography
experiments on one of the synthetic intermediates.
The synthesized ligands have been evaluated for their potential to function as chiral
catalysts in the asymmetric Henry reaction and asymmetric transfer hydrogenation. As a
function of both steric and electronic structural variation, a range of catalytic activities and
enantioselectivities in the Henry reaction were observed. The ligands proved to be less suitable
for asymmetric transfer hydrogenation with only a select number of ligands catalyzing the
reaction, and a single example resulting in a decent enantioselectivity.
We additionally explored the possibility of incorporating a chemical switch into the
scaffold, responsible for switching the axial chirality of the molecule. As a consequence of
inverting the axial chirality, the configuration of the potential reaction product in asymmetric
synthesis would also be inverted. To this extent, we performed the synthesis of a novel
specifically designed crown ether, dicyclohexeno-18-crown-6, furnished with two π-bonds in
the cyclohexane rings, allowing for additional modification into more advanced functionalized
structures.
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CHAPTER 1: INTRODUCTION

1.1 Origination of Diamine-Based Ligands for Asymmetric Synthesis
Perhaps the most frequently encountered ligands in the synthesis of optically pure
compounds through asymmetric catalysis are constructed from 1,2-diimino and, more recently,
1,2-diamino structural scaffolds.1–6 The first description of ligands based on such motifs
originates from 1889, where Combes et al. performed a condensation reaction between two
equivalents of salicylaldehyde with N,N’-bis-ethylenediamine for which the product is shown in
Figure 1.7 This particular [O,N,N,O]-tetradentate Schiff base set stage for the evolution of an
entire field of chemistry, using these Schiff base ligands for complexation with a large number
of metal ions.1

Figure 1. First reported salen compound N,N’-bis-(salicyladehydo)ethylenediamine and its
copper complex.7

Ligands of this general structure are named salen ligands, with the term derived from
the first described synthesis (N,N’-bis-(salicyladehydo)ethylenediamine, Figure 1).8 Combes
discovered that the compound was capable of forming stable copper complexes through the Nimino and O-phenolate donor atoms. This finding sparked the investigation of their potential as
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metal-complexing chiral ligands in asymmetric synthesis in the early 1990s,1 and led to the
development of many different salen ligands, with variations in both the diimine backbone (e.g.
freely rotating versus constrained) and the substitution around the aromatic rings. Several
prominent examples from literature are given in Figure 2.

Figure 2. Representative salen ligands that are varied both in the diimine backbone and the
substitution around the aromatic rings.1,7,9
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Varying the highlighted features in the figure above yields different effects on the
performance of the salen ligands as templates for asymmetric synthesis. Tuning of the diimine
backbone primarily leads to differences in orientation and steric interactions of the [O,N,NO]
complexing core, where modifications on the aromatic ring can lead to similar steric effects or
differences in electronic properties. As a consequence, the binding affinity to specific metals
can be altered for the purpose of stabilizing various oxidation states.8 As such, a ligand-metal
complex can be optimized to (primarily) adopt a specific configuration, controlling the
stereochemical outcome of the reaction under investigation. This control over configuration is
important, as there are typically three possible octahedral salen-metal complex configurations
that can promote different stereochemical outcomes (Figure 3).1

Figure 3. Three possible conformations for octahedral ligand-metal complexes.1

In case of the trans orientation, both ancillary ligands occupy apical sites, where the cisβ and cis-α orientations have one and two ancillary ligands in equatorial positions, respectively.
The ancillary ligands attached to the metal are known to play a large role in steering the
configuration of the ligand-metal complex emphasizing the importance of controlling their
orientation.10 Metal-salen complexes of the trans configuration have been shown to act as
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efficient catalysts in asymmetric epoxidations, aziridations, cyclopropanations, and 1,4additions, to name a few.10–13 The cis-β and cis-α configurations are less common and typically
formed with bidentate ligands. Of the two possible configurations, cis-β is the predominant
species due to its higher stability.10,14,15
More recently, an increasing interest in salan-metal complexes has emerged for their
applicability in asymmetric synthesis (Figure 4). From a structural perspective, the only
difference to salen Schiff bases is the replacement of the imino moieties by amino moieties,
which can be readily achieved through the reduction of the salen precursor.16

Figure 4. General structure for a salan Schiff base and its metal-complexed analogue.

In contrast to their seemingly high similarity to salen Schiff bases, salan compounds are
actually rather different in terms of their physical properties. One remarkable difference is the
increased stability of the metal-salan complexes, compared to their salen counterparts. Schiff
bases have a tendency to hydrolyze, which limits their use in (semi-)aqueous systems and under
oxidative conditions, in spite of their high complex-formation constants with metals.2,4
Additionally, this restricts their use as recoverable/reusable ligands, which proves to be a
valuable attribute in light of current efforts to perform greener chemistry.4 Salan-metal
complexes, in contrast, are hydrolytically stable and demonstrate to be more promising targets
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for reusable/recoverable ligands, both in solution, and attached to a solid phase. 4,17,18
Moreover, the greater stability of salan compounds compared to Schiff bases makes these
molecules promising targets as therapeutic drugs,2 which will be elaborated on in Chapter 1.3.
The increased stability of these complexes is mainly attributed to the higher basicity of the Namine atoms, as well increased flexibility of the CH2-NH bond (Figure 4 above), potentially
allowing for better orbital overlap between the ligand and the complexing metal. 19
Unfortunately, the increased rotation around the CH2-NH bond allows for a higher
number of possible conformations of the ligand and, thus, configurations with respect to the
metal-salan complex. This increased flexibility makes it harder to tune the (predominant)
configuration of the ligand, and multiple non-planar complex configurations of similar energy,
often exist. This is in sheer contrast to the mostly planar salen-metal complexes, and
complicates the applicability of salan-metal complexes in dictating the stereochemical outcome
of a potential asymmetric reaction. Furthermore, binding of the salan ligand to the metal
generates two additional stereogenic centers in the complex and, as a consequence, leads to
even more possible configurations.

Figure 5. Salan complexes generate additional stereogenic centers upon binding.
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Despite these drawbacks, their increased stability offers adequate potential for further
research into this type of ligand and many salan-metal complexes have been synthesized and
studied to date.20–28 Even though their potential has yet to be fully proven, the number of
applications in asymmetric synthesis has been vastly increasing over the past two
decades.5,17,20,23,25,27–31 Some of the more prominent examples of successful applications in
asymmetric synthesis are the topic of chapter 1.2.
The most recent development when it comes to the use of diamine-based ligands
departs from the conventional salen/salan [O,N,N,O] tetradentate coordination and rather
focuses on using diamines as such or in combination with different functional groups, to
complex metal ions in either a bidentate, or tetradentate fashion. Additionally, all examples so
far have concerned 1,2-diamines, while ligands currently exist of 1,3-, 1,4- and even 1,5connectivities capable of complexing metal ions for use in asymmetric synthesis.32–38 A few
examples of such compounds are given in the figure below:
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Figure 6. Novel diamine-based ligands used as chiral catalysts in asymmetric synthesis.32,34–38

As can be seen from the figure, many ligands keep elements of the original salen/salan
design intact, but the diversity in designs is constantly increasing and the number of reported
ligands far exceeds the handful given in this overview. Remarkably, most of the examples given
in this introduction so far comprise cyclic diamines in a trans orientation. This is a realistic
representation of the proportionality between cis- and trans-diamine-based chiral ligands, as
ligands of the latter sort substantially outnumber the first.2,3,5 In fact, only a single 1,2substituted salalen ligand (salen/salan hybrid) has been reported for use in asymmetric
synthesis, thus far (Figure 10, Chapter 1.2),16 and no examples exist utilizing a 1,2-cis-DACH
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scaffold. One of the major reasons that explains this phenomenon arises from the availability
of synthetic means through which optically pure ligands of either stereochemistry can be
obtained, as will become clear in the next chapter.
1.2 Synthetic Methods to Obtain Optically Pure Chiral Diamine Ligands and Their Potential in
Asymmetric Synthesis
The syntheses of salen- and salan-type ligands are largely identical due to the fact that
salan ligands are traditionally obtained through reduction of the salen ligands. Most
salen/salan ligands are obtained through the same modular synthesis used to obtain Schiff
bases in general, by condensing two equivalents of aldehyde with one equivalent of a 1,2diamine, as depicted in Scheme 1.

Scheme 1. Modular synthesis of salen and corresponding salan ligands through reductive
amination.

The removal of water from the system, which is done to push the equilibrium to favor
the product diimine, is generally achieved through azeotropic distillation in combination with a
Dean-Stark apparatus when the reaction is carried out in toluene or benzene. Alternatively,
ethanol proves to be a good solvent for such reactions,16 in which case magnesium sulfate is
often added as a dehydrating agent.8 Sometimes, the product diimine spontaneously

31
crystallizes from the solution, eliminating the requirement for water removal. The
condensation as described above can be performed either in the presence or absence of an
acid/base catalyst, and may require elevated temperatures, but not necessarily.16,39,40 Even
though the scheme above shows the reaction for a particular salen ligand, the synthesis is
generally applied for all diamine ligands featuring a similar connectivity, but varying in groups R,
and the substitution around the aromatic rings.
In order to tune ligands for their specific asymmetric purposes, various compounds are
often tested bearing different substituents on the aromatic ring in multiple orientations, to test
their electronic and steric effects on the outcome of the reactions. Such variations are typically
introduced prior to condensation with the diamine moiety through the Duff reaction (Scheme
2).41

Scheme 2. General approach towards substituted aromatic aldehydes for condensation
reactions through the Duff reaction.41
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The tuning of the substitution around the aromatic rings plays a pivotal role in the final
orientation adopted by the ligand with respect to the metal center and it is therefore not
surprising that significant effort has been devoted to the generation of ligand libraries in a
straightforward manner.42
Ligands obtained through the Duff reaction offer symmetrically substituted diimines and
diamines, yet possibilities exist to generate asymmetrically substituted compounds, as has been
described by Campbell et al.43 In this three-step procedure, the diamine, in this case trans-1,2diaminocyclohexane (trans-DACH), is first converted to a mono-ammonium salt with
hydrochloric acid and obtained as a solid through precipitation in ether (Scheme 3). Next, the
ammonium salt is added to one equivalent of aldehyde, producing the corresponding monoimino ammonium salt. Finally, the compound is added to a second equivalent of aldehyde in
the presence of triethylamine, which deprotects the primary amine and allows it to react,
yielding the asymmetrically substituted diimine.
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Scheme 3. Synthetic route to asymmetrically substituted diimines.43

Using this approach, Campbell et al. achieved yields of 80-85% for the mono-imino
ammonium salts, and between 60-86% yield for the final diimine after recrystallization from
acetonitrile. It is noteworthy that all examples from the paper involve racemic trans-DACH and
an optically pure compound could result in a mixture of two diimine products. Using a chiral
acid for the protection step may potentially steer which product is favorably formed.
A challenging task arises when varying the primary diamine backbone to which the
aldehydes will be attached. As briefly mentioned in the previous chapter, the constraints for
the amino backbone are rather strict due to the fact that this part typically requires optically
pure starting amines. For this reason, a case by case optical resolution is required to obtain the
desired primary diamine backbone, which limits the variation of this structural feature, making
it an unsuitable parameter in a systematic screening of ligands. It is therefore not surprising
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that the majority of diamine ligands features a relatively small number of different backbones,
in combination with a vast collection of attachments obtained through aldehyde
condensation.1–4,10,11,44 One of the more frequently encountered scaffolds is the trans-1,2diaminocyclohexane (trans-DACH), as shown in (Scheme 3 above). The simplicity by which
trans-DACH can be obtained in optically pure form makes this molecule a prominent candidate
for further derivatization. The optically pure (R,R)-1,2-diaminocyclohexane could be readily
obtained through selective crystallization of its (+)-tartrate salt, as described by Larrow.45
Combining a commercially available mixture of racemic cis- and trans-DACH with L-(+)-tartaric
acid in water resulted in a mixture of diastereomeric salts in solution. Subsequent addition of
glacial acetic acid led to the formation of a white precipitate, which, upon cooling yielded the
(R,R)-1,2-diammoniumcyclohexane mono-(+)-tartrate salt in a quantitative yield (Scheme 4).
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Scheme 4. Selective precipitation of (R,R)-1,2-diammoniumcyclohexane mono-(+)-tartrate
salt.45

Using this general resolution method, many ligands with the trans-DACH scaffold have
subsequently been synthesized and used in various asymmetric syntheses. Perhaps the most
famous example of asymmetric synthesis using a trans-DACH salen type ligand is the JacobsenKatsuki epoxidation.46,47 This method employs a manganese-salen type of ligand attached to a
trans-DACH backbone to asymmetrically epoxidize unfunctionalized olefins as is shown in
Scheme 5.
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Scheme 5. Jacobsen-Katsuki epoxidation of unfunctionalized olefins.46,47

This specific example resulted in only 49% e.e. however, further research and
optimization of both ligand and conditions increased the enantiomeric excess for this, and
many other substrates, to above 90%.48 The initial reaction was limited to cis-olefins but, more
recently, tri- and tetra-substituted double bonds have also been tested, with similar or higher
selectivity.49,50 The addition of pyridine N-oxide appeared to be a key improvement of the
enantioselectivity of the reaction.50
There has been a lot of debate on how the asymmetry is introduced mechanistically.49
Jacobsen and Katsuki both have different opinions on how enantiodiscrimination is introduced,
which may or may not have to do with the fact that both their groups discovered this reaction
simultaneously rather than in collaboration, as the name of the reaction might suggest. It is
certain, however, that epoxidation only takes place in the presence of an additive such as
sodium hypochlorite, responsible for oxidizing Mn(III) to Mn(V). The resulting Mn(V)=O
complex is thought to be the reactive species that transfers the oxygen atom to the substrate
(Figure 7).
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Figure 7. Sodium hypochlorite-induced oxidation of Mn(III) to Mn(V) followed by epoxidation
of the substrate.46,47,49,51

The controversy, however, lies in the approach taken by the substrate with regards to
the Mn(V)=O complex. Figure 8a below illustrates Jacobsen’s conviction, whereas Figure 8b
follows Katsuki’s view.

Figure 8. Two possible manners by which the substrate can orient itself with regards to the
catalyst according to Jacobsen (a) and Katsuki (b).49,51
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Jacobsen argues that the substrate approaches from the diimine bridge with the smaller
substituent (R2) on the same side as the axial hydrogen atom of the trans-DACH backbone,49
whereas Katsuki believes π-π interactions cause the substrate to approach from the diimine
double bond-side, with the smaller substituent (R2) on the same side as the tert-butyl group.51
Aside from this controversy, there is no dispute about the fact that steric hindrance around the
Mn(V)=O core is the leading factor responsible for enantiodiscrimination, and both approaches
explain the same selectivities.
Another example containing the trans-DACH scaffold worthy of mentioning is the salentitanium complex as devised by North.52 This complex was shown to aid the asymmetric
addition of trimethylsilylcyanide to carbonyl compounds (Scheme 6).

Scheme 6. Asymmetric cyanohydrin synthesis from aldehydes using a salen-titanium complex.52

This reaction appeared particularly useful because it allows access to a diverse collection
of more complex enantioenriched substances through subsequent chemical manipulation of
the cyanide or OTMS group.53 Based on this original discovery, many more examples were
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reported in the years that followed, using different ancillary ligands (e.g. iso-propoxy) on the
titanium core (Figure 9a),54 utilizing different metal complexes,55 and by expanding the
substrate scope (Figure 9b) through variation of the reaction conditions and/or the structure of
the ligand (Figure 9a and 9c).9

Figure 9. a) Variations to the original Ti-salen ligand for cyanohydrin synthesis; b) increased
substrate scope; and c) specific examples of obtained enantiomeric excess.52–54
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The examples presented here are just a minor fraction of the incredible number of
salen-metal complexes reported in literature, and their application in asymmetric synthesis
spans over twenty-six synthetically meaningful reactions described to date.1
The use of chiral ligands based on the salan/diamine core structure is a relatively new
research area, which makes sense considering the drawbacks of their usage in asymmetric
synthesis as described in Chapter 1.1 and the literature.2 Nevertheless, an increasing number of
such ligands has been reported in recent years, due to their improved stability and ease of
handling compared to their salen counterparts. A prominent example of a salan-type ligand has
been developed by Katsuki,56 who used it as chiral catalyst for the epoxidation of various
olefins, similar to his previous work.46 By varying the substitution around the aromatic rings of
the salen-titanium complexes, they managed to develop a ligand capable of facilitating
asymmetric epoxidation with excellent enantioselectivity (Table 1).
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Table 1
Effect of Substitution Around Aromatic Ring on Enantioselectivity in H2O2mediated Epoxidation.56

Entry
1
2
3
4
5
6

Catalyst
1
2
3
4
4
4

Time (h)
24
24
24
6
6
24

Yield (%)
No reaction
<5
19
73
87
79

e.e. (%)
N.A.
44
82
95
96
98

Entry 6 in the table resulted in a 98% e.e. in combination with an 87% yield, clearly
demonstrating the potential of this methodology. It appeared that the switch from a
diphenylethylenediamine to a trans-DACH scaffold was a major influencer in both the increase
in yield and enantioselectivity (compare entries 1 and 2 to 3-6).
In a recent study, Wang et al. reported one of the few examples in asymmetric synthesis
utilizing a cis-diaminocyclohexane (cis-DACH) scaffold, comparing its potential against Katsuki’s
salan catalyst described above.16 cis-DACH ligands are scarcely described which can
predominantly be attributed to the fact that symmetrical derivatization yields meso
compounds, in contrast to the C2-symmetry adopted by chiral trans-DACH ligands, resulting in
chiral complexes. One of the pathways to utilizing cis-DACH ligands includes a non-symmetrical
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substitution around the amine moieties, which can prove a challenging task due to the chemical
equivalence of the two amine groups. The earlier presented work by Campbell for example,
protecting one of the amines through protonation,43 would lead to a racemic mixture.
Nevertheless, controlled substitution on one of the two amino groups can be done, and
Berkessel et al. describe a rather elegant method that employs an enzymatic desymmetrization
of cis-DACH to obtain an enantiopure mono-protected alloc-cis-DACH.57 In this situation, the
enzyme Candida Antarctica lipase-B (CAL-B), recognizes (1R,2S)-diaminocyclohexane as a
substrate and selectively places the alloc-group onto the (2S)-amino group (Scheme 7).

Scheme 7. Modular synthesis of a cis-DACH salalen ligand utilizing a CAL-B (enzyme)
desymmetrization as the key step.57
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A subsequent condensation/reduction cycle of the mono-protected DACH allows for
substitution on the unprotected amine, followed by a deprotection/condensation sequence
yielding the imino moiety. The resulting amine/imine hybrid containing the [O,N,N,O]connectivity is termed salalen, and is comparable to other unsymmetrically substituted
salen/salan ligands. The potential of this novel type of salalen ligand was tested in the
asymmetric epoxidation reaction and after synthesizing many variations in terms of groups R1
and R2, two ligands were selected for yielding the best results (Figure 10).57 The fact that a total
of 21 structurally different ligands were tested, however, does illustrate the challenge of tuning
the sterics of the ligand properly as a consequence of having a freely rotating -NH-CH2- bond in
the molecule.

Figure 10. Optimal salalen ligands for asymmetric epoxidation of terminal olefins.16
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Although the results are encouraging, the catalytic system is currently restricted to
terminal, unconjugated olefins specifically.16 Nonetheless, the results of this pioneering work
are promising enough to promote further research into cis-DACH-based ligands.
Aside from the fact that derivatization of symmetrical cis-DACH ligands results in meso
structures, the interconversion of the two lowest-energy chair conformations of the
cyclohexane ring additionally inverts the chirality around the N-C-C-N axis. As a result, any
hypothetical symmetrically substituted cis-DACH ligand that could induce stereodiscrimination
in a reaction, would automatically cancel out its own effect due to the axial interconversion
(Figure 11).

Figure 11. Interconversion of chirality in cis-DACH ligands as a consequence of cyclohexane
chair-chair transitions.

In an attempt to tackle this problem, a few research groups have explored the possibility
of synthesizing cis-diamine scaffolds that do not suffer from this interconversion.32,58 A
fascinating example of this kind of cis-diamine scaffold has been devised by White et al. and
features a cis-bicyclo[2.2.2]octane-2,5-diamine scaffold.32 The synthesis of this scaffold,
including the necessary resolution of a chiral intermediate, is shown in the scheme below.
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Scheme 8. Synthetic route to cis-2,5-diaminobicyclo[2.2.2]octane scaffold and subsequent
derivatization to salan-type ligand.32

Although the overall yields for obtaining the salen (28%) and salan (27%) ligands are
more than respectable for such an extensive synthetic route, the relatively low yield compared
cis/trans-DACH scaffolds may pose a drawback for venturing in this direction. Having said that,

46
as this is one of the first examples of this type of ligand existing to date, this development could
still see some major improvements in time. Evaluation of the salan ligand in the nitro-aldol
reaction resulted in the conversion of a wide range of substrates with very respectable yields
(81-99%) and excellent enantiomeric excesses (91-98%), clearly demonstrating the potential of
the ligand (Table 2). Observing these excellent results, cis-diamines appear valuable scaffolds
with high potential in asymmetric synthesis, granted that the axial orientation can be controlled
(as is the case for this 1,4-substituted example), and an efficient synthetic method can be
provided for their synthesis.

Table 2
Efficiency of cis-2,5-Diaminobicyclo[2.2.2]-octane-based Salan Ligand in
Asymmetric Nitro-aldol Reaction.32

Entry
1
2
3
4
5

R-group
C6H6
3-CH3C6H4
4-CF3C6H4
2-(OH)C6H4
R=Me3C

Time (h)
20
24
24
24
51

Yield (%)
90
95
96
97
89

e.e. (%)
92
96
96
92
95
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1.3 Potential of Diamine Ligands in a Therapeutic Context
1,2-Diamine ligands are generally accepted to be privileged scaffolds. The reason for
this is derived from their incredibly wide applicability ranging from catalysis and asymmetric
synthesis as described above, to their use as enzyme mimics,59 and their use in DNA-directed
synthesis/DNA-binding,59 antimicrobial activity,60 bio-sensing and bio-imaging.61,62 Their
potential is not limited to these applications, however. Both metal-salen and metal-salan
complexes have been studied for their cytotoxic properties, where the latter have additionally
been studied as potential anticancer drugs of the cisplatin type.2,59–61,63 Obviously, until a
holistic cure is devised, cancer research is an ever-remaining topic of interest, and the potential
of these diamine ligands will continue to be evaluated.
1.3.1 Diamine Ligands as Potential Cisplatin Drugs
The first synthesis of cisplatin, or cis-diamminedichloridoplatinum(II) resulted in the
development of an entire field of anticancer drugs, generally referred to as cisplatin drugs. 63
This type of chemotherapeutic drug has frequently been used for a number of different cancer
types in humans including bladder, head, neck, and lung cancer. Mechanistically, cisplatin
drugs are capable of crosslinking with the purine bases in our DNA, causing irreversible DNAdamage which in turn leads to apoptosis.64 Unfortunately, this process is non-specific and can
lead to severe side-effects in humans including nephro- and ototoxicity, which severely limits its
therapeutical utility.65,66 To make matters worse, upon prolonged exposure, tumor resistance to
cisplatin may develop. To tackle this problem, considerable research has been devoted to
develop novel cisplatin-based drugs, e.g. carboplatin and oxaliplatin (Figure 12).67,68
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Figure 12. Structure of platinum complexes currently or previously used in medical treatments.

Recently, cisplatin complexes containing a steroidal backbone have seen increased
attention due to their capability of interacting with specific steroid hormone receptors in
human cancer cells.63,69–71 By exploiting this property, the specificity of the cisplatin drug for the
targeted cancer cells is increased. By observing the composition of these variations to the
original cisplatin drug, however, it is evident that the diamine-moiety remains the core
functionality of these drugs. Two cisplatin drugs of interest have recently been compared with
cis- and oxaliplatin (shown above), revealing interesting in vitro antitumor activities for these
compounds.72 Variations were made in both the diamine backbone and ancillary ligands
compared to cisplatin and the effects of these variations on the IC50 for several tumor cell lines
were tested, namely cervical (A431), breast (MCF-7), and colon cancer (HCT-15), along with
melanoma (A375). The results of this study are summarized in Table 3 below.
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Table 3
Comparison of in vitro Antitumor Activity of Different Cisplatin Drugs.72

Entry
1
2
3
4

Ligand
PtCl2(1R,2R-DACH)
PtCl2(cis-1,4-DACH)
Cisplatin
Oxaliplatin

HCT-15
2.66 ± 0.95
8.02 ± 1.84
1.25 ±1.05
15.53 ± 2.48

IC50 (µM) ± SD
MCF-7
A375
3.09 ± 1.06
1.87 ± 1.25
9.52 ± 2.36
6.14 ±1.45
3.36 ± 1.69
2.37 ± 1.31
8.37 ± 2.96
2.06 ± 1.01

A431
1.46 ± 0.91
6.69 ± 3.27
3.69 ± 1.03
1.96 ± 0.84

As can be seen from the table, the IC50 for entry 2 typically falls between or below those
for cis- and oxaliplatin, which demonstrates the apparent supremacy of having a 1,2-diamine
connection in comparison to a 1,4-diamine. These data question the potential of designs based
on this backbone. Entry 1, however, reveals a far more positive image and shows great potency
with regards to three of the four tested cell lines, emphasizing that variations in the diamine
backbone can lead to enhanced efficiency. For this reason, the trans-DACH scaffold reveals to
be a candidate of interest as a cisplatin drug, and many variations containing the trans-DACH
backbone have been synthesized and tested.67 Interestingly enough, the use of cis-DACH
ligands and analogues are rarely reported for this purpose and offer a potentially interesting
scaffold for further research.73
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1.3.2 Metal-free Diamine-based Ligands as Anticancer Agents
A major drawback of using cisplatin, or any other transition metal-based complex, in
medicinal applications is their typically high toxicity due to the consequential release of the
metal ion, and the potential drug resistance that may develop.2 For this reason, the
pharmaceutical industry grows increasingly reluctant in investigating metal-containing drugs.
Removing the metal ion from a diimine-type complex results in (partial) reduction of the
diimine bonds and leads to unpredictable behavior in biological systems. Diamine-based
complexes, however, are hydrolytically stable in the absence of a metal ion which makes them
interesting targets as metal-free anti-tumor agents. To this extent, a series of salan ligands
have been tested for their potential as cytotoxic agents (Figure 13).73

Figure 13. Chiral salan ligands tested for cytotoxicity in vitro, with stereochemistry (R,R), (R,S),
and (S,S).73

The exact mechanism of action is under current investigation but it is hypothesized that
evaluated salan ligands downregulate Bcl-2 activity, which is a programmed cell-death
regulator, inhibiting apoptosis. This Bcl-2 protein is overexpressed in many cancer type cells
and contributes to tumor initiation, progression, and therapy resistance.74,75 The cell lines
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tested include the non-small lung NCI-H460 and A549 cancer cell lines, for which the IC50 values
were quite low (0.8-1.8 µM) after two days of incubation.73 Interestingly enough, the (R,R)enantiomer demonstrated superior activity in comparison to the (S,S) and (R,S)-variants for
both the dicyclohexano- and diphenylethylene-based ligands,73 revealing the significance of
evaluating each optically pure compound separately. Testing of the salan ligands against breast
cancer MCF-7 cells and the normal human breast cells MCF-10 revealed a similar trend for MCF7, but an inverse effect for MCF-10, in terms of the IC50 values as a function of stereochemical
configuration (i.e. for MCF-10, the (R,S) isomer demonstrated the best result). Several
variations to these salan ligands were made in terms of aromatic ring substitution/substituents
(COOH or CH3 instead of OH), yet the original [O,N,N,O] connectivity with the hydroxyl group in
the 2-position remained the most potent.76
In a combinatorial study, the cyclohexane ligands from Figure 13 above, were evaluated
for inducing apoptosis alongside their phenyl-substituted analogues in the 3-position on the
aromatic ring. Additionally, the EC50 of these ligands was compared to the EC50 of their MoVIcomplexes (Figure 14).77

Figure 14. Comparison of chiral salan ligands as free amine versus their MoVI-complexes tested
for apoptosis in vitro, with stereochemistry (R,R), (R,S), and (S,S).77
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In contrast to what might be expected, the metal-free (R,R)- and (S,R)-ligands showed
the most promising results (EC50 = 1.7 µM, EC50 = 1.8 µM, respectively) for inducing apoptosis in
Nalm-6 cells after 72 hours of incubation. In contrast, their MoIV-complexes required
concentrations of 4.0 and >10 µM, respectively, to achieve the same result.77 The metal-free
ligands were additionally shown to induce apoptosis in leukemia, lymphoma, and solid tumor
cell lines.77 In addition, the metal-free complexes appeared to overcome multidrug resistances
in the leukemia and lymphoma cells in vitro, which is one of the major drawbacks of current
metal-based cancer treatments. It needs to be mentioned, however, that the use of non-metal
ligands does not exclude the possibility that the active species involves a metal-complexed
ligand formed with metal ions present in the cells. Although the exact mechanism of action
remains to be elucidated, the fact that a metal-free drug might be administered in future
treatments is of great significance and might be a key factor in the development of a new
generation of anticancer drugs.
1.4 Controlling the Stereochemical Outcome of Asymmetric Reactions: Potential of
Conformational Switches
One of the most prestigious goals in developing chiral ligands for asymmetric synthesis
is to not only obtain an optically pure product, but also to dictate the stereochemical
orientation of this product as desired in terms of its (R)- or (S)-configuration. In light of
commercial drug synthesis and the accompanied stringent FDA regulations on marketed drugs,
it may even be required to synthesize and characterize both enantiomers of a target API (active
pharmaceutical ingredient) e.g. to track the fate of impurities in the synthetic process or to
characterize their (potentially different) biological activities. Conventional approaches to
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tackling this difficulty include the use of both enantiomers of a chiral ligand or excipient, if
available. For example, the Sharpless epoxidation utilizes a chiral titanium catalyst for the
enantioselective epoxidation of allylic alcohols in the presence of tert-butyl hydroperoxide and
either (+)- or (-)-DET (diethyl tartrate), where the absolute configuration of DET dictates the
stereochemical outcome of the reaction (Figure 15a).78 This particular case is rather elegant
due to the fact that DET is a cheap commercially available reagent which eliminates the
requirement for synthesizing a complex chiral ligand in both enantiomeric forms. More often,
however, both enantiomers of the chiral ligand need to be obtained in order to synthesize two
optically pure products, as is the case for e.g. the Sharpless dihydroxylation (Figure 15b).79

Figure 15. a) Stereochemical outcome of Sharpless epoxidation as a function of DET chirality,78
and b) two enantiomers required to obtain (+)- and (-)-products in the Sharpless
dihydroxylation.79
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The number of catalytic systems with both enantiomeric forms of a ligand available,
however, is extremely limited, which calls for more innovative solutions to the problem. More
elegant means to control the configuration of the product as desired may be realized by
incorporating a structural/chemical switch into the ligand itself. This potential switch, for which
several sophisticated examples are discussed in this section, would fulfil the role of inverting
the chirality of the ligand. The inversion of this chirality in the ligand would consequentially
translate to the formation of products bearing the opposite configuration. Therefore, the
incorporation of a conformational switch into the chiral ligand is a particularly interesting
research goal that would yield an exceptionally elegant system for asymmetric synthesis,
addressing the important issues discussed in the beginning of this chapter.
The field of conformational switching is relatively new and involves both
macromolecular systems and small molecules.80 Conformational switches can be described as
molecular machinery that can undergo a conformational change in response to an external
stimulus. Such stimuli include pH changes, irradiation with light of certain energy, the addition
of specific ions to the system, or a chemical modification of the molecule on a remote
location.80–88 A practical example of an efficient molecular switch involves the cis- and transisomers of azobenzene . The trans-conformation of azobenzene is 10-12 kcal/mol more stable
than the cis conformation in the dark, shifting the equilibrium to >99.99% to the trans isomer.
Under the influence of light at 340 nm, however, a significant quantity of trans-azobenzene
converts to cis-azobenzene, causing a dramatic change in the spatial orientation of the two
aromatic rings.89 In a broader context, such a drastic change would also include the spatial
orientation of any functional groups R attached to the aromatic rings (Figure 16).
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Figure 16. Concept of a conformational switch induced by an external stimulus.89

Functional switches of this type have been extensively applied to drive structural
changes in peptides, proteins, nucleic acids, lipids, and carbohydrates.89
Another elegant example of a molecular switch is the pH-induced conformational
switching in aminocyclohexanols, as invented by Samoshin et al.81 In this case, the wellpredictable conformational behavior of cyclohexanes is exploited to tune whether substituents
are present in an axial or equatorial orientation on the cyclohexane ring as desired (Figure 17).

Figure 17. pH-induced conformational switch of aminocyclohexanols.81

At basic/neutral pH, the equilibrium favors the ester groups oriented in the equatorial
position due to their higher steric repulsion in the axial position comparison to the amine and
alcohol groups. Upon protonation of the basic amine moiety, a favorable hydrogen-bonding
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interaction exists between the protonated amine and the alcohol groups. This favorable
interaction is of sufficient magnitude to force the ester groups into a diaxial orientation despite
the steric repulsion between them, resulting in a shift of the equilibrium where the ester
groups now adopt a diaxial orientation. Subsequent deprotonation of the ammonium ion
results in a reversal of the equilibrium to its original state. Conformational switches of this sort
have been successfully applied in liposomal formulations using long alkyl-chain esters that
efficiently pack into a lipid bilayer in a diequatorial orientation. Then, upon protonation of the
amine, the ester tails are forced away from each other due to the conformational switch,
leading to disruption of the lipid bilayer and instant leakage of the liposomal content (Figure
18).83

Figure 18. Concept of triggered drug release using liposomal formulations containing
aminocyclohexanols facilitating a conformational switch upon protonation.83
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Such designs appear promising drug delivery systems for e.g. anticancer treatments due
to the fact that cancer cells typically produce a local acidic environment that could cause
liposomes of this sort to release a potential anticancer drug.81–83,90
A rather challenging type of conformational switching occurs by means of an actual
chemical modification of the molecule, and examples of such switches are relatively scarce.
Recent descriptions of this type of switch may even involve more than a single synthetic step to
facilitate the targeted conformational change.86,91,92 One example of interest involves a tetrasubstituted perhydroanthracene having two low-energy conformations (conceptually similar to
cyclohexanes) for which the possible interconversion is facilitated through chemical
modification.93 Initially, the molecule has one preferred conformation as a function of its four
substituents. Upon modification of these substituents, the other low-energy conformer
becomes favored and the switch is facilitated, as can be seen in the figure below.

Figure 19. Two low-energy conformations for a tetra-substituted perhydroanthracene. The
magnitudes of R1-R1 and R2-R2 steric repulsion dictate the conformational equilibrium.93

Berninger et al. realized the switch by synthesizing an optically pure
perhydroanthracene with hydroxyl groups for R1 and tert-butyldiphenylsiloxyl groups for R2.93
The initial conformation highly favored the bulky OTBDPS groups in the diequatorial position
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and, as a consequence, the hydroxyl groups in the diaxial position. However, conversion of the
diol into a diacetal and simultaneous removal of the TBDPS groups resulted in an inversion of
the conformational equilibrium towards the opposite conformer with R1 and R2 in the
diequatorial and diaxial conformations, respectively (Figure 20).

Figure 20. Two possible conformations for a tetra-substituted perhydroanthracene. The
equilibrium initially lies far to the left due to the bulky TBDPS group. Removal of the groups
and locking of the OH moieties results in an irreversible conformational switch.93

One potential issue with this design, however, is the possible acetalization of the
deprotected hydroxyl groups rather than the 1,2-diol originally present, due to the
simultaneous acetalization/deprotection. The conformation of the product is technically locked
after the reaction, however this example is still considered a switch due to the inversion of
diaxial to diequatorial and vice versa for the four substituents.
An elegant example of conformational switching where the axial chirality of the ligand
is inverted is based on a 5,6-dihydro-1,10-phenanthroline (dihyphen) scaffold (Figure 21a).94–98
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This class of molecules is comparable to 1,2-DACH-based scaffolds in the sense that both types
utilize basic nitrogen atoms for complexation. The nitrogen atoms in phenanthrolines,
however, are part of an aromatic system and are therefore both less nucleophilic and less basic.
From a structural perspective, phenanthrolines can exist as two low-energy conformers,
analogous to the two chair conformations in cyclohexanes, which are distinguishable from one
another through their helicity in terms of plus (P) and minus (M).

Figure 21. Two possible conformers of 5,6-dihydro-1,10-phenanthroline.95

As can be observed from Figure 21b, the helicity of the dihyphen dictates the axial
chirality of the molecule and, hence, the stereochemical outcome of a potential asymmetric
reaction. Without any energetic difference between the two conformations, in combination
with a low rotational barrier (5 kcal/mol),99 dihyphens will exist as an interconverting 50/50
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mixture of conformers. In order for dihyphens to exhibit any utility in asymmetric synthesis, it
is therefore necessary to stabilize only one of the two conformers (at a time), as can be
achieved through the introduction of substituents on the 5- and 6- positions. For example, the
introduction of a methyl group on the 5-position, as demonstrated by Chelucci et al., led to a
dihyphen that predominantly existed as its (P)-helical conformer (Figure 22).

Figure 22. Conformation equilibrium in (R)-5-methyl-5,6-dihydro-1,10-phenanthroline.100

With the proper modification of the 5- and 6-positions on the dihyphen, a certain
degree of control is gained over the axial chirality of the catalytic site. In perspective of
incorporating a conformational switch in the molecule, it is exactly this property that could be
exploited to facilitate an inversion in axial chirality. An elegant example of such a switch has
been invented Reichert, utilizing a 5,6-hydroxyl substituted scaffold.101 Although this is not a
dihyphen, the structure is of such similarity that it still serves as a useful illustration (Figure 23).

61

Figure 23. Switching of axial chirality as a function of the nature of the solvent. 101

As can be seen in the figure, the ligand prefers to orient the hydroxyl groups in a diaxial
position in methanol. In n-hexane, however, a stabilizing intramolecular hydrogen bond
between the 6-OH and the 7-OMe causes the ligand to adopt an inverted orientation resulting
in an accompanying inversion of the axial chirality with respect to the C1 and C10 containing
the two OMe groups.
In a similar fashion using dihyphens, the axial chirality could be inverted analogously,
albeit not entirely (Figure 24).98

Figure 24. Switching of axial chirality in 5,6-disubstituted dihyphens.98

Although numerous asymmetric reactions have been reported to work with dihyphens,
e.g. cyclopropanation and allylic substitution,94 current research that combines switching the
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axial chirality into the asymmetric system has not yet been reported. Compared to
cyclohexane-based chiral ligands, the 1,10-phenanthrolines are less widely used in asymmetric
synthesis, mainly due to their often complex synthetic pathways.95
Bringing the abovementioned conformational switches in perspective of cyclohexanebased ligands, a few generalizations can be made about the design of such a switch keeping
control over the reaction outcome in asymmetric synthesis in mind. The chemical switch
should only modify the chemical nature of the switch, or the trigger, itself, and not the nature
of the site facilitating the asymmetric reaction. Therefore, the chemical switch needs to be in a
remote location with respect to the catalytic site, as to not sterically or chemically
hinder/influence the asymmetric process. Moreover, the chemical switch needs to induce a
conformational change at the catalytic site that mirrors the chirality of the original ligand in
order to produce a product of the opposite configuration (Figure 25a). If these requirements
can be met, incorporating a chemical switch into a chiral ligand becomes a realizable goal. The
cyclohexane ring seems to be a particularly suitable scaffold for such a switch due to the
inversion of axial and equatorial oriented substituents throughout the ring as a function of
steric demands. This advantageous, well predictable property could be utilized to switch the
axial chirality of e.g. a cis-1,2-diamine moiety (Figure 25b), which would subsequently produce
a product of opposite chirality for the target asymmetric reaction. The design presented in this
figure is rather rudimentary and a more elaborate approach to the chemical switching concept
in a cis-1,2-diamine-based ligand will be discussed in chapter 3.7
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Figure 25. a) Inversion of axial chirality in the catalytic site of the ligand as a consequence of
a chemical switch and, b) Concept of the switchable chiral ligand, where a remote change in
interaction leads to interconversion between axially and equatorially oriented substituents.
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CHAPTER 2: RESEARCH GOALS

The goal of the research described in this dissertation encompasses the development of
a novel type of chiral ligand for asymmetric synthesis based on a 1,2-cis-diamine scaffold. After
a successful proof-of-concept in terms of inducing asymmetry in one or more synthetic
reactions, a pioneering effort will be pursued to incorporate a structural switch into the cisdiamine ligand, capable of inverting the chirality of the ligand itself. Moreover, the ligand will
be evaluated for its potential as a cisplatin-type anticancer drug. This comprehensive project
can be broken down into the following specific research aims:

1. Design and synthesis of a 1,2-cis-diamine scaffold in such a fashion that it allows for
convenient further derivatization.
2. Development of a straightforward methodology to separate the ligand enantiomers at a
strategic position in the synthesis.
3. Elucidation of the absolute configuration of the chiral ligands.
4. Synthesis of a diverse library of ligands based on the same general scaffold.
5. Evaluation of the ligands in asymmetric synthesis and studying the differences in
capability to induce selectivity in the reaction as a function of ligand variation.
6. Devise a methodology for incorporating a chemical switch into the ligand design.
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CHAPTER 3: RESULTS & DISCUSSION

The most important component of the suggested chiral ligand is the 1,2-diamine core,
responsible for complexing the metal catalyst involved in the asymmetric reaction. Based on
the literature examples in Chapter 1, it appears quite evident that cis-oriented diamines are
greatly underrepresented in terms of applications in asymmetric synthesis. This specific finding
made it interesting for us to explore exactly this niche in the field. In terms of inducing
asymmetry into a catalytic system, we either had the possibility to develop a ligand that is
chemically non-symmetrical in itself, or to design a chemically symmetrical ligand in which the
spatial orientation exclusively is responsible for inducing asymmetry. Advantages of pursuing
the latter approach include the possibility to design a convenient synthetic approach to the
chiral scaffold without the need for complex synthetic steps that require a significant amount of
fine-tuning, for example, using the approach presented in (Scheme 3, Chapter 1.2). Particularly,
in perspective of the vast amount of chiral ligands currently available, a convenient,
straightforward synthesis is much desired in order to generate a useful catalytic system. For
this reason, we believe developing a symmetrical scaffold, with a convenient synthetic strategy
for further (symmetrical) derivatization, is the best way to proceed. Accompanying this
approach is the requirement to develop the ligand such that a conformational asymmetry
exists, and with that, a concise control over the conformation of the ligand. The importance of
this conformational control is additionally reflected in the high number of possible orientations
a potential ligand can adapt in combination with the metal catalyst, as briefly discussed in
Chapter 1.1 (see Figure 3 for examples).
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If our design appears successful in inducing asymmetry into reactions of interest, the
ligand can be further developed to incorporate a structural switch, capable of inverting the
chirality of the ligand. Such a switch should be spatially removed from the catalytic site, as to
prevent any steric influence on the catalytic system.
3.1 Design of the 1,2-cis-Cyclohexanediamine Scaffold and Retrosynthetic Analysis
Considering the requirements stated above, utilization of a cis-diaminocyclohexanebased scaffold (cis-DACH scaffold) proves to be a sensible choice. The conformational
constraints and predictability of cyclohexane derivatives efficiently addresses the required 3D
spatial control over the ligand. Equipping the cyclohexane ring with a primary cis-1,2-diamine
moiety subsequently allows for derivatization to secondary amines applying the reductive
amination methodology as presented in Scheme 1 of Chapter 1.2. Asymmetry in this type of
ligand will be induced through the axial-equatorial orientation of the cis-diamino groups, i.e.
through the axial chirality (twist) of the cis-1,2-diamine moiety. Obviously a cis-1,2-DACH
scaffold as such will not be sufficient for conformational control in the ligand due to the existing
interconversion from one of the lowest-energy chair conformations to the other of equal
energy. It is essential to eliminate this interconversion between chair conformations due to the
fact that the change is accompanied by a change in axial chirality to the opposite sign (Figure
26) for the catalytic center, which will yield a product of the opposite sign correspondingly,
cancelling out any induced asymmetry.
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Figure 26. Interconversion from one low-energy chair conformation to the equivalent other
chair conformation leads to inversion of axial chirality of the cis-diamine moiety.

To efficiently control the chair-chair interconversion between the two equally stable
conformers, a conformational lock will have to be put in place that fixes the cyclohexane
conformation into one of two possible orientations, locking in the two amino moieties in one
single axial-equatorial orientation bearing a specific axial chirality. To this purpose, we
designed the cis-DACH ligand as shown in Figure 27 below. The dioxane moiety, located away
from the catalytic site, is present in a diequatorial orientation and (theoretical) interconversion
to the other chair conformation would result in a diaxially oriented ring that is far too strained
too exist, effectively eliminating the chair-chair interconversion (Figure 27).

Figure 27. Attaching a dioxane moiety to the diamine scaffold eliminates the possibility for a
chair-chair interconversion, yielding a single conformer for each possible configuration.
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Other options to prevent chair-chair interconversions exist, e.g. by placing a t-butyl
group on either the 4- or 5-position of the ring. However, this huge group is likely to sterically
interfere with any asymmetric reactions, which makes it impossible to induce asymmetry
through the axial chirality of the ligand alone. For this reason, the trans-fused-ring structure
provides to be an elegant solution to the problem due to its inherent symmetry as part of the
molecule. Moreover, introducing substituents on this end of the molecule provides a prospect
for more flexible conformational control in future models.
From a retrosynthetic perspective, obtaining structures as shown in Figure 27 above can
be realized through a series of relatively straightforward chemical modifications. It is evident
that derivatization of the 1° diamines to 2° diamines should be the final step, making the 1°
diamine scaffold an ideal first synthetic target. Obtaining the two amines in a cis-orientation
can be realized through the reduction of cis-diazides, which in turn can be obtained through the
nucleophilic substitution of a good leaving group oriented trans to an already present azide
moiety, fixing the desired stereochemistry. Starting from an olefinic moiety seems to be a
suitable way of realizing this. Introduction of this functionality should be preceded by the
conformational locking of the ring in order to maintain a specific conformational orientation of
all substituents attached to the cyclohexane ring. For the conformational lock, a similar
approach can be undertaken through intermolecular ring-closure, preceded by introduction of
the proper carbon skeleton through nucleophilic epoxide-ring opening. Based on this analysis,
1,4-cyclohexadiene seems to be an ideal starting point for this route, with convenient, readily
available reagents to realize the synthesis of the cis-1,2-diamine scaffold (Figure 28).
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Figure 28. Retrosynthetic analysis for the synthesis of the cis-DACH scaffold and derivatives.
FGI = Functional Group Interconversion.

In this specific design, separation of the enantiomers of the cis-DACH ligand has not yet
been incorporated. Due to the complexity of such a process, however, the entire chapter 3.3
will be devoted to various ways of achieving this goal. Prior to this, the synthesis of the racemic
ligand will be described, which is the topic of the next section.
3.2 Synthesis of Racemic Ligand
Using the retrosynthetic analysis from the previous chapter as a starting point,
commercially available 1,4-cyclohexadiene 1 was epoxidized with the use of mCPBA to initially
obtain mono-epoxide 2 in a 50% yield (Scheme 9), by following a literature procedure.102
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Scheme 9. Synthesis of mono-epoxide 2 and its bis-epoxide byproducts.

The relatively disappointing yield for this first step, as a consequence of the significant
formation of bis-epoxides 2a and 2b, motivated us to perform an optimization experiment
varying the reaction temperature and the equivalents of mCPBA used. Using gas
chromatography, we monitored the reaction outcome as a function of the mentioned variables
leading to the following result:
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Figure 29. Relative quantities formed as a function of molar mCPBA equivalents at 0°C and 24°C
after 18 hours, green = mono-epoxide 2, red = bis-epoxide 2a, orange = bis-epoxide 2b, blue =
1,4-cyclohexadiene 1.

Based on these data, it appeared that the use of 1.1-1.2 molar equivalents of mCBPA led
to an optimal composition in favor of mono-epoxide 2. The reaction temperature proved to be
an insignificant factor in terms of the reaction outcome. Using the optimal conditions, an
experiment at -78°C was conducted, which surprisingly led to the same composition of the final
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product. For the mono-epoxide 2, the optimal conditions were set to 1.1 equivalents of mCPBA
leading to yield increase from 50 to 70% after vacuum distillation for the pure compound. The
residue consisted of crude bis-epoxides 2a and 2b, in a 43:57 ratio favoring the cis isomer, in
agreement with the literature.103 The slight preference for the cis-isomer can possibly be
explained by a hydrogen-bonding-directing effect between mCPBA and the epoxide oxygen.
With mono-epoxide 2 in hand, the next step involved the opening of the oxirane ring by
nucleophilic addition using 2-chloroethanol, which contained the necessary –O-CH2-CH2connectivity for construction of the dioxane conformational lock. In a first attempt, we
performed the ring-opening based on a literature procedure, in the presence of 0.5 molar
equivalents of ytterbium(III)triflate functioning as a Lewis acid.96

Scheme 10. Cleavage of epoxide 2 with 2-chloroethanol, in the presence of Yb(III)OTf.

By utilizing 2-chloroethanol in a dual role, both as reagent and solvent, we effectively
minimized the formation of dimers and hard-to-control byproducts in the cleavage of epoxides
under Lewis-acidic conditions (see chapter 3.7, Figure 54). In contrast to the literature
conditions (24-48h reactions at 60-80°C), we observed a rapid consumption of the starting
material at ambient temperature within 75 minutes, leading to an 86% yield after
chromatography. The high observed reactivity prompted us to reduce the equivalents of the
Lewis acid from 0.5 to 0.005 which could be done without sacrificing either purity or yield.

73
Next, heterobicyclic compound rac-4 was synthesized by deprotonation of the 2°
hydroxyl group of rac-3 with sodium hydride, consequently substituting the chlorine atom on
the chloroethoxy moiety to complete the ring-closure (Scheme 11). Initially, the reaction was
performed at room temperature, leading to long reaction times of 120h before full
consumption of the starting material was observed. Increasing the reaction temperature to
65°C, and adding up to a full equivalent of sodium iodide to the mixture, resulted in a reduction
of the reaction time to 22h. Due to the volatility of the resulting ether rac-4, it was chosen to
generate epoxide rac-5 directly from the crude material after filtration of solid salts and careful
evaporation of the solvent, in identical fashion to how epoxide 2 was synthesized (Scheme 11).
Using the same arguments of volatility, crude rac-5 was immediately subjected to nucleophilic
cleavage with sodium azide,104 yielding the non-volatile trans azido alcohol rac-6 (Scheme 11).

Scheme 11. Synthesis of trans azido alcohol rac-6 through ring-closure of rac-3 , epoxidation of
crude rac-4, and subsequent cleavage of crude epoxide rac-5.
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Starting from rac-3, the pure azido alcohol rac-6 could be obtained in an 80% over three
synthetic steps, with only the azido alcohol subjected to column chromatography, resulting in
an efficient synthetic pathway to this intermediate.
Theoretically, the cleavage of rac-5 with sodium azide can lead to four different
configurations as both oxirane carbon atoms are susceptible to nucleophilic attack. However,
due to the general preferred trans-diaxial regioselective ring-opening of epoxides,105,106 only
the enantiomers of rac-6 are formed via a chair-conformation transition state (Figure 30). The
other (theoretical) products are not observed as they would be formed via a strained transition
state with a twist conformation.

Figure 30. Stereochemical fate of rac-6 configuration as a consequence of regioselectivity in
epoxide-ring opening.

In order to confirm that we obtained rac-6 in the expected configuration, and the
conformational lock does not allow for a chair transition to orient the azide and alcohol
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moieties in equatorial positions, we analyzed the coupling constants of the relevant protons in
the NMR spectrum (Figure 31).

W = 18.3 Hz

W = 16.0 Hz

W = 36.1 Hz

H8ax

H7

H6

H8a

H4a

Figure 31. NMR spectrum of rac-6 between 4.04 and 3.41 ppm in CDCl3 (600 MHz). The insert
on the right reveals the characteristic splitting pattern of proton H8 ax (1.78-1.73 ppm).

As can be seen from the figure, H6 and H7 have similar coupling widths (W, the sum of
all individual J-couplings) and exclusively share small coupling constants (J = 3.0-3.6 Hz) with
neighboring protons including each other, owing to their equatorial orientation. If either one of
these hydrogen atoms would be oriented axially, they would exhibit a large diaxial coupling to
the axial protons on either C5 or C8. The identity of H7 was confirmed through a 1H-13C HMQC
experiment combined with a 1H-1H COSY experiment. In the COSY spectrum H7 coupled to
H8ax, which has shown a very characteristic splitting pattern throughout the synthesis (see
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insert on the right in Figure 31). Proton 6 shows some additional coupling compared to H7
which may be attributed to a small interaction with the hydroxyl proton on C6. From this
analysis we could confirm that H6 and H7 were positioned in the necessary trans-diequatorial
orientation and assign their proton signals to the corresponding azide- and alcohol-bearing
carbon atoms. The current assignment was further corroborated during the next two steps of
the synthesis.
The next step in obtaining the cis-DACH scaffold involved the introduction of the second
azide moiety, which can be obtained in a cis-orientation with regards to the first one by
transforming the rac-6 hydroxyl group into a good leaving group through tosylation, followed
by nucleophilic substitution. Adapting from a standard synthetic protocol,107 the tosylate rac-7
was obtained through reaction of rac-6 with tosyl chloride as can be seen in Scheme 12.

Scheme 12. Tosylation reaction of rac-6.

Due to the severe steric demands, caused by the fact that free hydroxyl group is
positioned in an axial orientation on the cyclohexane ring, a total of 7.5 equivalents of tosyl
chloride were used in order to facilitate the reaction within 70 hours at 40°C. This led to the
isolation of the pure tosylate rac-7 after chromatography in a 92% yield. The NMR spectrum
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revealed a large downfield shift of H6 to 4.55 ppm, while H7 experienced a minor upfield shift
from 4.04 to 3.92 ppm, supporting the previously made assignment.
Subsequent synthesis of the diazide by nucleophilic substitution was initially performed
in DMSO at room temperature, using 5 equivalents of sodium azide. Unfortunately, this did not
lead to any significant product formation which moved us to apply harsher conditions to force a
more favorable outcome. To this extent, using 14 equivalents of sodium azide at 65°C resulted
in an isolated yield of 50% of the product after 87 hours of stirring. To further improve the yield
for this reaction, we evaluated alternative conditions by heating rac-7 in DMF for 15 hours with
only 2 equivalents of sodium azide,108 which led to an increased 84% yield of the pure diazide
rac-8 after chromatography.

Scheme 13. Comparative approach to the synthesis of rac-8 through two different conditions.

Based on the results shown in Scheme 13, switching to DMF revealed to be a major
improvement with regards to product yield. Although the reaction in DMSO had not been
carried out at 100°C, the efficiency of the DMF method proved adequate for use in the
synthetic route. A relatively small amount of elimination product was also found in the
mixture, which is a direct and inevitable consequence of using high temperatures for the
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reaction in the presence of the azide ion which, aside from being a good nucleophile, is also
quite basic.104
At this stage of the synthesis it made sense to confirm obtaining the product 8 in the
proper stereochemistry as was done for rac-6. For this reason, we observed the relevant
signals in the proton spectrum of the purified diazide rac-8, which are displayed in Figure 32
below.

W = 22.8 Hz

W = 30.0 Hz

W = 48.0 Hz
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Figure 32. NMR spectrum of rac-8 from 4.1 to 1.8 ppm in CDCl3 (600 MHz). W = coupling width
(the sum of all individual J-couplings).

The relative orientation of rac-8 can be deduced by observing the magnitude of the Jcoupling for H5ax, H6, and H7. In the image above, it can be seen that H7 only experiences
small coupling constants of approximately 4 Hz (J6-7 ≈ J7-8ax ≈ J7-8eq ≈ 4 Hz), which is to be
expected for an equatorially oriented proton. In contrast, H6 exhibits two small coupling
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constants (J6-7 ≈ J5eq-6 ≈ 4 Hz), and one large coupling constant (J5ax-6 = 12.4 Hz). The latter
coupling constant can only arise from splitting by an adjacent axial proton, allowing for a large
diaxial coupling. This coupling comes from proton H5ax, which is unique in this spectrum due to
the fact that it exclusively experiences large coupling constants (J5ax-6 = J5ax-5eq = J5ax-4a = 12.4
Hz) due to the two vicinal diaxial interactions and one geminal coupling. This type of signal can
only exist if proton H6 is positioned in the axial orientation as shown in Figure 32 above. A 1H1H

COSY experiment corroborated the deduced assignment, which justified our conclusion that

the diazide rac-8 was retrieved in the desired stereochemistry.
The final step in the synthesis of the 1° diamine scaffold concerned the reduction of the
diazide to the diamine. For this step, we applied both a Staudinger reduction and
hydrogenation reaction and evaluated their practical applicability side by side:

Scheme 14. Reduction of diazide rac-8 to cis-DACH scaffold rac-9 through two different routes.

Even though either method provided the target product, the Staudinger reduction gave
a near quantitative yield, making it the method of choice. The hydrogenation reaction suffered
from incomplete hydrogenation byproducts, which may be a consequence of the practical
limitation that the reaction could not be performed under pressure restricting the availability of
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H2 to the substrate to its natural diffusion between the gas and liquid phases of the reaction
vessel at ambient pressure.
Summarizing, a convenient synthetic route to the cis-DACH ligand rac-9 has been
developed through a series of (mostly) conventional synthetic steps. Regarding the overall
efficiency, the first step is the lowest-yielding in the entire synthesis (70%). Yet, the starting
reagents are relatively inexpensive, so a loss in the early stages of the synthesis can be
reasonably justified. For this 8-step synthesis (Scheme 15), the overall yield adds up to 35%.

Scheme 15. Synthetic route to cis-DACH ligand rac-9, starting from 1,4-cyclohexadiene. i)
mCPBA, DCM, rt, 12h, 70%; ii) 2-ClEtOH, Yb(III)OTf, rt, 18h, 84%; iii) NaH, NaI, THF, 65°C, 22h;
iv) mCPBA, DCM, rt, 12h; v) NaN3, H2O, 30°C, 80% from iii) to v); vi) TsCl, pyridine, CHCl3, 40°C,
70h, 92%; vii) NaN3, DMF, 100°C, 15h, 84%; viii) PPh3, H2O, THF, 50°C, 22h, 95%.
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3.3 Resolution of Chiral Intermediates
One of the key steps in this research is to obtain the chiral cis-DACH ligand in an
enantiopure form. Potential methods to separate enantiomers include the chemical
derivatization into diastereomers followed by chromatographic separation, the formation of
diastereomeric salts in combination with selective crystallization (Scheme 4),45 and enzymatic
resolution where the enzyme ideally recognizes only one enantiomer as a substrate, modifying
this substrate into an entirely different chemical entity.109–113 In order to make a proper
decision on what methodology to pursue, we identified potential intermediates in the synthesis
(Scheme 15 above) that could be subjected to one or more of the abovementioned
manipulations. From this analysis, we identified three suitable compounds:

Figure 33. Three possible substrates for chemical derivatization, diastereomeric salt formation,
and/or enzymatic resolution

Both rac-3 and rac-6 appear well suitable for chemical derivatization as the hydroxyl
groups allow for both esterification into diastereomeric esters with chiral acids, and subsequent
hydrolysis of the separated diastereomers into the original enantiomers. Note that this
chemical derivatization additionally expands the possibilities for enzymatic resolution, as will be
discussed in Chapter 3.3.2. In terms of forming diastereomeric salts, rac-9 demonstrates to be
the ideal candidate due to the diamine moiety, and its similarity to trans-1,2-
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diaminocyclohexane, for which separation through selective crystallization using chiral acids
has been widely studied.45 The major disadvantage of pursuing the latter approach, however,
arises from the fact that this is the final product, the cis-DACH scaffold itself. Establishing the
proper conditions for selective crystallization may prove to be a cumbersome process for which
a significant amount of material is required. Additionally, the possibility exists that only one
enantiomer can be obtained in (close to) pure form, which means that (more than) 50% of the
compound may be lost. Due to these potential risks, we chose not to pursue this pathway, and
explore the chemical derivatization and enzymatic resolution methodologies for intermediates
rac-3 and rac-6, which are described in the next two chapters.
3.3.1 Chemical Resolution of Synthetic Intermediates rac-3 and rac-6
Finding the proper conditions and derivatives to facilitate a separation of enantiomers
through their diastereomeric equivalents can be a daunting and time-consuming task. In order
to address this issue efficiently, and develop a suitable method for separating the enantiomers
of either rac-3 or rac-6, we chose to set up a screening experiment that would allow us to
answer the question “are these diastereomers separable with column chromatography?” With
this initial goal in mind we selected a total of six different chiral acids for the esterification of
rac-3 and rac-6 into diastereomers (Table 4), of which five were commercially available and
only (1R,2S,5R)-(-)-mentholacetic acid 10 had to be synthesized following a literature
procedure.114 This chiral acid 10 could be obtained through a reaction between (-)-menthol and
2-chloroacetic acid in the presence of sodium hydride as shown in the scheme below:
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Scheme 16. Synthesis of chiral acid 10 from (-)-menthol and chloroacetic acid.114

Following this straightforward coupling reaction, chiral acid 10 could be obtained in a
63% yield after purification.
Next, rac-3 and rac-6 were transformed into esters utilizing DCC and DMAP to generate
a total of twelve chemically diverse sets of diastereomers following a standard coupling
protocol, as is shown in the next table:
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Table 4
Synthetic Library of Diastereomeric Ester Derivatives with Identical rac3 and rac-6 Backbones

11a

12a

11b

12b

11c

12c

11d

12d

11e

12e

11f

12f
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To rapidly confirm the proper formation of each of the chiral diastereomeric esters 11af and 12a-f, all compound masses were analyzed through accurate mass on a time-of-flight
mass spectrometer. The confirmation of product formation is justified due to the generic type
of esterification reaction carried out and eliminates the need for a time-consuming work-up of
twelve different compounds. The accurate masses for all compounds are listed in Table 5.

Table 5
Calculated Exact Mass and Measured Accurate Mass for Esters of Type 11 and 12.
Ester
Exact mass
Accurate mass
Ester
Exact mass
Accurate mass
+
+
+
11
[M+H]
[M+H]
12
[M+H]
[M+H]+
a
357.1469
357.1540
a
380.1822
380.1831
b
309.1257
309.1291
b
332.1610
332.1680
c
365.1883
365.1893
c
388.2236
388.2377
d
325.1207
325.1283
d
348.1559
348.1616
e
353.1156
353.1202
e
376.1509
376.1595
f
373.2146
Not observed
f
396.2498
Not observed

Looking at all synthesized products, the accurate mass for the protonated molecules of
11f and 12f could not be identified, and were assumed to not have formed. For the eleven
remaining compounds, diastereomeric esters 11b and 11c both revealed two separate spots on
TLC after eluting the entire set of esters with various solvent mixtures on both silica and
aluminum oxide. This lower number of separable diastereomers further emphasizes the need
for a rapid initial screening of diastereomeric esters. From here on, it was chosen to further
develop the chemical resolution through derivatization to diastereomeric esters 11c, based on
the (S)-(+)-ibuprofen chiral acid. Two reasons for choosing 11c over 11b are the cost difference
of the chiral acid starting materials, and a seemingly better separation of diastereomers 11c.
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In order to properly monitor and optimize the separation efficiency, the diastereomeric
esters 11c synthesized during the first screening were analyzed using NMR spectroscopy after a
first (crude) separation on silica. From here onwards, a distinction will be made between the
(1R,6R)- and (1S,6S)-configuration of the cyclohexane-part of the molecules. The assignment of
the absolute configuration of the molecules is the subject of chapter 3.4, yet for convenience,
the result of this assignment has already been incorporated into the following discussion.
Figure 34 depicts an NMR-spectrum overlay of three different samples, each
representing the doublet of the chiral methyl group in the ibuprofen moiety, obtained through
a separation using column chromatography. The red doublet represents (S)-(1R,6R)-11c, the
major green doublet represents (S)-(1S,6S)-11c, the set of blue doublets represents a mixture
of the two diastereomers, mostly consisting of (S)-(1R,6R)-11c. Notably, a second doublet is
observed in the green spectrum that shows no overlap with either of the two diastereomers.
This doublet corresponds to compound 13, which was confirmed by synthesizing 13 from 2chloroethanol and (S)-(+)-ibuprofen. This compound is the product of the coupling reaction
between residual 2-chloroethanol from the synthesis of rac-3 and (S)-(+)-ibuprofen. Product 13
appeared to co-elute with (S)-(1S,6S)-11c, making the resolution more challenging.
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Figure 34. Overlay of three NMR spectra corresponding to the chiral CH3 in (S)-(1S,6S)-11c
(green doublet), (S)-(1R,6R)-11c (red doublet), a mixture of the two diastereomers (blue
signals). The green spectrum additionally reveals the presence of compound 13.

Overall, NMR spectroscopy can provide a good indication with regards to separation
efficiency, but is not nearly as quantitative as required to claim a certain diastereomeric excess.
For this reason, chiral HPLC was additionally utilized to establish the % d.e. after
chromatography during the optimization process. Additionally, following the optimization
process using chiral HPLC addresses a potential risk of racemization when using chiral acids or
esters of the type 11c.95 Enolization at the α-carbon may cause racemization of the chiral

88
center, which would lead to “mixing” of the enantiomeric parts of the molecules, and hence, a
lower enantiomeric excess after hydrolysis of the diastereomers (Figure 35).

Figure 35. Stereochemical consequences as a result of racemization.

As can be seen in the figure, the racemization of (S)-(1S,6S)-11c would result in the
formation of (R)-(1S,6S)-11c, the enantiomer of (S)-(1R,6R)-11c, and vice versa. This would lead
to co-elution of the enantiomers during chromatography and could significantly affect the %
e.e. of the hydrolyzed products. For this reason, an optimization experiment to minimize
racemization was conducted (Table 6). Additionally, to prevent compound 13 from interfering
with the analysis, it was chosen to first purify rac-3 to a higher degree through vacuum
distillation (60% yield) for this specific purpose.
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Table 6
Effect of Reaction Time, Stoichiometry, and Workup on enantiomeric excess for (S)-(1S,6S)11c.

Entry
1
2
3
4
5
6

Reaction
time (h)
0.5
1.5
1.5
3
3
6

Acid
eq.
2.4
1.2
1.2
1.2
1.2
1.2

DCC
eq.
3.0
1.5
1.5
1.5
1.5
1.5

DMAP
eq.
0.30
0.15
0.15
0.15
0.15
0.15

Premix
acid/DCC
No
No
Yes
No
Yes
No

Basic
workup
Yes
Yes
No
Yes
Yes
Yes

e.e (S)-(1R,6R)11c (%)
95
93
94
90
93
91

Entry 1 reveals the highest % e.e. for the reaction. Extended reaction times lead to
more racemization at the α-carbon of the ibuprofen moiety as can be seen through entries 4
and 6, although entry 5 seems to suffer from less racemization than 4, even though their
reaction times are identical. Premixing of the acid and DCC may offer an additional advantage
in terms of minimizing racemization. Elimination of the basic workup as was done for entry 3
induces a small increase in enantiomeric excess as well. Based on these findings, it was chosen
to proceed with the chiral resolution, combining the reaction times and equivalents used for
entry 1 with the exclusion of a basic work-up as was done for entry 3. Under these conditions,
(S)-(1S,6S)-11c and (S)-(1R,6R)-11c were synthesized and separated on silica to give yields of
40% and 47%, respectively. Subsequent HPLC analysis of the isolated compounds revealed a
>99% d.e. for (S)-(1S,6S)-11c and a 91% d.e. for (S)-(1R,6R)-11c. Chiral HPLC revealed a 96%
e.e. for (S)-(1S,6S)-11c. Unfortunately, (S)-(1R,6R)-11c could not be baseline-resolved from its

90
enantiomer on chiral HPLC, requiring an alternative method for determining the enantiomeric
excess, which will be discussed shortly.
A small set of conditions were tested in order to obtain enantiomerically pure/enriched
3 with high yields from the separated diastereomers 11c. The results of this experiment are
presented in Table 7 below:

Table 7
Optimization of Reaction Conditions to Obtain Compound 3, 72 Hour Reaction.

Entry
1
2
3
4
5
6
7

Solvent
MeOH
EtOH
MeOH
EtOH
MeOH
MeOH
H2O

Catalyst
H2SO4
H2SO4
H2SO4
H2SO4
H2SO4
NaOH
NaOH

Catalyst eq.
0.5
0.5
1.0
1.0
2.0
1.3
1.3

Temperature (°C)
24
24
60
75
60
60
60

Yield (%)
0%
0%
94%
49%
75%
0%
0%

Due to the possibility for side reactions taking place, the conditions were initially set
very mild (entries 1 and 2). This, however, did not result in any significant product formation,
which may be attributed to the steric environment of the electrophilic carbonyl carbon. Raising
the temperature and increasing the equivalents of sulfuric acid drastically increased the yield
for entries 3-5, with the methanolysis under the conditions stated in entry 3 yielding an
excellent 94% yield for the isolated (1S,6S)-3 after chromatography. Using too much sulfuric
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acid adversely affected the yield as can be seen for entry 5. It is also worth mentioning that no
reaction took place using a basic catalyst, even at elevated temperature (entries 6 and 7). In
order to establish the % e.e. for the optically enriched (1S,6S)-3 and (1R,6R)-3 with good
accuracy, we chose to synthesize diastereomeric carbamate derivatives as both optically pure
cyanates and carbamates suffer no racemization at the chiral center. After screening a few
different compounds, the chiral (R)-α-methylbenzyl isocyanate resulted in baseline resolution
of the corresponding carbamate 14 on chiral HPLC (Scheme 17). By first synthesizing the
carbamate 14 from rac-3 and analyzing the product, a 50:50 ratio between the two
diastereomers was observed, revealing a proportionate 50:50 UV-response that justifies
determining the ratio between the derivatized products directly from this response. The
synthesis for the optically pure/enriched compounds 3 was conducted according to Scheme 17
below and subsequent analysis by chiral HPLC yielded the enantiomeric excess for both
enantiomers 3 as is shown in Table 8.

Scheme 17. Derivatization of both enantiomers 3 to diastereomeric carbamates for
determination of enantiomeric excess.
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Table 8
Optical purity for enantiomers 3 determined by chiral
resolution of their carbamates 14.
Compound (1S,6S)-3 (%) (1R,6R)-3 (%)
e.e. (%)
(1S,6S)-3
98
2
96
(1R,6R)-3
10
90
80

Overall, a robust chemical separation method was developed for the chiral resolution of
rac-3 into its corresponding enantiomers. In particular, (1S,6S)-3 could be obtained in good
enantiomeric excess, while (1R,6R)-3 was highly enantioenriched, yet of a lesser quality. An
efficient synthesis of the diastereomers 11c in combination with a near quantitative
methanolysis after separation, resulted in an overall yield of 38% and 44% for (1S,6S)-and
(1R,6R)-3, respectively, and an 82% yield overall (Scheme 18).

Scheme 18. Chemical resolution of rac-3, i) DCC, DMAP, DCM, 1.5h, RT, 40% (S)-(1S,6S)-11c,
47% (S)-(1R,6R)-11c after separation; ii) Sulfuric acid, MeOH, 60°C, 72h, 94%.
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Further research into this chemical resolution could be performed by evaluating the
potential of diastereomeric ester derivative 11b, which also appeared separable on column
chromatography. Perhaps the separation of this ester can lead to a higher diastereomeric and
enantiomeric excess for the second enantiomer, which would be a major improvement over the
enantiopurity of (1R,1S)-3 obtained through the use (S)-(+)-ibuprofen as the chiral acid.
Alternatively, additional research into the chromatographic separation of diastereomers 11c
may also be sufficient in achieving this goal.
3.3.2 Enzymatic Resolution of Synthetic Intermediates rac-3 and rac-6
Although the chemical resolution of rac-3 appears fruitful, several drawbacks exist for
this method, e.g. the relatively low %e.e. for (1R,6R)-3. This motivated us to investigate a
potentially more elegant methodology to obtain the desired compound in an enantiopure form,
by employing nature’s own machinery. In recent history, enzymes have been frequently
employed for the chiral resolution of a wide range of substrates, with high selectivity and
yield.111,115–123 Interestingly enough, acetic- and butyric ester derivatives of six-membered ring
substrates, possessing the same azido alcohol functionality as rac-6 have been extensively used
for this purpose.110–113,118 The general idea behind this enzymatic approach is that only one of
two enantiomeric azido esters is recognized by the enzyme and hydrolyzed to the
corresponding alcohol of the type 6. Owing to the large difference in polarity between the
product alcohol and starting ester, a facile chromatographic separation will allow for the
isolation of both optically pure compounds. Subsequent methanolysis of the optically pure
starting ester results in obtaining both enantiomerically pure alcohols. This entire process is
conceptually visualized in Figure 36 below.
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Figure 36. Schematic process for enzymatic resolution of azido alcohols.110

After separating the optically pure (R,R)-alcohol from the enantiomerically enriched
ester, a second treatment of the ester with enzyme can remove residual (R,R)-compound, after
which the optically pure (S,S)-alcohol can be obtained through hydrolysis.110
Owing to its similarity to the substrates described above, azido alcohol rac-6 seems a
probable candidate for chiral resolution through enzymatic hydrolysis. Obviously, the dioxane
moiety is significantly different from a simple cyclohexane backbone, yet, studies suggest that
some enzymes still accommodate larger structures containing the azido ester recognition
site.124 Based on these considerations, the idea that esters generated from rac-6 can be
selectively hydrolyzed seems rational. Additionally, we were interested in investigating
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whether the ester derivatives of chloroethoxy alcohol rac-3 could be utilized as substrates for
chiral resolution due to the similarity of its overall structure, bearing a 2-chloroethoxy group
instead of an azide. Clearly, these two moieties are hardly isoelectronic, but it is reasonable to
assume that the hydrolyzable part of the molecule will still be recognized by the enzyme with a
certain degree of selectivity. One major economic advantage of resolving rac-3 over azido
alcohol rac-6 arises from the fact that it is encountered earlier in the synthetic route. In the
scenario where only one enantiomer can be obtained in good enantiomeric excess, this would
limit the impact of losing the other enantiomer.
A systematic study was devised to evaluate the potential of a range of enzymes for
selectivity with regards to the ester derivatives of rac-3 and rac-6. Prior to commencing the
study, enzyme substrates rac-15 and rac-16 were obtained by reacting the corresponding
alcohols with butyric anhydride under standard coupling conditions (Scheme 19). We chose the
synthesis of the butyrate esters due to their reported success with the resolution of
azidocyclohexanol and comparable structures.110,118,124 The yields for rac-15 and rac-16 were
75% and 84%, respectively.

Scheme 19. Synthesis of racemic ester derivatives for the enzyme screening.
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Our initial goal was to perform a screening of the available enzymes for substrate
recognition (Table 9). Adapting from a literature procedure,109 we mixed our substrates with
each of the enzymes in a sodium phosphate buffer, followed by stirring for 72 hours at ambient
temperature. From this experiment, we excluded all enzymes that either showed no activity for
the substrate, or consumed the substrate entirely (indicating a non-selective process). The
product alcohols were isolated for the enzymes that did show activity. Enzymes producing an
insignificant amount of product were additionally excluded at this stage. For all other enzymes,
the enantiomeric excess was estimated using Eu(hfc)3 as a chiral shift reagent in combination
with 1H-NMR spectroscopy (products of type 6), or determined through polarimetry (products
of type 3, no signal separation was observed using Eu(hfc)3 with NMR spectroscopy). The
enantiomeric excesses for the azido alcohol 6 are largely indicative due to the fact that baseline
resolution could not be achieved using the lanthanide shift reagent (Figure 37).
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Table 9
Selectivity Screening of Various Enzymes for Ester Derivatives rac-15 and rac-16

Enzymea

Microorganism

R = OCH2CH2Cl
(rac-15)

R = N3
(rac-16)

L1
L2
L3
L4
L5
L6
L7
E1
E2

Burkholderia sp.
Burkholderia sp.
Pseudonomas sp.
Candida sp.
Rhizopus sp.
Aspergillus sp.
Aspergillus sp.
E.coli
E.coli

Active
Active
Inactive
Non-selective
Active
Active
Active
Inactive
Non-selective

Active
Active
Inactive
Non-selective
Active
Inactive
Non-selective
Inactive
Non-selective

e.e.
(1R,6R)-3
from rac 15
(%)b
75
52
N/A
N/A
90
81
76
N/A
N/A

e.e.
(6R,7R)-6
from rac-16
(%)b
34
79
N/A
N/A
50
N/A
N/A
N/A
N/A

a L=lipase, E=Esterase.
b Optical rotation correlated to absolute configuration through X-ray data of (4aS,6S,7S,8aS)-7 (Chapter 3.4).

Figure 37. NMR-spectral overlay of rac-6 (red) and enantioenriched (6R,7R)-6 obtained through
hydrolysis with enzyme L2 (green) with the addition of 10 mol% Eu(hfc)3. Signals correspond to
the circled proton of the enantiomers of compound 6.
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In Figure 37 above, the signals for H6 appear as singlets due to peak broadening as a
consequence of complexation with the lanthanide shift reagent. Additionally, the lanthanide
shift reagent causes H6 to become more deshielded and is very sensitive to small differences in
the ratio between 6 and the chiral shift reagent. For this reason, the ppm scale is not shown in
the figure and the overlap is merely used to illustrate the observed result.
Comparing the results between the two different substrates it becomes evident that
substrate rac-15 is recognized by more enzymes than rac-16 (Table 9 above). In general, it
appeared that the esterases were not useful to our purpose, in contrast to the lipases that are
showing more promising results. Enzymes L1, and L5-L7 all demonstrated reasonable to good
selectivity for the 2-chloroethoxy ester rac-15, while enzyme L2 gave a reasonable resolution of
substrate rac-16. Interestingly, all enzymes demonstrated selectivity towards the formation of
(-)-(1R,6R)-3, which so happened to be the less well-resolved enantiomer through the chemical
resolution (chapter 3.3.1). The isolated yields after chromatography for the reactions
demonstrating enzyme activity initially were not very promising, as can be seen in Table 10.

Table 10
Yield and Enantiomeric Excess for Products Showing Moderate to Good Selectivity (1R,6R)-3.
EnzymeL1-3
L2-3
L2-6
L5-3
L5-6
L6-3
L7-3
product
e.e. (%)
75
52
79
90
50
81
76
Yield (%)
23
28
23
6
8
16
22

Even when taking into account that the theoretical maximum yield is 50% for this type
of reaction, these results are still far from desirable as no combination of good selectivity and
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reasonable yield was found. However, rac-15 seemed to be a more promising candidate for the
continuation of the study, and was therefore chosen as the target substrate for further
optimization.
First, we decided to vary the length of the alkyl chain of the ester, as it has been shown
in previous literature that shorter-chain esters, in particular acetate esters, are also recognized
by several enzymes in the selective hydrolysis process.125 Additionally, we anticipated a possibly
higher solubility of the acetate esters versus the butyrate esters in the buffer solution used in
the reaction. To this extent, we synthesized the acetate ester of rac-3 in an analogous fashion
to the butyrate derivative rac-15 to obtain rac-17 in an 82% yield after chromatography
(Scheme 20).

Scheme 20. Synthesis of acetate rac-17.

Based on our previous results we combined the acetyl ester with the most promising
enzymes under identical conditions as for the butyrate ester. In order to decrease the black
box-character of these reactions we utilized GC to monitor the reaction progress over time,
using a convenient SPE column-based sample isolation. The rationale behind this was to stop
the reactions as soon as 40% substrate consumption was achieved, to minimize the decrease
in % e.e. due to the (possible) slower hydrolysis of the other enantiomer. This process could
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otherwise negatively skew the selectivity of the enzymes. Figure 38a below shows the reaction
progress over time for the enzymes used and Figure 38b shows the calibration curve used to
correct for the disproportionate response of the alcohol in comparison to the ester as analyzed
by the FID (due to the additional carbon present in the ester). This second experiment was
deemed necessary in order to accurately determine when 40 mol% of alcohol had formed.
Here, we correlated the FID-response of several mixtures of the alcohol and esters at different
mol ratios versus the actual mol ratio between the two compounds determined through
integration using NMR spectroscopy. This allowed us to determine the mol ratio of the mixture
from the GC analysis directly, through the correction factor derived from the graph in Figure
38b.
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Figure 38. a) Hydrolysis of rac-17 to alcohol 3 as a function of time; b) Calibration curve to
correct for disproportionality of FID-detector. Mol% as determined by NMR offset to area% as
measured by GC.

Based on the data presented in Figure 38a, it becomes evident that there are significant
differences between reaction times as a function of the different enzymes used. Enzymes L2
and E2 both rapidly convert the starting material to product, L7 is moderately quick, and L1, L3,
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and L4 require significantly longer reaction times to approach the 40% conversion threshold. L5
appeared too slow to convert a meaningful amount of substrate in a decent amount of time,
and E1 was considered to be completely inactive. Isolation of the product alcohols and
determination of the yield and %e.e. gave the following results:

Table 11
Yield and Enantiomeric Excess for Resolution of rac-17 as a Function of Enzyme at 25°C.

Entry
1
2
3
4
5
6
7
a
b

Enzymea
L1
L2
L3
L4
L5
L7
E2

Buffer pHb
7.5
7.5
7.5
6.5
6.5
6.5
7.5

Yield (%)
14
28
4
15
9
24
26

e.e. (%)
97
97
48
23
22
75
92

Configuration
(R,R)
(R,R)
(R,R)
(S,S)
(R,R)
(R,R)
(S,S)

Enzyme quantity is set as 1 mg on 40 mg rac-17.
Buffer pH is set to value of highest enzyme activity as reported by Amano Enzyme.

Overall, the acetyl ester rac-17 seems a more suitable substrate than its butyric ester
counterpart rac-15. The enantiomeric excesses are generally higher, and two relatively good
combinations of yield and %e.e. are found for enzymes L2 and E2, which also happen to
demonstrate the shortest reaction times. Interestingly enough, E2 and L4 in combination with
the acetic ester are the only two examples of enzyme-substrate combinations producing (+)(1S,6S)-3. The results for L2 were highly encouraging and this enzyme was therefore selected
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for further optimization. Furthermore, E2 was incorporated into the optimization process
because of its selectivity towards the opposite configuration. We decided to vary several
factors for these reactions in an attempt to maximize both yield and enantiomeric excess.
Due to the fact that the initial screening reaction already demonstrated 97% e.e. for L2,
polarimetry seemed too inaccurate for monitoring further improvement reliably. Therefore, we
sought a method to increase the accuracy for determining this parameter. Consequently, we
employed the same analysis method as in chapter 3.3.1, utilizing carbamate ester derivatives 14
(Scheme 17) which were readily separable on chiral HPLC, allowing us to determine the % e.e.
with good accuracy.
With the analysis set up properly we performed an experiment using enzymes L2 and
E2, varying the pH of the phosphate buffer, and monitoring the reactions over time at room
temperature (Figure 39). From the collected results, we sought to establish the optimal
reaction times for reaching a 40% product formation as monitored by gas chromatography (yaxis in Figure 39).

104

Hydrolysis of rac-17 by enzyme L2
60%

% Alcohol formed

50%

40%
30%

pH=7.5

pH=7.0

20%

pH=6.5

10%
0%
0

2

4

6

8

10

Reaction time (h)

Hydrolysis of rac-17 by enzyme E2
60%

% Alcohol formed

50%
40%

30%

pH=7.5
pH=7.0

20%

pH=6.5

10%

0%
0

0.5

1

1.5

2

2.5

Reaction time (h)
Figure 39. Hydrolysis of rac-17 by enzymes L2 and E2 over time at different pH-values.
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For enzyme L2, both pH 7.0 and 7.5 produced a significant amount of product in a very
reasonable timeframe of four to six hours. At pH 6.5, hydrolysis of the ester to 3 appeared to
be significantly slower than for the other two pH-values and was therefore not monitored in
the same time interval after 1 hour. At pH 7.5, a strong decrease in rate of the percentage
alcohol forming as a function of time was observed between six and eight hours, indicating the
presence of two different reaction rates for the individual enantiomers. From this observation
it can be inferred that kR,R>>kS,S indicating a promising selectivity towards ester (1R,6R)-17. For
pH 7.0, a similar stabilization was observed after 21 hours (data point not shown in the graph),
and no meaningful quantity of product could be obtained at pH 6.5 after stopping the reaction
at 125 hours (data point not shown in the graph). Observing the reaction rate of enzyme E2 at
different pH-values resulted in a rather dramatic contrast when comparing pH 6.5 to 7.0 and
7.5. Where the substrate got consumed at a reasonable speed to about 45% in 2 hours at pH
6.5, performing the same reaction at pH 7.0 or 7.5 resulted in an (almost) instant 50%
conversion after 15 minutes of stirring. A reaction-rate decrease similar to that of enzyme L2
was observed for E2, indicating a kR,R<<kS,S type of system. The small dip in product formation
at pH 7.5 for E2 can be attributed to the accuracy of the measurement after sample treatment.
By fitting the collected data using polynomial functions, the ideal reaction time to reach 40%
conversion was extracted for both enzymes at each pH-value, with the exception of L2 at pH 6.5
(due to its lack of activity). New reactions were performed at the estimated optimal time for
each pH value, with the remaining conditions identical to those reported in Table 11 above.
The enantiomeric excess was determined for each reaction product through derivatization to
carbamate 14 (Scheme 17) and subsequent analysis using chiral HPLC (Table 12).
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Table 12
Enantiomeric Excess for Hydrolysis of rac-17 as a Function of Enzyme and pH.
Entry Enzyme pH
Reaction time (h)
e.e.
Configuration Conversion (%)a
(%)
1
L2
7.5
5.00
67
(R,R)
N/A
2
L2
7.0
3.25
> 99
(R,R)
32
3
E2
7.5
0.25
97
(S,S)
47
4
E2
7.0
0.25
98
(S,S)
46
5
E2
6.5
2.00
89
(S,S)
49
a

Determined through integration of NMR signals at 5.04 ppm (17, CHOCOR) and 3.93 ppm (3, CHOH).

For enzyme L2, applying the conditions as shown in entry 2 yield an optically pure
(1R,6R)-3, with no detectable (1S,6S)-3 on HPLC. Enzyme E2 delivers an 98% enantiomeric
excess following the conditions from entry 4 in the table. Based on these results, enzyme L2 is
found to be very suitable for this type of resolution, and E2 may prove to be of similar efficiency
if the % e.e. can be optimized just a bit further. Lowering the reaction temperature or time for
this enzyme may prove a viable solution in bringing the enantiomeric excess to the same level
as for enzyme L2. To investigate this hypothesis, we performed two additional experiments
with E2 at 0°C for pH 7.5 and 7.0, for which the results are shown here:
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Hydrolysis of rac-17 by enzyme E2
60%

% Alcohol formed

50%
40%
pH=7.5 at 0 °C

30%

pH=7.0 at 0 °C

pH=7.5 at 24 °C

20%

pH=7.0 at 24 °C
10%
0%

0

0.5

1

1.5

2

2.5

Reaction time (h)
Figure 40. Comparison of reaction time at 0°C (full) and 24°C (dashed) for rac-17 hydrolysis by
E2.

As can be observed from the graph, lowering the temperature to 0°C significantly
reduced the reaction rate at pH 7.0 and additionally appears to flatten the curve in terms of
product formation around 40% rather than 55% (compare green to yellow). A less dramatic
effect is seen at pH 7.5, where the reaction rate is only slightly lowered, and the overall
product formation in two hours is similar at either temperature (compare blue to red). The
quantitative results are shown in the table below (entries 1 and 2), with the 25 °C experiments
included for comparison (entries 3 and 4).
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Table 13
Enantiomeric Excess for Hydrolysis of rac-17 as a Function of Temperature and pH.
Entry Enzyme Temperature pH
Reaction
e.e. Configuration
Conversion
(°C)
time (h)
(%)
(%)a
1
E2
0
7.5
0.25
> 99
(S,S)
35
2
E2
0
7.0
1.00
> 99
(S,S)
50
3
E2
25
7.5
0.25
97
(S,S)
47
4
E2
25
7.0
0.25
98
(S,S)
46
a

Determined through integration of NMR signals at 5.04 ppm (17, CHOCOR) and 3.93 ppm (3, CHOH).

Lowering the temperature to 0°C resulted in a significant increase in selectivity for the
enzyme at either pH, with both conditions leading to an enantiomeric excess of >99%. In terms
of conversion, the reaction at pH 7.0 revealed a maximum 50% consumption of one the
enantiomers (within the accuracy of quantification by NMR), where the pH 7.5 experiment led
to a 35% conversion. This difference may be due to the fact that small variations in reaction
time and enzyme quantity will have a more pronounced effect on the conversion rate in a 15minute reaction than in a 1-hour reaction.
Summarizing the results, we have accomplished the development of an enzymatic
methodology for the selective hydrolysis of rac-17 to either (1S,6S)-3 or (1R,6R)-3 as a function
of enzyme L2 or E2 employed as the reaction catalyst, with an enantiomeric excess >99% for
the desired enantiomer. The reaction times are convenient (1 hour, E2; 3.25 hour, L2) and the
conversion is high (50%, E2; 35%, L2). Nevertheless, hydrolysis through L2 could benefit from a
slightly longer reaction time to promote additional product formation, for which further
optimization is required. In terms of isolated yield and efficiency, larger-scale experiments will
need to be conducted in combination with methanolysis of the remaining ester after separation
(Figure 36), to obtain both enantiomers in >99% enantiomeric excess and a good yield.
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Alternatively, performing enzymatic hydrolysis using E2, followed by separation and enzymatic
hydrolysis of the remaining ester using L2 may also provide a viable, high-yielding method to
obtain both optically pure enantiomers of 3. If either of these processes can be efficiently
realized, the enzymatic resolution of rac-3 would be superior to the chemical resolution
discussed in chapter 3.3.1 in terms of yield. Comparing the enantiomeric excess and waste
production of the enzymatic resolution to that of the chemical resolution, it is evident that the
enzymatic resolution would be the method of choice. Finally, this method may be applicable
to a wider range of substrates bearing an identical trans-1,2-chloroethoxy alcohol recognition
motif, expanding the generality of this method significantly.
3.4 Assignment of Absolute Configuration through X-ray Crystallography
In order to unambiguously determine the absolute configuration of the cis-DACH
scaffold after resolution, we resorted to single-crystal X-ray crystallography. From all available
intermediates, the tosylate 7 was identified as a suitable candidate for this purpose due to the
fact that it contains a sulfur atom (Figure 41).

Figure 41. Structure of (4aS,6S,7S,8aS)-7 used for the determination of the absolute
configuration through X-ray crystallography.
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The presence of sulfur is crucial in the determination of the absolute configuration due
to the fact that an atom of phosphorus or bigger is required to reliably assign the
stereochemistry in the molecule.126 Alternatively, an absolute configuration can be assigned to
a molecule if the configuration of at least one stereocenter is already known, which would
make (1S,6S)-11c another suitable candidate. Attempts to grow suitable crystals for this
compound, however, led to the formation of a waxy solid instead, rendering the compound
unsuitable. Due to the typically good crystallization behavior of tosylated compounds,
however, we could readily obtain high quality crystals from tosylate 7 through slow evaporation
of n-hexane. In collaboration with the Chemistry Department of the University of Nevada,
Reno, a crystal structure was successfully generated for this compound, as is shown below:

Figure 42. ORTEP-diagram of (4aS,6S,7S,8aS)-7 obtained through single-crystal X-ray
crystallography.
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Conventions in atom-counting in crystallography differs from the IUPAC counting for
organic compounds, which is why the numbers displayed in Figure 42 above deviate from the
atom-counting used throughout this dissertation.
The crystals of tosylate 7, obtained through the chemical resolution as described in
chapter 3.3.1, correspond to the isolated (1S,6S)-3. After assigning the absolute configuration,
we could readily correlate polarimetry signs with the appropriate enantiomer, as well as
retention times on chiral HPLC, resulting in the claims made for the absolute configurations in
chapters 3.3.1 and 3.3.2, corresponding to the enantiomers of compounds 3, 6, and the
diastereomers of carbamate 14. For compound 3, the optical rotation and HPLC data are
shown in the overview below, because of its importance in the two preceding chapters:

Table 14
Polarimetry Data Pertaining to the Absolute Configuration of Enantiomers
3 and Relative Polarity of Derivatives 14.

Sign

Positive

Negative

Less polar

More polar

Configuration of
derivatives 14

Relative polarity of
derivatives 14a
a

Measured on a NP Astec Cellulose DMP Chiral HPLC column.
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3.5 Synthesis of the Library of Optically Pure Ligands
After establishing an efficient synthetic route for the chiral cis-DACH scaffold 9, and
developing efficient methods for the chiral resolution of intermediate 3 of the synthesis, we
had the proper tools at our disposal to construct a library of chemically diverse diamine ligands
for asymmetric synthesis. Based on the literature reviewed in chapter 1, we chose to explore
ligands of various nature, either obtained through the reductive amination method (Scheme 1,
Chapter 1.2), to obtain secondary diamines with different electronic and steric properties, or
sulfonylation methods yielding sulfonamides.
To first develop the reductive amination method we started from rac-9 and performed a
condensation reaction with 2 equivalents of benzaldehyde adapted from a literature
procedure.16 This resulted in isolation of the crude diimine rac-18a in a 99% yield. Subsequent
reduction of the diimine functionality yielded the corresponding diamine rac-19a in a 74% yield
after column chromatography (Scheme 21).

Scheme 21. Synthesis of diimine/diamine ligands rac-18a and rac-19a through two-step
reductive amination.

Attempts to purify rac-18a using column chromatography failed due to the instability of
the diimine on both silica and alumina. During elution from the column, the hydrolysis of
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diimine rac-18a took place in a rapid manner, leading to the isolation of (mostly) starting
material rac-9. Attempts to prevent the reverse reaction from happening, e.g. by adding basic
modifiers to the mobile phase proved insufficient. Luckily, the diimine rac-18a could be
crystallized directly from the reaction mixture by placing it at -18°C overnight, resulting in the
formation of yellow crystals (78% yield). For analogous ligands synthesized in a similar fashion
as shown in Scheme 21 above, however, only a few produced crystals through this method.
Nevertheless, we were able to isolate the pure diamine analogues 19 in the corresponding
syntheses.
The method of reductive amination proved to be an efficient method to obtain
secondary diamine ligands and we decided to synthesize a whole array of compounds, varying
the nature of the aldehyde in the condensation reaction, through the same synthetic pathway.
From here on, unless stated otherwise, the assigned stereochemistry conforms the absolute
configuration of the cis-DACH scaffold (4aS,6R,7S,8aS)-9. All synthesized ligands through the
reductive amination methodology are shown in Table 15 below. In terms of variation, we
broadly discriminated on three factors of interest. Firstly, we synthesized a range of ligands
that, aside from the secondary diimine/diamine moiety, would only have steric interactions
with the potential catalyst in a future reaction (18/19a-d,f). The second series of ligands
contained additional heteroatoms, in absence of the possibility to formally form a tetradentate
complex with the catalyst (18/19e, g, and h). Finally, we synthesized two ligands that could
formally bind a metal center in a tetradentate orientation (18/19i and j).
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Table 15
Synthetic Library of Chiral Ligands Based on the Chiral cis-DACH scaffold (4aS,6R,7S,8aS)-9.

18a

18b

19a

19b

18c

18d

19c

19d

18e

18f

19e

19f

18g

18h

19g

19h

18i

18j

19i

19j
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The ligands depicted in the table above were all purified through column
chromatography prior to use in the asymmetric reactions described in the next chapter. The
yields for the reductive amination varied significantly as a function of the nature of the
aldehyde. For the diimines 18a and 18i, crystals could be isolated directly from the reaction
mixture, in 78% and 68% yield, respectively. Their corresponding diamines 19a and 19i were
subsequently isolated in yields of 74% and 64%, in that order. For the derivatives that did not
show crystal formation in the diimine stage, the overall diamine yields over two steps were
found to be in the range of 42% to 98% after purification of the target diamines. The only
exceptions to this were diamines 19c and 19d, which were both isolated in a low 9% yield. For
diamine 19c, no clear reason could be found to explain this low yield, especially considering the
fact that other, more sterically demanding diamines 19g and 19i each resulted in yields of 64%
after chromatography. In the case of 19d, a solution of formaldehyde in methanol had to be
used, which altered the reaction conditions slightly. Moreover, this specific reaction led to an
array of products, likely owing to the high reactivity of formaldehyde, in combination with its
low steric demands. In general, lower yields could typically be attributed to the difficult
removal of small impurities, which was prioritized at the expense of product yield.
To increase the diversity of the ligands, we synthesized three sulfonamides to
incorporate into our studies. The introduction of sulfonyl groups on the diamines drastically
affects the basicity of the nitrogen atoms through a strong electron-withdrawing effect induced
by the sulfonyl group, yet, such compounds have been reported as active catalyst in some
(asymmetric) reactions.127–129 By using two different sets of literature conditions,130,131 we
synthesized ligands 20a-c, as is shown in the scheme below:
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Scheme 22. Synthesis of sulfonylated ligands, starting from (4aS,6R,7S,8aS)-9.

Ligand 20a was isolated in a 45% yield after chromatography, which can mostly be
attributed to difficulties with removing small impurities during separation. Analogous to the set
of ligands synthesized through reductive amination, the purity of the ligands was prioritized
over incorporating small (potentially insignificant) impurities, at the expense of product yield.
We anticipated a significant difference between the reactivity of the equatorial 1° amine versus
its axial equivalent. Therefore, we decided to synthesize both ditosylated ligand 20b and
monotosylated compound 20c in one reaction by using 1.75 equivalents of tosyl chloride, and
incorporate 20c into our library. After purification this led to a 92% yield for ditosylate 20b and
a 42% yield for 20c, with the calculations corrected for the 1.75 equivalents used. To confirm
our hypothesis that the sulfonyl group was indeed attached to the equatorial amino group in
20c, we compared the proton spectrum to that of (4aS,6R,7S,8aS)-9 as is shown in Figure 43
below.
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H6

H7

H6
H7

Figure 43. NMR-spectral overlay of (4aS,6R,7S,8aS)-9 (red) and 20c (green) in CD3OD (600
MHz).

As can be seen from the figure, a significant downfield shift is observed for H6 attached
to the carbon bearing the equatorial amino group from 2.86 ppm to 3.23 ppm upon
sulfonylation, in comparison to a slight upfield shift for H7 attached to the carbon bearing the
axially oriented amino group (3.11 ppm to 3.03 ppm). Distinguishing between these two
protons in the (4aS,6R,7S,8aS)-9 was done based on the fact that one large axial-axial coupling
is observed for H6 (J5ax-6 = 13.1 Hz) in combination with two small(er) axial-equatorial couplings
(J5eq-6 ≈ J6-7 ≈ 3.7 Hz), and that H7 is expected to exclusively exhibit three small axial-equatorial
and equatorial-equatorial coupling constants (J6-7 ≈ J7-8ax ≈ J7-8eq ≈ 4.2-4.8 Hz). The widelystudied magnetic anisotropy of cyclohexane rings predicts equatorial protons to be more
deshielded in (4aS,6R,7S,8aS)-9 than axial protons, further supporting our claim that the amino
group on C6 was sulfonylated (compare H6 at 2.86 ppm to H7 at 3.16 ppm for diamine 9).
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Through the two methodologies described in this chapter, we managed to synthesize a
respectable number of secondary diamine ligands. These ligands, constructed using the central
cis-DACH backbone, contain a variety of functional groups that may affect the asymmetry
induced in certain chemical reactions through steric or electronic interactions with the metal
catalyst, for which the results will be described in the next chapter. An overview of the isolated
yields for these compounds is given in the table below:

Table 16
Isolated yields after chromatography for ligands 18a,i, 19a-j, and 20a-c.

Ligand
Yield
(%)

18a

18i

19a

19b

19c

19d

19e

19f

19g

19h

19i

19j

20a

20b

20c

78

68

74

98

9

9

60

42

64

38

64

79

45

92

42

Based on the synthetic methods presented here, further variation in ligand design may
be introduced by utilizing different aldehydes or sulfonyl compounds. Alternative synthetic
methods may additionally expand the nature of the ligands (e.g. through alkylation), that could
possibly lead to more efficient catalyst. However, at this stage, we decided to evaluate our
current ligands for a small collection of asymmetric reactions first. From the data obtained
through these experiments, sensible follow-up designs for the chiral ligands may be generated.
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3.6 Evaluation of Chiral cis-Diamine Ligands in Asymmetric Synthesis
The application of secondary diamine ligands in synthetically relevant asymmetric
reactions has been a topic of interest for many years and is expected to remain one for many
years to come (Chapter 1). The diversity of reactions for which asymmetric systems have been
explored is incredibly great, as has been briefly described in the introductory chapters of this
dissertation. To gain some insight in the type of reactions we could catalyze (asymmetrically)
with our ligands, we chose to screen a set of four different reactions in order to investigate
whether our ligands were capable of facilitating product formation. To this extent we identified
the following four metal-catalyzed reactions as potentially suitable systems for our ligands:



Copper-catalyzed asymmetric Henry reaction.29,38,132,133



Ruthenium/Manganese-catalyzed asymmetric transfer hydrogenation.134–138



Zinc-catalyzed asymmetric addition of alkanes to aldehydes.139



Palladium-catalyzed asymmetric allylic substitution.94

The selection was made based on three factors. First, we needed a proof-of-concept on
which we could state that our ligands are suitable for (asymmetric) catalysis. Therefore, we
selected two well-reported reactions (the Henry reaction and the diethyl zinc addition) for
which both the reaction conditions, and physical data of a multitude of products, were
described, allowing us to benchmark these data for the development of our own system. Both
these reactions were reported to be compatible with chiral DACH-based ligands and
enantiomeric excesses of up to >99% have been reported.29,139 The second factor on which we
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based our selection was focused towards asymmetric reactions that could be improved further
in terms of asymmetric induction. This is the case for the asymmetric transfer hydrogenation
(ATH) with enantiomeric excesses reported between 25% and 93% using trans-DACH
ligands,134,138 or between 9% and 84% e.e. using sulfonylated ligands135–137. Our third goal was
to identify an asymmetric reaction that had only been reported to work with ligands of a
slightly different nature, for which we could potentially claim the first asymmetric example
using a diamine-based ligand (palladium-catalyzed asymmetric allylic substitution).94
To perform our comparative screening, we carried out a standard literature experiment
for each of the four reactions mentioned in the presence of rac-19a or rac-trans-1,2-DACH and
observed the efficacy of these ligands in terms of product formation (Scheme 23). For the
asymmetric transfer hydrogenation, it was reasonable to use a simple primary diamine for the
initial screening due to the higher similarity to the ligands used in the literature. 134
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Scheme 23. Reactions performed to screen for catalytic activity using 1,2-diamines under
representative literature conditions.94,132,134,139
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Three out of the four selected reactions were catalyzed by either rac-19a or trans-1,2DACH. No product could be observed for the allylic substitution reaction which prompted us to
eliminate this system from further investigation. At this point, it also seemed practical to not
continue with the diethyl zinc reaction, due to the extended reaction time (72h) and low yield
of 32%. In order to efficiently investigate reactions for asymmetric synthesis, a quick
turnaround from starting the experiment to the final result is highly valuable. In this sense, the
Henry reaction and asymmetric transfer hydrogenation (ATH) appeared to be promising
candidates, and our efforts to develop proper systems for asymmetric synthesis in these
reactions is described in the next two chapters.
3.6.1 Chiral cis-DACH Ligands in Asymmetric Henry Reaction
When developing novel chiral ligands for asymmetric synthesis, the nitroaldol reaction,
or Henry reaction, is one of the most frequently used model systems. Due to the full
characterization of a wide range of asymmetric products, including their chiral resolution, one
can conveniently measure the impact of their chiral ligands on the reaction selectivity.
Moreover, the Henry reaction yields a new C-C bond and the additional nitro-group can be used
for further transformation, making this a synthetically relevant reaction. The first asymmetric
version of this reaction dates back to 1992, where Sasai et al. utilized (S)-(-)-binaphtol in
combination with a lanthanum metal catalyst, to facilitate the reaction (Figure 44a).140 Since
then, numerous efforts have been made to generate more efficient and convenient systems for
the nitroaldol reaction, with the bis(oxazoline)-catalyzed version being the most elegant
example to date (Figure 44b).132
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Figure 44. a) First reported catalyst for the asymmetric Henry reaction,140 and b) One of the
most efficient catalysts reported to date.132

Interestingly enough, the asymmetric Henry reaction has been a topic of extensive
research for almost 30 years, yet the reaction mechanism has never been elucidated with
certainty, thus far. This is mostly attributed to the complexity of the asymmetric reaction in
terms of the more subtle interactions that can possibly influence the outcome of the reaction.
A widely accepted general mechanism is shown in Figure 45.132

Figure 45. Proposed mechanism for the nitroaldol addition, adapted from literature.132
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In the mechanism, nitromethane binds to the preformed ligand-metal complex,
followed by the expulsion of X-, a basic charged ligand that facilitates the deprotonation of the
methyl group to form the nitro-enolate (e.g. X = OAc-). Subsequent addition of the aldehyde to
the metal center increases the electrophilic character of the carbonyl carbon, making it more
susceptible to nucleophilic attack by the adjacent enolate. Dissociation of the resultant
nitroalcohol product regenerates the ligand-metal complex.
Prior to starting the evaluation of our ligands for asymmetric synthesis, we wanted to
gain insight into the reaction time, produce a racemic product for HPLC separation purposes,
and compare the difference between a diimine versus a diamine ligand. To this purpose we
monitored the Henry reaction over time, using rac-18a and rac-19a (Table 15, chapter 3.5),
performed the reaction under standard conditions (Scheme 24), and isolated the resulting
products for analysis. We chose p-nitrobenzaldehyde as a model substrate due to the fact that
the product is a solid, which is convenient for chromatographic purposes and the subsequent
retrieval of the purified product.

Scheme 24. Racemic nitroaldol reaction to form nitroalcohol rac-21 under standard conditions.
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Using NMR spectroscopy, we quantified the ratio between starting material and product
rac-21 over time, and subsequently plotted the product formation for rac-18a, rac-19a, 1,4dioxane, and in the absence of ligand. The 1,4-dioxane variant was performed to observe
whether any catalytic properties existed for the 1,4-dioxane moiety in the ligand. The results of
this study are depicted in the figure below:

Reaction progress

Conversion(%)
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80%
60%

cis-Diamine
rac-19a
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cis-Diimine
rac-18a

20%

Blank
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1,4-dioxane
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0%
0
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4

6

8
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18
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22

24

Time (hours)
Figure 46. Reaction monitoring of Henry reaction over time by NMR spectroscopy.

As can be seen from the figure, both the diamine rac-19 and diimine rac-18 facilitate the
progress of the reaction over a course of 24 hours. In presence of the diamine rac-19 , the
reaction takes place within 8 hours, whereas the diimine rac-18 requires more time. In the
same 24 hours, neither 1,4-dioxane nor the blank reaction produces a significant amount of
product. Interestingly enough, a small reduction of product formation is observed going from 8
hours to 24, which may have to do with coincidental small inaccuracies of the measurement, or
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a decomposition of the product. For all four reactions, the products were purified using column
chromatography, and their respective yields are shown in the table below:

Table 17
Yield for Henry Reactions Using Diimine rac-18 and Diamine rac-19
Ligands After 24 Hours at Room Temperature.
Ligand
rac-19
rac-18
Blank
1,4-dioxane
Yield 21 (%)
90
74
5
4

From these results, it becomes evident that the diamine rac-19 facilitates the reaction
with very respectable yield of 90% in 8 hours, while diimine rac-18 results in a slightly lower
yield over the course of 24 hours, and both the blank and 1,4-dioxane produce negligible
quantities of product.
Next, we chose to evaluate a series of six of our ligands 19 under identical conditions
(Scheme 24 above) and determine the %e.e., yield, and absolute configuration for their
corresponding products. Reaction times were varied based on observation of substrate
consumption on TLC. The minimum reaction time was set to 14 hours (Table 18).
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Table 18
Yield and Enantiomeric Excess for Several cis-DACH Ligands 19 in Henry Reaction.

a
b

Entry

Aldehyde

Ligand

1
2
3
4
5
6
7
8

p-nitrobenzaldehyde
p-nitrobenzaldehyde
p-nitrobenzaldehyde
p-nitrobenzaldehyde
p-nitrobenzaldehyde
p-nitrobenzaldehyde
benzaldehyde
benzaldehyde

19a
19b
19e
19f
19h
19j
19a
19a

Reaction
time (h)
14
18
14
23
23
38
10
96

Yield
(%)
99
85
75
90
89
88
46
N/A

e.e. (%)a

Configurationb

51
48
44
46
55
30
50
67

R
R
R
R
R
S
R
R

Determination through chiral HPLC.
Assignment by correlating sign (polarimetry) for entry 1 and comparison to literature.

Looking at entries 1-6, it can be concluded that each ligand is capable of catalyzing the
reaction with a good to excellent product yield as result (75-99%). In terms of reaction time,
most ligands facilitate the reaction in a comparable number of hours, with the exception of 19j.
In terms of configuration, a very similar trend is observed with each ligand favoring (R)-21, with
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19j again deviating from the trend, forming (S)-21 instead. Interestingly, 19j is the only ligand
capable of formally forming a tetradentate ligand, which can be reasonably assumed to be a
determining factor in explaining its opposing product preference. In contrast to the yield, the
enantioselectivity of the ligands seems to be lacking in this first experiment. All ligands are
capable of inducing some asymmetry, but the differences between the individual ligands are
rather small (44-55 %e.e., excluding 19j) which indicates that variation in the diamine side-chain
has a relatively small effect on the selectivity under these conditions, and potentially in general.
In comparison, trans-DACH ligands of a similar nature have produced enantiomeric excesses of
up to 91% in this reaction, albeit at lower temperature and with higher catalyst quantities
(Figure 47).141

Figure 47. Two trans-DACH ligands achieving 91% enantiomeric excess in 95% (left) and 64%
(right) yield for the asymmetric Henry reaction at 0°C with 10 mol% Cu(OAc)2 and ligand.

To observe the substrate dependence of the system we evaluated benzaldehyde under
the same conditions as p-nitrobenzaldehyde to produce nitroalcohol 22 (Table 18 above)
leading to a similar enantiomeric excess in combination with a lower yield (entry 7). The latter
can be attributed to the higher reactivity of the nitro-variant in combination with stopping the
reaction before full consumption was observed. This was done, however, to rapidly elucidate
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whether the difference in substrate would lead to a different enantioselectivity. Lowering the
temperature to 0°C (entry 8) resulted in a major increase from 50 to 60% e.e. for nitroalcohol
22, unfortunately accompanied by a drastic decrease in reaction rate, which led to an
insignificant amount of product using ligand 19a over the course of 96 hours. Ideally, the Henry
reaction should be completed within a reasonable timeframe due to the fact that slow
racemization of the product had been observed during one of our experiments. Using ligand
19h, we measured the % e.e. of the product at different time intervals (2 hours, 6 hours, and
24 hours) and saw a small decrease in enantiomeric excess from 64% to 60% and a final
enantiomeric excess after workup of 55%.
To investigate whether we could increase the % e.e. for our ligands, we decided to vary
a number of parameters, starting by mimicking a small set of literature conditions
demonstrating high enantioselectivities with the use of various additives and copper salts, to
establish what type of systems would be most suitable for our ligands.29,38 The results of this
screening with ligand 19a are summarized in the table below. The use of 3-nitrophenol as an
additive has been reported to enhance both yield and enantioselectivity in the literature, and
was therefore included in the study.142 For convenience, the result for ligand 19a using the
conditions from the previous table is included as a comparison (entry 1).
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Table 19
Enantiomeric Excess for Various Reaction Conditions in Henry Reaction.

Entry
1
2
3
4
5
6
a
b

Solvent
EtOH
EtOAc
i-PrOH
i-PrOH
i-PrOH
i-PrOH

CuX2
X = OAc
X = Cl
X = Cl
X = OAc
X = OAc
X = OAc

Additive
None
Et3N
Et3N
Et3N
3-Nitrophenol
None

e.e. (%)a
51
46
40
51
66
66

Configurationb
R
R
R
R
R
R

Determination through chiral HPLC.
Assignment by correlating sign (polarimetry) for entry 1 and comparison to literature.

Compared to our original result (entry 1), the use of copper chloride in combination with
triethylamine as a base clearly led to an inferior selectivity (entries 2 and 3). Switching to
isopropanol in the presence of triethylamine resulted in a selectivity similar to the original
(entry 4). The best results were obtained by using copper acetate in isopropanol, leading to a
66% e.e. both in the presence and absence of 3-nitrophenol, which is a 15% increase in
selectivity as a function of changing solvent (entries 5 and 6). Owing to this drastic effect, we
decided to reproduce the conditions used in entry 6 with different solvents. We evaluated a
total of nine solvent systems in combination with ligand 19a, and observed the effect on the
enantiomeric excess, as summarized in Table 20. The solvents were selected based on the
frequency with which they were encountered in comparable optimization studies from the
literature, yielding moderate-to-excellent results.17,29,38,129,132,141,143 Entries 1 and 6 from the
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previous table are included as entries 1 and 2 for convenient comparison of the different
solvents.

Table 20
Enantiomeric Excess for Various Solvents in Henry Reaction.

Entry
1
2
3
4
5
6
7
8
9
10

Solvent
EtOH
i-PrOH
n-PrOH
MeOH/ i-PrOH 1:1
MTBE
Toluene
DCM
MeCN
EtOAc
THF

e.e. (%)a
51
66
57
55
39
48
39
44
56
49

Configurationb
R
R
R
R
R
R
R
R
R
R

a

Determination through chiral HPLC.
Assignment by correlating sign (polarimetry) for entry 1 and comparison to
literature.
b

Looking at the results, our initial reaction in i-PrOH appeared to induce the highest
selectivity among the solvents tested (entry 2). In general, alcohols consistently induced a
selectivity between 51-57 %e.e. (entries 1, 3, and 4), with i-PrOH being an exception. Possibly,
its more sterically hindered isopropyl group influences the selectivity through coordination to
the metal center. tert-Butanol was not included in this study due to its (relatively) high melting
point, which would force us to increase the temperature of the reaction. Elevated
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temperatures are known to negatively affect the enantioselectivity of the Henry reaction.132
Out of the aprotic solvents, MTBE and DCM had the lowest selectivity (entries 5 and 7) where
toluene, acetonitrile, and THF demonstrated slightly better results (entries 6, 8, and 10). Ethyl
acetate was the only aprotic solvent that could induce a selectivity in the same range as the
alcohols (entry 9), which may also be due to its steric environment and increased coordination
to the metal center compared to the other aprotic solvents.
With i-PrOH generating the highest selectivity, a reproduction of this experiment was
performed at 0°C, leading to an increased enantioselectivity of 72% along with a 51% yield in 20
hours. In comparison to the 0°C results obtained in ethanol (Table 18, entry 8) after 96 hours,
we observed a significant increase in reaction rate in isopropanol. Further efforts to increase
the reaction rate at this temperature can be realized by increasing the equivalents of ligand in
the system. However, our priority was first focused on increasing the enantiomeric excess, and
under these conditions a decent yield was achieved for further analysis. Next, we utilized a
series of our ligands at 0°C in i-PrOH to evaluate their enantioselectivity in this improved
system. The results of this study are shown in Table 21 below.

133
Table 21
Evaluation of Ligand Selectivity for Henry Reaction in i-PrOH at 0°C.

Entry
1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
a

Ligand
(4aS,6R,7S,8aS)-9
18a
19a
19b
19c
19e
19f
19g
19h
18i
19i
19j
20a
20b
20c

Reaction time (h)
14
14
20
14
14
14
14
14
14
14
14
14
14
14
14

e.e. (%)a
2
11
72
23
42
53
53
52
75
N/A
1
46
N/A
0
N/A

Configurationb
R
S
R
R
R
R
R
R
R
N/A
R
S
N/A
N/A
N/A

Conversion (%)c
95
40
51
2
64
trace
trace
12
35
0
trace
60
0
2
0

Determination through chiral HPLC.
Assignment by correlating sign (polarimetry) for entry 1 and comparison to literature.
c
Calculated through integration of CH(OH) at 5.6 ppm for product 21 vs. aldehyde CHO at 10.2 ppm.
b
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Observing these results, it becomes clear that the methoxy-substituted dibenzylamine
ligand 19h induces the greatest enantioselectivity with 87.5% of (R)-21 forming, versus 12.5% of
(S)-21, resulting in an overall 75% enantiomeric excess (entry 9). Within 14 hours, this ligand
yields a 35% conversion of starting material to product, which might possibly be enhanced by
extended reaction times or a higher equivalent of the ligand-catalyst complex. On the other
end of the spectrum we find the sulfonylated compounds that virtually do not yield any
product, with the exception of a trace amount of racemic 21 for ligand 20b (entries 13-15). A
very high conversion rate is found for the 1° diamine (4aS,6R,7S,8aS)-9, which is a somewhat
surprising result, as it was expected that the diamine would undergo condensation with the
aldehyde substrate. Despite the quick conversion, however, no significant asymmetry was
induced by this ligand (entry 1). Observing the diimine/diamine ligand pair 18a and 19a, it
turns out that the diimine produces the (S)-product, whereas the diamine favors the formation
of the (R)-enantiomer. The diamine 19a, however, induced a superior asymmetry (72% e.e.
versus 11% e.e.) compared to the diimine 18a. Ligands 19e,f reveal a decent asymmetric
induction, both containing a modest substitution around the aromatic rings, while the more
bulky 19g produces a similar result despite its increased steric demands (entries 6-8). None of
these three ligands, however, seems to produce a significant amount of product, yet, sufficient
quantities for analysis by chiral HPLC. Interestingly enough, the similarly crowded 19c (entry 5)
produces a lower enantiomeric excess than 19g, emphasizing the importance of the methoxygroup in the ligand. The use of large bulky groups may even be detrimental to the catalytic
system, as can be seen by comparing 19i and 19j, both ligands capable of forming a
tetradentate complex, with 19i producing a trace of near-racemic 21, where 19j produces a
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60% conversion with an enantiomeric excess of 46% (S)-21 (entries 11 and 12). Another good
indicator that the steric environment may have significant effects on the outcome of the
reaction can be found when comparing 19a versus 19b, where the fused aromatic system
causes a drop from 72% e.e. to a far lesser 23% e.e. (entries 2 and 3). Finally, even more
subtle changes in the structure of the ligand, e.g. comparing the tri-methoxy-ligand 19e to
mono-methoxy-ligand 19h, can cause dramatic changes in the enantiomeric excess (22%
difference, entries 6 and 9). Based on these findings, it becomes evident that the outcome of
the Henry reaction using this type of ligand requires significant fine-tuning of the steric and
electronic environment of the ligand. Fortunately, this fine-tuning can be realized conveniently
by varying the aldehyde in the reductive amination of diamine 9.
Our best results were obtained with the dibenzyl ligand 19a, leading to a 72% e.e, with a
50% conversion, and the methoxy-substituted ligand 19h, producing a 75% e.e. of (R)-21 in a
35% conversion. Based on these results we can conclude that our cis-DACH ligands are capable
of inducing asymmetry in the Henry reaction through the axial chirality of the cis-DACH scaffold
9. Analogous to the literature, ligands containing less sterically-demanding groups typically
lead to better results, yet our yields and enantioselectivities remain inferior to what has already
been reported for trans-DACH derivatives and comparable structures (Figure 47
above).17,29,38,129,132,141,143
Further optimization of the asymmetric system might be achieved through varying the
stoichiometry between catalyst and substrate, or by additional fine-tuning of the structure of
the ligand. One viable method for investigating the latter is by restricting the flexibility of the
diamine ligand. Through the general reductive amination method, any attached R-group will
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always be connected to the amine through a methylene group. This connection induces a
certain flexibility in the ligand, that may cause the ligand-metal complex to adopt more than
one of several possible conformations of which not all may lead to the same configuration in
the final product. Limiting this flexibility, e.g. by alkylating the amino groups, or applying a
different methodology of derivatizing the primary diamine 9 may restrict the number of
configurations that can be adopted by the ligand-metal complex.
3.6.2 Chiral cis-DACH Ligands in Asymmetric Transfer Hydrogenation
The reduction of aldehydes and ketones to alcohols is a fundamental transformation in
organic synthesis. It is therefore not surprising that a vast number of methods to realize this
transformation is described in the literature, with newer methods frequently emerging. In
general, three common methods exist to realize this reduction in a chemical fashion:



Addition of molecular hydrogen under catalytic conditions.



Stoichiometric reaction with a metal hydride.



Transfer hydrogenation using a benign hydrogen source

Of these three, the first two are the more conventional approaches and described to be
highly efficient. Transfer hydrogenation, is a relatively novel approach and currently receiving
significant attention from the scientific community. The motivation for this recent emergence
has to do with the safety and environmental impacts of the first two methods. In comparison
to the conventional approaches, transfer hydrogenation typically involves readily available
equipment, low catalyst loading, environmentally green(er) reagents and solvents, and easy-to-
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remove byproducts.144 Moreover, the transfer hydrogenation reaction involves a highly
reduced safety profile in comparison to the use of hydrogen gas or metal hydrides, making it an
attractive methodology for industrial processes. Owing to these favorable properties, a first
asymmetric transfer hydrogenation (ATH) equivalent was described by Noyori et al. utilizing a
ruthenium catalyst in combination with a phosphodiamine ligand to facilitate the
transformation of symmetric ketones to chiral secondary alcohols, with a widely varying
selectivity (5-99% e.e.),145 leaving ample room for optimization and scope expansion. This
original example utilizes isopropanol as the hydrogen source which, to date, is the most widely
used reagent to this purpose, due to its convenient volatility during reaction work-up.144
Generally, two mechanistic approaches have been accepted to explain the formation of the
product in (asymmetric) transfer hydrogenation reactions using a secondary alcohol as the
hydrogen source. One of these involves a dihydride intermediate (Figure 48a), while the
second concerns a monohydride pathway containing two possible variants (Figure 48b and
48c).
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Figure 48. Transfer hydrogenation mechanisms; a) dihydride route; b) monohydride inner
sphere; and c) monohydride outer sphere.144,146
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Based on a literature study, we decided to evaluate the potential of our ligands in three
different systems using various catalysts. Of the conditions tested, the experiments utilizing iPrOH or a formic acid/triethylamine azeotrope in a 5:2 ratio as hydrogen transfer agents are
relatively common in combination with ruthenium-type catalysts.135–137,145 These systems have
mostly been explored using sulfonylated diamine ligands, which constitute a relatively small
part of our ligand library. Less commonly described in literature are the alkylated diamine
ligands utilized in conjunction with manganese-based catalyst and i-PrOH to facilitate an
identical type of transformation,134 for which the results were typically inferior to rutheniumbased systems.144 For this reason, and to increase our chance of identifying a suitable system
for our ligands, we evaluated different combinations of conditions based on the literature
mentioned here. First, we experimented with a series of our ligands using the manganesecatalyzed reaction conditions. The results of this study are summarized in the following table.
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Table 22
Evaluation of Ligand Selectivity for ATH Using a Manganese-based Catalyst.

Entry
1
2
3
4
5
6

Ligand
(4aS,6R,7S,8aS)-9
19a
19b
19d
19j
20a

e.e. (%)a
42
N/A
N/A
N/A
N/A
N/A

Configurationb
R
N/A
N/A
N/A
N/A
N/A

Conversion (%)c
22
0%
0%
0%
0%
0%

a

Determination through chiral HPLC.
Assignment by correlating HPLC data to literature.137
c
Calculated through integration of CH(OH) at 4.89 ppm for product 23 vs. aldehyde CH3 at 2.59 ppm
b

Surprisingly enough, only the primary diamine 9 showed activity for this reaction with a
decent initial selectivity of 42% e.e., albeit in a low yield (entry 1). The other five ligands tested
showed no activity whatsoever, which caused us to abandon this approach. Specifically, the
fact that the bis(methylamino) derivative 19d, differing only from the 1° diamine 9 by the
presence of two methyl groups, revealed no activity at all (entry 4), gave a strong indication
that this was not the right system for our ligands to be applied to. Strikingly, the literature
describing this catalytic system mainly involved alkylated trans-diamine-based ligands, for
which the results are in sheer contrast to our experience (see Figure 49 for a few examples).134
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Figure 49. Representative examples of optically pure diamine ligands used in ATH with
manganese pentacarbonyl bromide.134

Next, we decided to evaluate our ligands using a ruthenium-based system with i-PrOH
as the reducing agent that had been described in literature to give good results in combination
with sulfonamide type ligands.137 To this extent, we combined two ruthenium catalysts with our
sulfonamide ligands, and compared them side-by-side. We deviated from the literature
procedure by stirring our reaction mixtures for 48 hours instead of 72 hours. The results are
shown in the following table:
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Table 23
Evaluation of Ligand Selectivity for ATH Using a Ruthenium-based Catalyst.

Entry
1
2
3
4
5
6

Ligand
20a
20a
20b
20b
20c
20c

X=
Benzene
Cymene
Benzene
Cymene
Benzene
Cymene

e.e. (%)a
2
4
1
2
14
9

Configurationb
R
R
R
R
R
R

Conversion (%)c
Trace
Trace
10
7
87
87

a

Determination through chiral HPLC.
Assignment by correlating HPLC data to literature.137
c
Calculated through integration of CH(OH) at 4.89 ppm for product 23 vs. aldehyde CH3 at 2.59 ppm.
b

Aside from the relatively quick conversion observed for monotosylate ligand 20c, the
results were rather disappointing. Neither 20a nor 20b could produce a decent amount of
product, and the small quantity that did form was close to racemic, regardless of the catalyst
used (entries 1-4). For 20c a small increase in selectivity was observed, yet, the numbers were
not nearly sufficient to claim a decent asymmetric process. Between the two catalysts,
however, the benzene-ruthenium complex appeared to be more effective than its cymene
counterpart (entries 5,6). Overall, the presence of a primary amino group in combination with
a sulfonamide group resulted in the highest conversion in 48 hours. The increase in selectivity
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might also be explained by the fact that 20c is actually not symmetrically substituted and,
therefore, it is not the axial chirality of this ligand (alone) that induces the asymmetry in the
reaction. The enantioselectivity of comparable trans-amino sulfonamides described in the
literature, far exceed ours (14% versus 68% enantiomeric excess).137 A significant difference,
however, can be found in the fact that a (-)-menthol-derived backbone was used in the
literature rather than a conventional cyclohexane-based scaffold (Figure 50), which allows for
the introduction of additional asymmetry in the system.137

Figure 50. Representative chiral ligand used in ATH bearing the trans-amino sulfonamide
functionality.137

Finally, we tested our sulfonamide ligands using formic acid as an alternative hydrogen
source,136 in combination with a different solvent, to test whether our ligands would yield more
useful results.138 Evaluating the same two ruthenium catalysts as before, the following data
were generated:
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Table 24
Evaluation of Ligand Selectivity for ATH Using a Ruthenium-based Catalyst with a Formic Acid
Hydrogen Source in Acetonitrile.

Entry
1
2
3
4
5
6

Ligand
20a
20a
20b
20b
20c
20c

X=
Benzene
Cymene
Benzene
Cymene
Benzene
Cymene

Reaction time (h)
22
22
48
48
48
48

e.e. (%)a
3
0
19
14
9
11

Configurationb
R
R
R
R
R
S

Conversion (%)c
5
7
4
6
39
15

a

Determination through chiral HPLC.
Assignment by correlating HPLC data to literature.137
c
Calculated through integration of CH(OH) at 4.89 ppm for product 23 vs. aldehyde CH3 at 2.59 ppm
b

It is quite evident from the table that neither 20a nor 20b could produce a decent
amount of product, as was observed under the conditions of Table 23 (previous experiment)
where i-PrOH served as both the hydrogen source and solvent. A small increase in selectivity
with regards to the previous conditions was observed for 20b, with the benzene-ruthenium
complex being the more suitable catalyst (entries 3, 4). However, a decent enantioselectivity
was not obtained. It is quite apparent that the requirement for the ligand possessing at least
one (primary) amine is vital to the process as both 20a and 20b lack the capability of producing
a significant amount of product under either set of typical conditions tested. Looking at the
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results of ligand 20c, a small increase in conversion can be found (particularly for entry 5), yet a
good catalytic activity as was observed for entries 5 and 6 in Table 23 (previous experiment)
remains lacking. One remarkable observation can be made by looking at the preference for
either (R)- or (S)-23, which appears to switch as a function of the ruthenium complex (benzene
versus cymene).
Thus far, the results are not very promising for asymmetric transfer hydrogenation
based on the type of ligands we synthesized. With the exception of (4aS,6R,7S,8aS)-9 (42%
e.e.), none of the ligands caused a significant enantiodiscrimination in any of the three systems
evaluated. Perhaps the interatomic distance between the amino-/sulfonamide-groups is of an
inappropriate dimension to properly complex the ruthenium/manganese catalyst, in which case
using a different-size metal may offer a potential pathway leading to better results. X-ray
crystallography or computational studies might aid in the selection of an appropriate metal
catalyst in the future. Optimization of the reaction conditions in combination with ligand 9 or
newly synthesized comparable derivative may alternatively increase the enantiomeric excess
for this asymmetric system.
3.7 First Exploration Towards Switchable Chiral Ligands
In parallel to our efforts of investigating efficient asymmetric systems for our ligands, we
pursued the development a ligand capable of switching its axial chirality and, as a consequence,
the configuration of the product of the asymmetric reaction. In other words, if the original
ligand would produce an (S)-configured product, the ligand with a switched conformation
would produce the opposite (R)-configured enantiomer. We deemed our type of ligand
particularly suitable for such a concept due to the fact that only the axial chirality of the
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molecule is supposed to induce enantiodiscrimination in the product formation (ligand 20c
being the only exception). The switching of this axial chirality would invert the axial-equatorial
relation between the two amino groups to equatorial-axial and, hence, the axial chirality would
be inverted. A chemical modification on a remote location could hypothetically induce a
conformational change in the structure that mechanically transfers to the catalytic site of the
molecule, with an inversion of its axial chirality as a result (Figure 51).

Figure 51. Inversion of axial chirality in the catalytic site of the ligand.

This inverted conformation of a ligand would then catalyze the formation of a product
of opposite configuration. In order to design such a molecule, three components need to be
considered: the catalytic site, a remote chemical switch, and a linker to transfer the chiral
information (see chapter 1.4). With the catalytic site already designed, we needed to construct
a chemical switch that could be readily modified.
A cyclohexene-based structure seems suitable due to the versatile reactivity of the πbond. As a linker responsible for connecting the two components, options as described in the
literature based on perhydroanthracene or, cis-decalin (Figure 19, chapter 1.4), may seem
useful at first, 93 but come with major (synthetic) challenges (Figure 52):
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Figure 52. a) Conformational switching of tetra-substituted perhydroanthracene,93 and b)
Consequences of applying perhydroanthracene type structure for cis-DACH-based ligand.

First of all, our catalytic site is cis-oriented, meaning that on its own it has no preference
for either chair conformation of the ring, forcing the switch to solely occur based on the
modification done on the other end of the molecule (Figure 52a). Looking at the
perhydroanthracene structure, any substituents R2 would initially assume a trans-diequatorial
orientation, making it exceptionally difficult to induce a conformational switch utilizing these
substituents because they would need to be forced into a diaxial position. Removal of the
TBDPS group would leave the conformation unchanged in this case. Secondly, utilizing a
chemical means to switch conformations, is not applicable to our situation becasue no
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possibility exist to lock the other side in place, as this is our catalytic site (see Figure 52b above).
For this reason, the use of a “simple” mono-, di, or tricyclohexane fused-ring system seems
impractical to our cause. For this reason, we envisioned the use of two cyclohexene rings,
connected through a less rigid, and sterically less demanding, crown-ether-based linker.
Ever since their first discovery by Pedersen,147 crown ethers have seen a tremendous
increase in their stand-alone applications ,87,148–150 as well as their utility as fundamental
building blocks comprising higher order structures in the shape of cryptands and
(pseudo)rotaxanes.151,152 Their unique suitability in host-guest chemistry has sparked the
emergence of supramolecular chemistry and molecular machinery.87,148,150,153 We envisioned
that by designing our chemical switch in a specific manner, we could utilize a crown ether linker
for the purpose of transferring a conformational change from one cyclohexane ring to another
(Figure 53).

Figure 53. Concept of the switchable chiral ligand, where a structural modification on a remote
location in the molecule induces a substituent interconversion from axial to equatorial and vice
versa.
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From a practical perspective, the amino groups in ring A will originally reside in an axialequatorial orientation, and the crown ether linker will reside in tetra-equatorial positions on all
connecting carbon atoms. Upon epoxidation of ring B followed by cleavage with a nucleophile,
the OH-X system will be oriented in a trans-diaxial orientation, as long as there is no favorable
interaction between the substituents and/or X is small enough not to force the crown ether
linkage in a diaxial position. Chemically modifying the OH-X system to a ring-closed variant, will
lock the ether linkage on ring B in a diaxial position. The consequential extension of the linker
may cause the ether linkage on ring A to adopt the same conformation As a result the amino
groups on ring A are forced to interchange conformation, which leads to an inversion of axial
chirality at the catalytic site. Crown ethers seem particularly useful as linkers due to the facile
variation in their length, allowing for a trial-and-error determination of the optimal size, and
their relatively small steric hindrance as a result of axially oriented C-O fragments compared to
a C-CH2 connection.
We started our synthesis from the earlier described mono-epoxide 2 to construct the
half-crowns 24 (meso) and 25 (racemic) as a mixture (Scheme 25), following a literature
procedure.154

Scheme 25. Simultaneous synthesis of half-crowns 24 and 25 by epoxide cleavage of 2.154

150
Two equivalents of epoxide 2 were reacted with diethylene glycol in the presence of a
catalytic amount of sodium hydride at 60°C. This resulted in a combined 32% yield for the
trans-syn-trans (24) and trans-anti-trans (25) diols after chromatography. In an attempt to
increase the yield we performed identical reactions utilizing different solvents, and replacing
sodium hydride with a variety of Lewis acids, for which the results are summarized in the table
below.

Table 25
Synthesis of half-crowns 24 and 25 under various conditions.
Entry
Catalyst
Solvent
Temperature (°C)
Result
1
NaH
Neat
60
32% yielda
2
NaH
THF
50
No reaction
3
NaH
DMSO
50
No reaction
4
BF3.(OEt)2
DCM
-84
Multiple products, 27% yield,a impure
5
Cu(II)OTf2
DCM
25
Multiple products
6
Zn(II)OTf2
DCM
25
No reaction
7
LiClO4
DCM
40
No reaction
a

After chromatography.

As can be seen from entry 1, the original conditions resulted in obtaining the highest
product yield. Performing the same reaction in solvents THF and DMSO surprisingly did not
lead to any (significant) product formation (entries 2 and 3). Performing the reaction in the
presence of a Lewis acid instead of sodium hydride led to various results with weaker Lewis
acids not being able to facilitate the ring opening (entries 6 and 7). Conversely, when the Lewis
acid appeared strong enough, a multitude of products was obtained (entries 4 and 5). Analysis
of the crude mixture synthesized according to entry 4 through accurate mass determination,
revealed the presence of extended “half-crowns” containing one or two additional cyclohexanol
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moieties (Figure 54). It turned out that the 2° alcohol on the cyclohexane ring, generated by
cleaving one of the available epoxides, demonstrated a superior reactivity towards the
subsequent cleavage of another epoxide compared to the di(ethylene glycol) 1° alcohol. A
possible explanation for this may be that the 1° alcohol, due to its high flexibility and increased
movement, is less available for cleavage than a more rigid 2° alcohol under Lewis-acidic
conditions. A second possibility involves the potential complexation of the product resulting
from the initial cleavage with the Lewis acid, making the 2° alcohol more available as a
nucleophile, or more closely connected to the metal cation because of the convenient gauchearrangement with the next oxygen attached to the same ring. Alternatively, the primary
alcohol could be more basic in the presence of NaH, making this the more suitable nucleophile
under basic conditions. To further support our hypothesis, and to eliminate the possibility that
the masses found using the DART-AccuTOF were due to reactions in the ion source, we purified
the target product obtained through entry 4 (Table 25 above) using column chromatography.
Analysis of the “pure” compound revealed a single spot on TLC, yet appeared to consist of more
than one product when analyzed by NMR, most likely due to the fact that the sample consists
of 24/25 in combination with the second compound shown in Figure 54, possessing an identical
exact mass.
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Figure 54. Analysis of crude product obtained through synthesis of the half-crowns following
entry 4 in Table 25 on a DART-AccuTOF mass spectrometer.

Due to the significant formation of side-products using Lewis acids, in combination with
the fact that one of these products co-elutes with our target compound, we decided not to
pursue the synthesis of 24 and 25 through this method, and use the original approach adapted
from literature.154
Cyclization to the desired dicyclohexeno-18-crown-6 was conducted following a
procedure as described by Huber and Dietz.155 The diols were transformed into their
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corresponding alkoxides using stoichiometric quantities of sodium hydride, after which they
were allowed to react with di(ethylene glycol) ditosylate to give the trans-syn-trans (26) and
trans-anti-trans (27) isomers of DCE18C6 (42% combined yield).

Scheme 26. Simultaneous cyclization of trans-syn-trans-DCE18C6 26 (17% yield) and trans-antitrans-DCE18C6 27 (25% yield).

To our disappointment, attempts to separate the isomers through crystallization
appeared unsatisfactory, unlike what had been reported for the analogous DC18C6 isomers.154
Luckily, the products could be separated by chromatography on silica and, in contrast to the
literature,154 both compounds were obtained in pure form. The meso isomer 26 and racemic
isomer 27 were isolated in 17% and 25% yield, respectively. To unequivocally determine the
relative stereochemistry of crown ethers 26 and 27, suitable single crystals for both compounds
were obtained through the slow-evaporation technique using n-hexane. Subsequent analysis of
the crystals through X-ray crystallography yielded the ORTEP diagrams as shown in Figure 55.
trans-syn-trans-DCE18C6 26 crystallizes in the triclinic space group P-1 with two half-molecule
fragments in the asymmetric unit straddling an inversion center.156 The two fragments are
nearly superimposable on each other with only slight deviations in the dihedral angles around
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the ethylene linkages. Both fragments contain an identical trans-syn-trans stereochemistry
around the cyclohexene moieties. An ORTEP diagram for one of the molecules of trans-syntrans-DCE18C6 (26) is shown in Figure 55 (top). The trans-anti-trans isomer (27) crystallizes in
the orthorhombic space group Pbca with one complete molecule in the asymmetric unit. 156 The
trans-anti-trans relative stereochemistry is clearly displayed in the ORTEP drawing shown in
Figure 55 (bottom).

Figure 55. ORTEP diagrams for trans-syn-trans-DCE18C6 (26, top) and trans-anti-trans-DCE18C6
(27, bottom).
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With the relative stereochemistry elucidated for both crown ethers 26 and 27, each
compound can be studied in terms of conformational switching. In their current state, all
cyclohexene attachments reside in a diequatorial orientation. With the modification of one of
the π-bonds through e.g. epoxidation and cleavage, the newly introduced groups will possibly
force one side of the crown ether moiety to adopt a diaxial conformation. The primary
hypothesis that this chiral information can be transferred to the other side of the crown ether,
inducing a conformational switch in the catalytic site, will be investigated.
Potentially, a shorter crown ether segment may need to be introduced due to the
relative flexibility of the crown ether moiety. Nevertheless, a first fundamental step towards
understanding the mechanistic properties of this type of crown ether has been made, that
allows for convenient study of this type of system. Finally, the synthesis of the crown ethers 26
and 27 itself is the first example of a dicyclohexene-based crown ether described in the
literature.157 We have realized this through a convenient 3-step route combined with a
chromatographic separation of the final products resulting in the isolation of the pure crown
ethers. Potentially, this novel compound may find many other applications in molecular
machinery or supramolecular chemistry, owing to the well-defined conformational behavior of
substituents in cyclohexane derivatives.
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CHAPTER 4: CONCLUSIONS

1. A convenient 8-step synthetic route has been developed for the purpose of
obtaining a chiral cis-DACH scaffold, containing two vicinal primary amines. An
overall 35% yields from 1,4-cyclohexadiene to the target scaffold has been achieved.
2. Chiral resolution of the 6-(2-chloroethoxy)cyclohex-3-enol intermediate has been
achieved through both chemical and enzymatic methodologies. Of these two, the
chemical resolution, utilizing (S)-(+)-ibuprofen to obtain separable diastereomers,
resulted in retrieval of the intermediate in high optical purity for the (1S,6S)enantiomer. The other, however, was less well-resolved. In comparison, the
enzymatic approach yielded both enantiomers at optically pure quality (>99% e.e.).
3. Chiral resolution of the abovementioned intermediate was followed by a multistep
stereospecific synthesis of both enantiomers of a model cis-1,2-diaminocyclohexane
scaffold in a locked conformation. Unambiguous determination of the absolute
configuration of both enantiomers of the final products and every intermediate was
achieved through single-crystal X-ray crystallography of the tosyl azide intermediate.
This absolute configuration has subsequently been linked to the optical rotation
signs retrieved through polarimetry, and the retention times on chiral HPLC.
4. The resolved primary diamine scaffold proved to be particularly suitable for
derivatization into a library of secondary cis-diamine-based ligands through two-step
reductive amination, or sulfonylation, leading to the synthesis of 15 chemically
diverse and enantiomerically pure ligands in a range of yields.
5. The synthesized ligands proved to be capable of efficiently catalyzing the Henry
reaction, with moderate to good enantiodiscrimination. Optimization of the
reaction conditions in terms of solvent and temperature led to a maximum of 75%
enantiomeric excess, yet further optimization is possible. Unfortunately, less
success was achieved when applying the chiral ligands in asymmetric transfer
hydrogenation, where a single ligand resulted in a decent catalytic activity at the
cost of selectivity, while another chiral ligand induced a maximum of 42%
enantiomeric excess, at a low conversion of 22% starting material to product.
6. A pioneering step has been made towards the construction of a chiral ligand, based
on the cis-1,2-diaminocyclohexane motif, capable of inverting its own chirality
through a conformational switch. For this purpose, two of the possible five
stereoisomers of the novel cyclohexeno-18-crown-6 have been synthesized and fully
characterized through NMR spectroscopy and single crystal X-ray crystallography.
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The results of our research have been partially published in a peer-reviewed chemical
journal and presented at the National Meetings of the American Chemical Society in San Diego
(2019) and San Francisco (2020), and the American Association of Pharmaceutical Scientists
InSight Symposium in Nanjing, China (2018).

JOURNAL ARTICLE(S)


van Beek, C., Catalano V.J., Samoshin, V.V., Synthesis of novel dicyclohexenocrown ethers with strategically incorporated double bonds for further
functionalization, ARKIVOC, 2020, (vi), 60-65.

POSTERS AND PRESENTATIONS


van Beek, C., Mendoza, O., Samoshin, V.V., Potential of cis-diaminocyclohexanebased conformationally locked chiral ligands in asymmetric synthesis, ACS Fall
2020 National Meeting & Exposition, San Francisco, CA, United States, August
2020.



van Beek, C., Samoshin, V.V., Exploration of cis-diamine-based conformationally
locked chiral ligands in asymmetric synthesis, ACS Fall 2019 National Meeting &
Exposition, San Diego, CA, United States, August 2019.



van Beek, C., Zheng, Y., Liu, X., Franz, A., Guo, X., Samoshina, N.M., Samoshin,
V.V., pH-Induced conformational switching in novel amphiphiles for potential
application in liposomes for targeted drug delivery, 3rd American Association of
Pharmaceutical Scientists InSight Symposium, Nanjing, China, May 2018.

158
CHAPTER 5: EXPERIMENTAL

5.1 Materials & Methods
Starting reagents were purchased from commercial sources (Sigma Aldrich, TCI, Alfa
Aesar, AKSci) and used without additional purification. All solvents were dried/purified by
conventional techniques. The reactions were monitored by TLC on silica gel (8 x 2 cm) plates
from Analtech Inc. (visualization by UV light, staining with I2, phosphomolybdic acid, KMnO4,
ninhydrin, or a combination of one or more of these methods). Column chromatography was
performed on silica gel (40-75 μm, Sorbent Technologies). Hypersep C18 (1 mL, 50 mg; 6 mL,
500 mg) SPE columns were purchased from Thermo Fisher. Bond Elut C18 (1 mL, 50 mg) SPE
columns were gifted by Agilent Technologies. Enzymes used in the chiral resolution were
received as a gift from Amano Enzyme. 1H-NMR and 13C-NMR spectra were acquired on JEOL
ECA-600 NMR-spectrometer (600 MHz for 1H and 151 MHz for 13C). NMR chemical shifts are
reported in parts per million (ppm) and reported relative to the chemical shift of the solvent
residual peaks of the deuterated solvent used (7.26/77.16 ppm, CDCl3; 3.31/49.00 ppm,
CD3OD). High resolution mass spectra (HRMS) were obtained on a JEOL AccuTOF time-of-flight
mass spectrometer (Peabody, MA) coupled with an Ionsense DART open-air ionization source
(Saugus, MA), or an ESI source. Chiral HPLC chromatograms were obtained using a Shimadzu
LC-10AT VP liquid chromatography system with an SPD-M10A VP diode array detector
(tungsten and hydrogen lamps) and a SCL-10A VP system controller. Solvents used in this
analysis were of HPLC grade. Chiral separation was realized using an Astec Cellulose DMP chiral
column (25 cm x 4.6 mm, 5 µm particle size). Gas chromatography chromatograms were
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obtained with a Shimadzu GC-2014 AFsc GC system, equipped with an AOC-20i auto injector.
Separation was achieved using a SHRXI-5MS capillary column (FD = 0.25 mm, ID = 0.25 µm, L =
15 m). Crystallographic data were collected the University of Nevada, Reno, at 150K using a
Bruker Smart Apex II single crystal diffractometer with MoKα (λ = 0.71073 Å) using omega and
psi scans. Frames were integrated with the Bruker SAINT software package using a narrowframe algorithm. Data were corrected for absorption effects using the Multi-Scan method
(SADABS). Structures were solved and refined using the Bruker SHELXTL Software Package.
Optical rotations were recorded at room temperature on an Autopol® I automatic polarimeter
using a 100 mm cell with quartz glass windows.
5.2 Synthesis of Chiral cis-DACH Scaffold
Synthesis of 7-oxa-bicyclo[4.1.0]hept-3-ene (2)

To a stirred solution of 1,4-cyclohexadiene 1 (20.0 mL, 205 mmol) in dichloromethane
(1.00 L) at 0°C was added mCPBA (55.4 g, 238 mmol) in a portion-wise fashion. The mixture
was subsequently stirred at 0°C for 1h, followed by stirring at room temperature for 16 hours.
Next, 5% w/w Na2SO3 (aq.) (400 mL) was added, followed by vigorous stirring for 1 hour at
room temperature. The water layer was extracted with DCM (2x200 mL). The combined
organic extracts were washed with saturated NaHCO3 (aq.) (2x250 mL) and brine (1x100 mL),
dried over anhydrous Na2SO4, and concentrated in vacuo. The residual yellow oil was subjected
to vacuum distillation (20 mbar, 47-49°C), yielding the pure epoxide 2 as a colorless oil (13.73 g,
70%). 1H-NMR (600 MHz, CDCl3) δ 5.44 (dd, 2H; H3, H4), 3.24-3.25 (m, 2H; H1, H6), 2.58-2.60
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(m, 1H; H2), 2.54-2.56 (m, 1H; H5), 2.46-2.47 (m, 1H; H2), 2.43 (m, 1H; H5).

13C-NMR

(151 MHz,

CDCl3) δ 121.67 (C3, C4), 51.15 (C1, C6), 25.11 (C2, C5). HRMS: calculated for C6H8O [M+H]+ m/z
97.0653; observed m/z 97.0646.
Synthesis of 6-(2-chloroethoxy)cyclohex-3-enol (3)

The epoxide 2 (2.29 g, 23.8 mmol) was added to a flame-dried argon-flushed roundbottomed flask followed by 2-chloroethanol (10 mL) and ytterbium(III)triflate (74 mg, 0.12
mmol). The resulting solution was stirred at room temperature for 16 hours. The reaction
mixture is then diluted with chloroform (345 mL) and washed with 5% NaOH (aq.) (30 mL).
Next, the aqueous phase was extracted with chloroform (2 x 236 mL) and the combined organic
layers were washed with brine (70 ml), dried over anhydrous Na2SO4, filtered, and concentrated
in vacuo to give a crude solution (18 g, 428%). The excess 2-chloroethanol is removed using
vacuum distillation in a temperature range of 38-48°C between 0-30 mbar. The residue was
collected as a crude orange oil (4.6 g, 118%) that was subsequently submitted to column
chromatography (SiO2, hexane/ethyl acetate 3:1). After removal of the solvents the pure
compound 3 was obtained as a colorless liquid (3.59 g, 86%). 1H-NMR (600 MHz, CDCl3) δ 5.585.52 (m, 2H; H3, H4), 3.95-3.92 (m, 1H; ROHCHCH2Cl), 3.82-3.78 (m, 1H; H1), 3.73-3.69 (m, 1H;
ROHCHCH2Cl), 3.67-3.64 (m, 2H; CH2Cl), 3.42 (td, J = 9.4, 5.8 Hz, 1H; H6), 2.91 (d, J = 1.3 Hz, 1H;
OH), 2.47-2.62 (2H; H21, H51), 2.12-2.00 (m, 2H; H22, H52).

13C-NMR

(151 MHz, CDCl3) δ 124.9

(C3), 123.8 (C4), 80.7 (C6), 70.4 (C1), 69.5 (ROCH2CH2Cl), 43.6 (CH2Cl), 32.8 (C2), 30.6 (C5).
HRMS: calculated for C8H13ClO2 [M+H]+ m/z 177.0682; observed m/z 177.0673.
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Synthesis of 2,3,4a,5,8,8a-hexahydrobenzo[b][1,4]dioxine (4)

A flame-dried 500 mL RB flask is placed under argon atmosphere and equipped with
stirrer bar. To this is added anhydrous THF (140 mL) followed by NaH (973 mg, 24.32 mmol)
and NaI (3.04 g, 20.27 mmol). Next, 6-(2-chloroethoxy)cyclohex-3-enol (3) (3.58 g, 20.27 mmol)
was dissolved in THF (180 mL) and added to the flask. The glassware containing the initial
solution was rinsed with anhydrous THF (38 mL), and additionally added. The resulting
suspension was stirred at room temperature for 30 minutes and subsequently heated to 65°C
followed by stirring for 22h at this temperature. Next, THF was carefully removed under
reduced pressure (product 4 has a high volatility). The flask containing the residue washed with
DCM (3 x 36 mL), filtered to remove any solid salts, to obtain heterobicyclic compound 4 as a
turbid solution in DCM. The solution was used without further purification in the synthesis of
epoxide 5 (see next experiment). For the purpose of characterization, a small aliquot of the
DCM solution was withdrawn, carefully concentrated under reduced pressure, and purified
using column chromatography (SiO2, hexane/ethyl acetate 3:1). 1H-NMR (600 MHz, CDCl3) δ
5.55-5.51 (m, 2H; H3, H4), 3.82-3.76 (m, 4H; -O(CH2)2O-), 3.51-3.49 (m, 2H; H1, H6), 2.40-2.33
(m, 2H; H21, H51), 2.11-2.05 (m, 2H; H22, H52).

13C-NMR

(151 MHz, CDCl3) δ 124.3 (C3, C4), 76.3

(C1, C6), 67.1 (-OCCO-), 31.1 (C2, C5). HRMS: calculated for C8H13O2 [M+H]+ m/z 141.0916;
observed m/z 141.0885.
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Synthesis of octahydrooxireno[2',3':4,5]benzo[1,2-b][1,4]dioxine (5)

The DCM solution containing heterobicycle 4 (2.84 g, 20.27 mmol, 108 mL) from the
previous experiment was added to a 250 mL round-bottomed flask equipped with stirrer bar.
The solution was cooled to 0°C under stirring. Next, mCPBA 77% (7.00 g, 30.40 mmol ) was
added to the solution at 0°C, in a few portions. The resulting mixture was allowed to reach
room temperature and was stirred for 16 hours. The resulting suspension is quenched with 5%
w/w Na2SO3 solution (aq.) (36 mL) and stirred for 30 minutes at room temperature. Starch
paper was used to check for peroxide presence which showed up negative. The resulting 2phase system was separated and the water layer extracted with DCM (2 x 36 mL). The
combined organic layers were washed with saturated sodium bicarbonate (1 x 100 mL, 1 x 70
mL) and brine (1 x 70 mL). The combined organic layers dried over Na2SO4, filtered and partially
concentrated under reduced pressure, yielding epoxide 5 as a clear solution in DCM (4.5 g,
142%). This solution was used in the next experiment without further purification. For the
purpose of characterization, a small aliquot of the DCM solution was withdrawn, carefully
concentrated under reduced pressure, and analyzed as a crude sample. 1H-NMR (600 MHz,
CDCl3) δ 3.72-3.67 (m, 4H; -O(CH2)2O-), 3.38 (td, J = 10.1, 5.3 Hz, 1H; H1), 3.26 (ddd, J = 13.7,
6.5, 4.0 Hz, 1H; H6), 3.21-3.20 (m, 1H; H4), 3.07-3.14 (m, 1H; H3), 2.47 (dddd, J = 14.5, 5.3, 2.1,
0.6 Hz, 1H; H21), 2.32 (ddd, J = 15.3, 7.2, 5.4 Hz, 1H; H51), 1.88 (dd, J = 15.3, 10.6 Hz, 1H; H22),
1.73 (ddd, J = 14.5, 10.6, 1.7 Hz, 1H; H52).

13C-NMR

(151 MHz, CDCl3) δ 75.3 (C6), 73.2 (C1), 67.1
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(-OCCO-), 67.0 (-OCCO-), 53.2 (C4), 50.7 (C3), 29.9 (C2), 29.9 (C5). HRMS: calculated for C8H13O3
[M+H]+ m/z 157.0865; observed m/z 157.0936.
Synthesis of 7-azidooctahydrobenzo[b][1,4]dioxin-6-ol (6)

Epoxide 5 in DCM (4.5 g, 20.27 mmol) was added to a 100 mL round-bottomed flask and
placed in a 30°C water bath under stirring. Next, NaN3 (1.41 g, 101.3 mmol) in H2O (41 mL) was
added followed by stirring for 16 hours at this temperature. The resulting emulsion is
subsequently transferred to a separatory funnel and extracted with Et 2O (2 x 180 mL) and
saturated with NaCl. This aqueous mixture is extracted with Et2O (180 mL) once more. The
combined organic layers are the dried over Na2SO4 and concentrated in vacuo to give the crude
azido alcohol 6 as a yellow oil. Subsequent purification using column chromatography
(hexane/ethyl acetate 4:6) yielded the pure azido alcohol 6 as a colorless oil (3.20 g, 80% from 3
to 6). 1H-NMR (600 MHz, CDCl3) δ 4.03 (s, 1H; H7), 3.84 (d, J = 2.9 Hz, 1H; H6), 3.78-3.77 (m, 4H;
-O(CH2)2O-), 3.60-3.56 (m, 1H; H8a), 3.45 (dd, J = 16.5, 8.9 Hz, 1H; H4a), 1.97 (d, J = 3.1 Hz, 1H;
H5eq), 1.95 (d, J = 3.1 Hz, 1H; H5ax), 1.92-1.89 (m, 1H; H8eq), 1.82 (d, J = 3.0 Hz, 1H; OH), 1.791.74 (m, 1H; H8ax).

13C-NMR

(151 MHz, CDCl3) δ 75.3 (C4a), 74.9 (C8a), 68.8 (C7), 67.6 (-OCCO-),

61.6 (C6), 32.8 (C5), 29.2 (C8). HRMS: calculated for C8H14N3O3 [M+H]+ m/z 200.1035; observed
m/z 200.1022, [2M+H]+ m/z 399.2081.

164
Synthesis of 7-azidooctahydrobenzo[b][1,4]dioxin-6-yl 4-methylbenzenesulfonate (7)

7-azidooctahydrobenzo[b][1,4]dioxin-6-ol (6) (2.98 g, 14.95 mmol) is dissolved in freshly
distilled chloroform (30 mL) and transferred to a flame-dried, argon-flushed 100 mL roundbottomed flask, equipped with stirrer bar. Pyridine (9.13 mL) is added to the solution, followed
by cooling the to 0°C under argon atmosphere using an ice-bath. Next, p-toluenesulfonyl
chloride (18.72 g, 97.23 mmol) is added and the reaction is subsequently stirred at 0 °C for 30
minutes. Then, the mixture is heated to 40 °C and stirred at this temperature for 70 hours. The
solution is then transferred to a separatory funnel and extracted with 0.5 M HCl (3 x 15 mL),
H2O (1 x 10 mL), and brine (1 x 10 mL). The organic phase is then dried over Na2SO4 and
concentrated in vacuo to yield the crude product as a light-yellow solid. Subsequent
purification using column chromatography (SiO2, hexane ethyl acetate 4:1  1:1) gave the pure
product 7 as a white solid (4.86 g, 92%). 1H-NMR (600 MHz, CDCl3) δ 7.80 (dt, J = 8.4, 1.9 Hz,
2H; o-CH), 7.38 (dd, J = 8.6, 0.6 Hz, 2H; m-CH), 4.54 (d, J = 2.9 Hz, 1H; H7), 3.93-3.92 (m, 1H; H6),
3.77-3.72 (m, 4H; -O(CH2)2O-), 3.47-3.42 (m, 1H; H8a), 3.42-3.38 (m, 1H; H4a), 2.47 (s, 3H, CH3),
2.01-1.97 (m, 1H; H5eq), 1.90-1.85 (m, 1H; H5ax), 1.85-1.81 (m, 1H; H8eq), 1.74-1.69 (m, 1H;
H8ax).

13C-NMR

(151 MHz, CDCl3) δ 145.6 (CSO2 , 133.3 (CCH3), 130.3 (m-CH), 127.9 (o-CH), 77.3

(C7), 74.4 (C4a), 74.4 (C8a), 67.5 (-OCCO-), 59.4 (C6), 30.5 (C8), 29.3 (C5), 21.9 (CH3). HRMS:
calculated for C15H20N3O5S [M+H]+ m/z 354.1124; observed m/z 354.1251.
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Synthesis of 6,7-diazidooctahydrobenzo[b][1,4]dioxine (8)

Tosylate 7 (2.00 g, 5.66 mmol) is placed in a flame-dried argon flushed 100 mL roundbottomed flask, equipped with stirrer bar. Next, anhydrous DMF (52 mL) and sodium azide
(743 mg, 11.32 mmol) are added to the flask under stirring. The resulting suspension is heated
to 100°C in an oil bath and stirred for 15 hours at this temperature. After this time, the reaction
mixture was allowed to reach room temperature followed by the addition of H2O (17.3 mL).
The resulting solution is extracted with pentane (1 x 52 mL) and Et2O (3 x 52 mL). The
combined organic layers are washed with brine (20 mL), dried over Na2SO4, and concentrated
under reduced pressure yielding the crude product as a yellow solution in DMF (± 10 mL). This
crude solution was submitted to column chromatography (SiO2, pentane/diethyl ether 3:1 
1:1). After removal of the solvents in vacuo this resulted in the isolation of the pure diazide 8 as
a white solid (1.27 g , 84%). 1H-NMR (600 MHz, CDCl3) δ 3.98 (d, J = 2.1 Hz, 1H; H7), 3.79-3.70
(m, 4H; -O(CH2)2O-), 3.51 (dt, J = 12.3, 3.7 Hz, 1H; H6), 3.47-3.44 (m, 1H; H8a), 3.19 (ddd, J =
12.5, 8.2, 3.6 Hz, 1H; H4a), 2.13 (dt, J = 13.9, 3.9 Hz, 1H; H8eq), 2.06 (dtd, J = 12.2, 4.2, 1.4 Hz,
1H; H5eq), 1.91 (q, J = 12.1 Hz, 1H; H5ax), 1.56-1.51 (m, 1H; H8ax).

13C-NMR

(151 MHz, CDCl3) δ

77.4 (C4a), 74.2 (C8a), 67.4 (-OCCO-), 67.2 (-OCCO-), 61.1 (C6), 59.6 (C7), 32.4 (C5), 29.6 (C8).
HRMS: calculated for C8H13N4O2 [M-N2+H]+ m/z 197.1038; observed m/z 197.1033.
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Synthesis of octahydrobenzo[b][1,4]dioxine-6,7-diamine (9)

The diazide 8 (2.00 g, 8.92 mmol) was dissolved in anhydrous THF (77 mL) and added to
a 250 mL flame-dried, argon-flushed round-bottomed flask. Next water (803 μL, 44.6 mmol)
was added to the mixture and the resulting solution was cooled to 0°C on an ice bath. Finally,
triphenylphosphine (5.85 g, 22.3) in THF (38 mL) was added drop-wise at 0°C. The solution was
subsequently heated to 50°C using a heating mantle under stirring and an argon atmosphere.
After 22 hours of stirring, the reaction mixture is concentrated under reduced pressure yielding
the crude product as a white solid. The product was subsequently submitted to column
chromatography (chloroform/methanol/concentrated ammonia 10:1.5:0.15  10:2:0.2) which
resulted in isolation of the pure title compound 9 as a light-yellow solid (1.45 g, 95%). 1H-NMR
(600 MHz, CD3OD) δ 3.74-3.68 (m, 4H; -O(CH2)2O-), 3.47-3.43 (m, 1H; H8a), 3.18 (ddd, J = 12.4,
8.3, 3.7 Hz, 1H; H4a), 3.06 (d, J = 3.2 Hz, 1H; H7), 2.89 (dt, J = 12.4, 3.8 Hz, 1H; H6), 1.89 (ddd, J =
13.3, 4.2, 3.1 Hz, 1H; H8eq), 1.75 (dt, J = 12.3, 3.9 Hz, 1H; H5eq), 1.58-1.51 (m, 2H; H5ax, H8ax).
13C-NMR

(151 MHz, CD3OD) δ 79.6 (C4a), 76.0 (C8a), 68.4 (-OCCO-), 68.1 (-OCCO-), 52.4 (C7),

52.3 (C6), 35.9 (C8), 33.6 (C5). HRMS: calculated for C8H17N2O2 [M+H]+ m/z 173.1290; observed
m/z 173.1240.
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5.3 Resolution of Chiral Intermediates
Synthesis of 2-(((1R,2S,5R)-2-isopropyl-5-methylcyclohexyl)oxy)acetic acid (10)

(-)-menthol (7.8 g, 49.9 mmol) was added to a 250 mL 3-necked round-bottomed flask
followed by 1,4-dioxane (100 mL). The mixture was stirred until full dissolution of the starting
material was achieved. Next, 60% sodium hydride in mineral oil (9.98 g, 250 mmol) was added
in small portions leading to the formation of a white suspension. 2-chloroacetic acid (9.53 g,
99.8 mmol) was then dissolved in 1,4-dioxane (50 mL) and added to the mixture in a drop-wise
fashion. The resulting suspension was heated to reflux and stirred at this temperature for 4
hours. After completion of the reaction, dioxane was removed under reduced pressure. The
residue was dissolved in toluene (200 mL) and washed with H2O (3 x 100 mL). The water layers
were combined, acidified to pH 2 using 37% HCl and extracted with toluene (3 x 100 mL). The
organic layers were combined, dried over Na2SO4 and concentrated under reduced pressure
yielding the crude compound as a light-yellow oil. Purification was carried out using column
chromatography (SiO2, hexane/ethyl acetate 6:4) to yield the title compound as an orange oil
(6.77 g, 63%). 1H-NMR (600 MHz, CDCl3) δ 4.19 (d, J = 16.5 Hz, 1H; HCHCO2H), 4.07 (d, J = 16.5
Hz, 1H; HCHCO2H), 3.22 (td, J = 10.6, 4.2 Hz, 1H; H1), 2.21-2.16 (m, 1H; H5), 2.06-2.04 (m, 1H),
1.67-1.63 (m, 2H), 1.37-1.29 (m, 2H), 1.01-0.84 (m, 9H; (CH3)2C), 0.78 (d, J = 6.9 Hz, 3H; CH3).
13C-NMR

(151 MHz, CDCl3) δ 173.7 (CO2H), 80.9 (C1), 65.6 (CH2CO2H), 48.0, 40.0, 34.4, 31.6,
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25.9 (C5), 23.3, 22.3 ((CH3)2C), 21.1 ((CH3)2C), 16.3 (CH3). HRMS: calculated for C12H23O3 [M+H]+
m/z 215.1647; observed m/z 215.1607.
General procedure for the derivatization of racemic alcohols to diastereomeric esters

A 20 mL test tube with screwcap is purged with argon, equipped with a stirrer bar and
charged with alcohol (rac-3 or rac-6, 0.25 mmol) and chiral acid (0.28 mmol) in dry DCM (3 mL).
The resulting solution is cooled to 0°C in an ice bath. Next, a DCC stock solution (1.25 mL, 201
mM, 0.30 mmol) is added to the solution under stirring. Finally, DMAP stock solution (365 μL,
25.4 mM, 0.025 mmol) is added to the tube followed by dry DCM (1.85 mL). The resulting
mixture is subsequently stirred at 0°C for 1 hour, followed by continued stirring for 20 hours.
Next, dicyclohexylurea is filtered off and the DCM solution is washed with 5% NaHCO 3 solution
(3 mL) and brine (1 mL). Then, the solution is dried using Na2SO4, and the solvent removed
under reduced pressure to give a white solid. This general procedure led to the following crude
yields and mass-spectral data for compounds 11a-f and 12a-f:

Table 26
Crude Yields, Calculated Exact Mass, and Measured Accurate Mass for Esters 11 and 12.
Ester Crude
Exact
Accurate
Ester Crude
Exact mass
Accurate
+
11
Yield
mass
mass
12
Yield
[M+H]
mass [M+H]+
+
+
(%)
[M+H]
[M+H]
(%)
a
90
357.1469
357.1540
a
128
380.1822
380.1831
b
94
309.1257
309.1291
b
121
332.1610
332.1680
c
120
365.1883
365.1893
c
117
388.2236
388.2377
d
91
325.1207
325.1283
d
102
348.1559
348.1616
e
101
353.1156
353.1202
e
76
376.1509
376.1595
f
0
373.2146 Not observed
f
0
396.2498
Not observed
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Simultaneous synthesis of (S)-(1S,6S)- and (S)-(1R,6R)-6-(2-chloroethoxy)cyclohex-3-en-1-yl 2(4-isobutylphenyl)propanoate (11c)

DCC (18.23 g, 87.5 mmol) and (S)-(+)-2-(4-Isobutylphenyl)propionic acid (14.73 g, 70
mmol) are added to a flame-dried 500 mL round-bottomed flask, containing anhydrous DCM
(309 mL) at 0°C in an ice/acetone-bath under argon atmosphere. The resulting mixture is
stirred for 5 minutes. Then, racemic 6-(2-chloroethoxy)cyclohex-3-enol (3) (10.3 g, 58.3 mmol)
in anhydrous DCM (34 mL) is added, followed by DMAP (1.08 g, 8.75 mmol). The reaction is
stirred for 90 minutes at 0°C. Dicyclohexylurea is subsequently filtered off, the residue is
washed with 0°C DCM (10 mL) and the combined filtrate is concentrated under reduced
pressure yielding a combination of yellow oil and white solid. The crude material is triturated
with hexanes (1 x 50 mL, 2 x 10 mL) and filtered off. The hexane layers are combined and
concentrated under reduced pressure to yield a crude yellow oil. Purification was performed
submitting the crude sample to column chromatography (SiO2, hexane/ethyl acetate 97.5:2.5
 95.5:4.5), leading to the separate isolation of the diastereomers (S)-(1S,6S)-11c (8.51 g, 40%)
and (S)-(1R,6R)-11c (10.0 g, 47%). (S)-(1S,6S)-11c: 1H-NMR (600 MHz, CDCl3) δ 7.20 (d, J = 8.0
Hz, 2H; o-CH), 7.09 (d, J = 8.0 Hz, 2H; m-CH), 5.52 (t, J = 11.4 Hz, 2H; H3, H4), 5.03-4.99 (m, 1H;
H1), 3.67 (q, J = 7.1 Hz, 1H; -COCH-), 3.53-3.48 (m, 2H; H6, -OHCHCH2Cl), 3.42-3.38 (m, 1H; OHCHCH2Cl), 3.29-3.22 (m, 2H; -CH2Cl), 2.56 (dd, J = 16.1, 5.6 Hz, 1H; H2eq), 2.44 (d, J = 7.1 Hz,
2H; CH2, i-Bu), 2.31 (dd, J = 16.2, 5.5 Hz, 1H; H5eq), 2.08-2.04 (m, 2H; H2ax, H5ax), 1.84 (tt, J =
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20.2, 6.7 Hz, 1H; CH, i-Bu), 1.48 (d, J = 7.1 Hz, 3H; CH3), 0.89 (d, J = 6.6 Hz, 6H; (CH3)2, i-Bu).

13C-

NMR (151 MHz, CDCl3) δ 174.2 (C=O), 140.7 (C, Ph), 138.0 (C, Ph), 129.5 (m-CH), 127.4 (o-CH),
124.1 (C3), 123.7 (C4), 76.2 (-OCCCl-), 71.9 (C1), 70.4 (-CCl-), 45.5 (CH2, i-Bu), 45.2 (COCH), 42.9,
30.4, 30.3 (C2), 30.1 (C5), 22.5 (CH3, i-Bu), 18.6 (CH3, i-Bu). HRMS: calculated for C21H29ClO3
[M+H]+ m/z 365.1883; observed m/z 365.1893. (S)-(1R,6R)-11c: 1H-NMR (600 MHz, CDCl3) δ
7.20 (d, J = 8.0 Hz, 2H; o-CH), 7.09 (d, J = 7.9 Hz, 2H; m-CH), 5.54-5.47 (m, 2H; H3,H4), 5.01 (dd, J
= 14.1, 7.8 Hz, 1H; H1), 3.76-3.67 (m, 3H; -COCH-, H6, -OHCHCH2Cl), 3.60 (dd, J = 13.9, 7.9 Hz,
1H; -OHCHCH2Cl), 3.52-3.49 (m, 2H; CH2Cl), 2.44 (d, J = 7.1 Hz, 4H; H2eq, H5eq, CH2, i-Bu), 2.152.11 (m, 1H; H2ax), 1.96-1.92 (m, 1H, H5ax), 1.87-1.81 (m, 1H; CH, i-Bu), 1.50 (d, J = 7.2 Hz, 3H;
CH3), 0.89 (d, J = 6.5 Hz, 6H; (CH3)2, i-Bu).

13C-NMR

(151 MHz, CDCl3) δ 174.3 (C=O), 140.7 (C,

Ph), 137.8 (C, Ph), 129.4 (m-CH), 127.3 (o-CH), 123.9( C3), 123.8 (C4), 76.3 (C6), 71.8 (C1), 45.5 (COCH-), 45.2 (CH2, i-Bu), 43.2 (CCl), 30.4 (C5), 30.3 (CH, i-Bu), 29.8 (C2), 22.5 ((CH3)2, i-Bu), 18.5
(CH3). HRMS: calculated for C21H29ClO3 [M+H]+ m/z 365.1883; observed m/z 365.1893.
Synthesis of (S)-2-chloroethyl 2-(4-isobutylphenyl)propanoate (13)

(S)-(+)-2-(4-Isobutylphenyl)propionic acid (154 mg, 0.75 mmol) and 2-chloroethanol (42
µL, 0.62 mmol) are added to a flame-dried 10 mL round-bottomed flask, containing anhydrous
DCM (4 mL) at 0°C in an ice/acetone-bath under argon atmosphere. Then, DCC (192 mg, 0,93
mmol) in anhydrous DCM (1 mL) is added, followed by DMAP (11 mg, 0.26 mmol). The reaction
is stirred for 90 minutes at 0°C, followed by stirring for 20 hours at room temperature.
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Dicyclohexylurea is then filtered off, the residue is washed with 0°C DCM (10 mL) and the
combined filtrate is concentrated under reduced pressure yielding a yellow oil. The crude
material is used as such for the purpose of NMR analysis (see Chapter 3.1, Figure X). 1H-NMR
(600 MHz, CDCl3) δ 7.21 (d, J = 8.0 Hz, 2H; o-CH), 7.10 (d, J = 8.2 Hz, 2H; m-CH), 4.35-4.26 (m,
2H; -OCH2CH2Cl), 3.74 (q, J = 7.2 Hz, 1H; COCH), 3.63-3.61 (m, 2H; CH2Cl), 2.45 (d, J = 7.2 Hz, 2H;
CH2, i-Bu), 1.88-1.81 (h, J = 6.6 Hz, 1H; CH, i-Bu), 1.51 (d, J = 7.2 Hz, 3H; CH3), 0.89 (d, J = 6.6 Hz,
6H, (CH3)2, i-Bu).

13C-NMR

(151 MHz, CDCl3) δ 174.5 (C=O), 140.8 (C, Ph), 137.4 (C, Ph), 129.4

(m-CH), 127.2 (o-CH), 64.2 (-OCCCl-), 45.1 (CH, i-Bu), 45.1 (CH, i-Bu), 41.5 (-CCl), 30.3, 22.5
((CH3)2, i-Bu), 18.5 (CH3). HRMS: calculated for C15H22ClO2 [M+H]+ m/z 269.1308; observed m/z
269.1318.
General procedure for the hydrolysis of diastereomeric esters to 6-(2-chloroethoxy)cyclohex3-enol (3)

A 250 mL 3-neck round-bottomed flask is equipped with stirrer bar, thermometer, and
refluxed condenser. The flask is then charged with (S)-(1S,6S)- 6-(2-chloroethoxy)cyclohex-3en-1-yl 2-(4-isobutylphenyl)propanoate 11c (8.24 g, 22.58 mmol) and methanol (150 mL). To
this is carefully added sulfuric acid (1.23 mL, 22.58 mmol) in methanol (56 mL). The solution is
subsequently heated to 60°C and stirred at this temperature for 72 hours. The work-up is
conducted by cooling the reaction mixture to room temperature, followed by the careful
addition of crushed solid sodium hydroxide until the pH of the solution reached 7. Next,
methanol was removed under reduced pressure and the residue was dissolved in DCM (206
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mL). The organic solution was washed with H2O (103 mL) and the water layer, in turn, was
extracted with DCM (2 x 206 mL). The combined organic layers were dried over Na2SO4 and
concentrated under reduced pressure yielding a crude yellow oil. Purification using column
chromatography (SiO2, hexane/ethyl acetate 4:1  1:1) resulted in the isolation of the pure
compound (1S,6S)-3 after removal of the solvents as a colorless liquid (3.76 g, 94%).
Polarimetry ([a]d24 = +129° (c = 0.1, DCM). 1H-NMR (600 MHz, CDCl3) δ 5.58-5.52 (m, 2H; H3,
H4), 3.95-3.92 (m, 1H; ROHCHCH2Cl), 3.82-3.78 (m, 1H; H1), 3.73-3.69 (m, 1H; ROHCHCH2Cl),
3.67-3.64 (m, 2H; CH2Cl), 3.42 (td, J = 9.4, 5.8 Hz, 1H; H6), 2.91 (d, J = 1.3 Hz, 1H; OH), 2.47-2.62
(2H; H2ax, H5ax), 2.12-2.00 (m, 2H; H2eq, H5aq).

13C-NMR

(151 MHz, CDCl3) δ 124.9 (C3), 123.8

(C4), 80.7 (C6), 70.4 (C1), 69.5 (ROCH2CH2Cl), 43.6 (CH2Cl), 32.8 (C2), 30.6 (C5). HRMS:
calculated for C8H13ClO2 [M+H]+ m/z 177.0682; observed m/z 177.0673.
General derivatization of 6-(2-chloroethoxy)cyclohex-3-enol (3) to 6-(2chloroethoxy)cyclohex-3-en-1-yl ((R)-1-phenylethyl)carbamate (14)

6-(2-chloroethoxy)cyclohex-3-enol 3 (100 mg, 0.57 mmol) and (R)-α-methylbenzyl
isocyanate (96 µL, 0.68 mg) are placed in a ½ dram vial and heated to 100 °C for 12 hours. Next,
the temperature is lowered to 60 °C immediately followed by the addition of isopropanol (1
mL). The vial is left to stand at this temperature for 1 hour after which it is left to cool to room
temperature. The resulting suspension is diluted with n-hexane (9 mL), filtered over a 0.2 µm
filter, and directly analyzed on chiral HPLC for enantiomeric excess determination. For

173
structure determination, a small aliquot of the n-hexane/i-PrOH solution was concentrated
under reduced pressure and analyzed using NMR spectroscopy. 1H-NMR (600 MHz, CDCl3) δ
7.35-7.25 (m, 5H, Ph), 5.56 (d, J = 4.8 Hz, 2H; H3, H4), 4.97-4.94 (m, 1H; NHCH), 4.85-4.85 (m,
1H; H1), 3.84-3.47 (m, 5H; -OCH2CH2Cl-, H6), 2.57-2.41 (m, 2H; H2eq, H5eq), 2.17-2.08 (m, 2H;
H2ax, H5ax), 1.49 (d, J = 6.0 Hz, 3H; CH3). HRMS: calculated for C17H23ClNO3 [M+H]+ m/z
324.1366; observed m/z 324.1358. HPLC (Astec Cellulose DMP, n-hexane/isopropanol 92:8, 0.5
mL/min, 212 nm, 25°C) (R)-(1S,6S)-14 tr = 21.6 min; (R)-(1R,6R)-14 tr = 23.4 min).
Synthesis of 6-(2-chloroethoxy)cyclohex-3-en-1-yl butyrate (15)

6-(2-chloroethoxy)cyclohex-3-enol 3 (371 mg, 2.10 mmol) is placed in a flame-dried 10
mL round-bottomed flask, followed by anhydrous DCM (5 mL). Next, anhydrous pyridine (220
μL, 2.73 mmol), butyric anhydride (455 μL, 2.73 mmol), and DMAP (2.6 mg, 0.02 mmol) are
added to the flask under stirring. The resulting solution is stirred at room temperature for 22
hours. Excess anhydride was then quenched with methanol (74 μL) under stirring for 2 hours.
Next, the solution was washed with saturated NaHCO3 (aq.) (2 x 1 mL), 5% HCl (2 x 1 mL), water
(1 x 1 mL), and brine (1 x 1 mL), dried over Na2SO4, and concentrated under reduced pressure
yielding a crude colorless oil. Purification using column chromatography (SiO2, hexane/ethyl
acetate 85:15) resulted in the isolation of the pure compound rac-15 as a colorless liquid (381
mg, 74%) after removal of the solvents. 1H-NMR (600 MHz, CDCl3) δ 5.59-5.53 (m, 2H; H3, H4),
5.08-5.04 (m, 1H; H1), 3.85-3.78 (m, 2H; -OCH2CH2Cl), 3.69-3.63 (m, 1H; H6), 3.58 (t, J = 5.9 Hz,
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2H; CH2Cl), 2.59-2.54 (m, 1H; H2eq), 2.51-2.46 (m, 1H; H5eq) 2.31 (t, J = 7.4 Hz, 2H; -CH2CH2CH3),
2.19-2.14 (m, 1H; H5ax), 2.11-2.06 (m, 1H; H2ax), 1.69-1.63 (m, 2H; -CH2CH2CH3), 0.96 (t, J = 7.4
Hz, 3H; CH3).

13C-NMR

(151 MHz, CDCl3) δ 173.3 (C=O), 124.0 (C3), 123.9 (C4), 76.4 (C6), 71.2

(C1), 70.4 (-OCCCl), 43.2 (CCl), 36.6 (-CH2CH2CH3) , 30.3 (C2), 30.1 (C5), 18.6 (-CH2CH2CH3) , 13.8
(CH3). HRMS: calculated for C12H19ClO3 [M+H]+ m/z 247.1101; observed m/z 247.0998
Synthesis of 7-azidooctahydrobenzo[b][1,4]dioxin-6-yl butyrate (16)

7-azidooctahydrobenzo[b][1,4]dioxin-6-ol 6 (210 mg, 1.05 mmol) is placed in a flamedried 5 mL round-bottomed flask, followed by anhydrous DCM (3 mL). Next, anhydrous
pyridine (110 μL, 1.37 mmol), butyric anhydride (229 μL, 1.37 mmol), and DMAP (1.3 mg, 0.01
mmol) are added to the flask under stirring. The resulting solution is stirred at room
temperature for 22 hours. Excess anhydride was then quenched with methanol (42 μL) under
stirring for 2 hours. Next, the solution was washed with saturated NaHCO3 (aq.) (2 x 0.6 mL),
5% HCl (2 x 0.6 mL), water (1 x 1 mL), and brine (1 x 1 mL), dried over Na2SO4, and concentrated
under reduced pressure yielding a crude colorless oil. Purification using column
chromatography (SiO2, hexane/ethyl acetate 8:2) resulted in the isolation of the pure
compound rac-16 as a colorless liquid (236 mg, 84%) after removal of the solvents. 1H-NMR
(600 MHz, CDCl3) δ 5.01 (dd, J = 2.8, 1.2 Hz, 1H; H6), 3.89 (d, J = 2.7 Hz, 1H; H7), 3.83-3.77 (m,
4H; OCH2CH2Cl), 3.50-3.44 (m, 2H; H4a, H8a), 2.31 (t, J = 7.4 Hz, 2H; CH2CH2CH3), 2.01 (dd, J =
13.7, 4.0 Hz, 1H; H8eq), 1.97-1.94 (m, 1H; H5eq), 1.84-1.77 (m, 2H; H5ax, H8ax), 1.66 (td, J = 14.8,
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7.4 Hz, 2H; CH2CH2CH3), 0.96 (t, J = 7.4 Hz, 3H; CH3).

13C-NMR

(151 MHz, CDCl3) δ 172.3 (C=O),

75.2 (C4), 74.8 (C6), 69.9 (C6), 67.5 (-OCCCl), 67.5 (-CCl), 58.8 (C7), 36.3 (CH2CH2CH3), 30.0 (C5),
29.9 (C8), 18.5 (CH2CH2CH3), 13.7. (CH3) HRMS: calculated for C12H20N3O4 [M+H]+ m/z
270.1454; observed m/z 247.1404
Synthesis of 6-(2-chloroethoxy)cyclohex-3-en-1-yl acetate (17)

6-(2-chloroethoxy)cyclohex-3-enol 3 (5.00 g, 28.3 mmol) is placed in a flame-dried 50 mL
round-bottomed flask, followed by anhydrous DCM (25 mL). Next, anhydrous pyridine (3.42
mL, 42.5 mmol), acetic anhydride (4.05 mL, 42.5 mmol), and DMAP (279 mg, 2.26 mmol) are
added to the flask under stirring. The resulting solution is stirred at room temperature for 24
hours. Next, the solution was washed with saturated 1.1 M HCl (3 x 10 mL), saturated sodium
bicarbonate solution (3 x 5 mL), and brine (1 x 5 mL). The organic solution is dried over Na2SO4
and concentrated under reduced pressure yielding a crude light-yellow oil. Purification using
column chromatography (SiO2, hexane/ethyl acetate 4:1) resulted in the isolation of the pure
compound rac-17 as a colorless liquid (5.08, 82%) after removal of the solvents. 1H-NMR (600
MHz, CDCl3) δ 5.58-5.53 (m, 2H; H3, H4 ), 4.97-5.14 (1H; H1), 3.86-3.77 (m, 2H, -OCH2CH2Cl),
3.63 (td, J = 8.0, 5.8 Hz, 1H; H6), 3.59 (t, J = 5.8 Hz, 2H; CH2Cl), 2.57-2.48 (m, 2H; H2eq, H5eq),
2.19-2.08 (m, 5H; H2ax, H5ax, CH3).

13C-NMR

(151 MHz, CDCl3) δ 170.7 (C=O), 124.0 (C3), 123.8

(C4), 76.5(C1), 71.5 (-OCCCl), 70.4 (C6), 43.3 (CCl), 30.4 (C2), 30.1 (C5), 21.5 (CH3). HRMS:
calculated for C10H16ClO3 [M+H]+ m/z 219.0788; observed m/z 219.0767
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General procedure for the selective enzymatic hydrolysis of compounds 15, 16, and 17

To a 20 mL vial is added ester (40 mg) followed by sodium phosphate buffer (4 mL,
0.1M) of a specific pH. Next, enzyme (1 mg based % w/w active enzyme, 1:40 on substrate) is
added, followed by vigorous stirring at a specified temperature for a specific amount of time.
After the reaction has completed, the suspension/emulsion is brought onto a C-18 SPE column
(500 mg, 6 mL) and the aqueous buffer is filtered off. The organic components are
subsequently eluted with diethyl ether (3 mL). The ether solution is dried over anhydrous
sodium sulfate and concentrated under reduced pressure to give the crude product as an oil.
Optional subsequent purification using column chromatography (SiO2, hexane/ethyl acetate 3:1
 1:1) yields the pure 6-(2-chloroethoxy)cyclohex-3-enol (3).
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Table 27
Selective Enzymatic Hydrolysis of 15, 16, and 17 varying enzyme, pH, reaction time, and
temperature.
Enzymea Substrate Product pH Temp. Reaction e.e. Configuration Conversion
(°C)
time (h) (%)b
(%)
L1
15
3
7.5
25
19
-75
(S,S)
23d
L2
15
3
7.5
25
43
-52
(S,S)
28d
L3
15
3
7.5
25
43
N/A
N/A
N/A
L4
15
3
6.8
25
19
N/A
N/A
N/A
L5
15
3
6.8
25
65
90
(S,S)
6d
L6
15
3
6.8
25
65
81
(S,S)
16d
L7
15
3
6.8
25
19
76
(S,S)
22d
E1
15
3
7.5
25
65
N/A
N/A
N/A
E2
15
3
6.8
25
19
N/A
N/A
N/A
L1
16
6
7.5
25
144
34
(S,S)
trace
L2
16
6
7.5
25
144
79
(S,S)
23
L3
16
6
7.5
25
144
N/A
N/A
N/A
L4
16
6
6.8
25
144
N/A
N/A
N/A
L5
16
6
6.8
25
144
50
(S,S)
8
L6
16
6
6.8
25
144
N/A
N/A
N/A
L7
16
6
6.8
25
144
N/A
N/A
N/A
E1
16
6
7.5
25
144
N/A
N/A
N/A
E2
16
6
6.8
25
144
N/A
N/A
N/A
L1
17
3
7.5
25
94
97
(S,S)
14d
L2
17
3
7.5
25
2.0
97
(S,S)
28d
L3
17
3
7.5
25
94
48
(S,S)
4d
L4
17
3
6.8
25
72
23
(R,R)
15d
L5
17
3
6.8
25
335
22
(S,S)
9d
L7
17
3
6.8
25
22
75
(S,S)
24d
E1
17
3
7.5
25
24
0
N/A
100
E2
17
3
6.8
25
3.5
92
(R,R)
26d
L2
17
3
7.5
25
5.0
67
(R,R)
N/A
L2
17
3
7.0
25
3.3
>99
(R,R)
32c
E2
17
3
7.5
25
0.3
97
(S,S)
47c
E2
17
3
7.0
25
0.3
98
(S,S)
46c
E2
17
3
6.5
25
2.0
89
(S,S)
49c
E2
17
3
7.5
0
0.3
>99
(S,S)
35c
E2
17
3
7.0
0
1.0
>99
(S,S)
50c
a L=lipase, E=Esterase.
b Optical rotation correlated to absolute configuration through X-ray data of (S,S,S,S)-7.
c

Determined through integration of NMR signals at 5.04 ppm (17, CHOCOR) and 3.93 ppm (3, CHOH)

d Isolated yield after column chromatography.
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5.4 Synthesis of Optically Pure Chiral Ligands
General Procedure for diimine synthesis from octahydrobenzo[b][1,4]dioxine-6,7-diamine

To a flame-dried, argon-flushed 5 mL vial is added (4aS,6R,7S,8aS)octahydrobenzo[b][1,4]dioxine-6,7-diamine 9 (50 mg, 0.29 mmol) followed by anhydrous
ethanol (726 μL). Next, aldehyde (0.58 mmol) is added to the solution under vigorous stirring.
The resulting mixture is heated to 80°C and stirred for 16 hours at this temperature Then, the
mixture is allowed to reach room temperature and kept at -18 °C for 12 hours. If crystals
appear in the vial, these are filtered off, washed with ice-cold ethanol, and dried in a 40 °C
oven. If no crystals appear, the solution is used according to the general procedure for the
diimine reduction.
(4aS,6R,7S,8aS,N6E,N7E)-N6,N7-dibenzylideneoctahydrobenzo[b][1,4]dioxine-6,7-diamine
(18a)

The title compound was synthesized through the condensation with benzaldehyde
according to the general procedure for diimine synthesis. This resulted in the isolation of
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yellow crystals (88 mg, 78%). 1H-NMR (600 MHz, CD3OD) δ 8.39 (s, 1H; N=CH), 8.17 (s, 1H;
N=CH), 7.76 (d, J = 5.8 Hz, 2H; CH, Ph), 7.63 (d, J = 7.1 Hz, 2H; CH, Ph), 7.43-7.34 (m, 6H; CH, Ph),
4.07-4.03 (m, 1H; H4a), 3.86-3.80 (m, 5H; -OCH2CH2O-, H8a), 3.68 (d, J = 2.7 Hz, 1H; H6), 3.583.54 (m, 1H; H7), 2.48 (q, J = 11.9 Hz, 1H; H5ax), 1.96-1.88 (m, 2H; H5eq, H8eq), 1.84 (td, J = 7.8,
3.8 Hz, 1H; H8ax).

13C-NMR

(151 MHz, CD3OD) δ 163.7 (N=CH), 163.0 (N=CH), 137.7 (C, Ph),

137.3 (C, Ph), 132.1 (CH, Ph), 131.7 (CH, Ph), 129.7 (CH, Ph), 129.6 (CH, Ph), 129.4 (CH, Ph),
129.3 (CH, Ph), 80.2 (C8a), 76.9 (C4a), 72.2 (C7), 70.4 (C6), 68.5 (-OCCO-), 68.4 (-OCCO-), 37.4
(C5), 33.4 (C8). HRMS: calculated for C22H25N2O2 [M+H]+ m/z 349.1916; observed m/z
349.1873.
(4aS,6R,7S,8aS,N6E,N7E)-N6,N7-bis(naphthalen-1-ylmethylene)octahydrobenzo[b]
[1,4]dioxine-6,7-diamine (18b)

The title compound was synthesized through the condensation with 1-naphtaldeyde
according to the general procedure for diimine synthesis. No crystals had formed. Solution
used as such according to the general procedure for diimine reduction.
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(4aS,6R,7S,8aS,N6E,N7E)-N6,N7-bis(3,5-di-tert-butylbenzylidene)octahydrobenzo[b]
[1,4]dioxine-6,7-diamine (18c)

The title compound was synthesized through the condensation with 3,5-di-tertbutylbenzaldeyde according to the general procedure for diimine synthesis. No crystals had
formed. Solution used as such according to the general procedure for diimine reduction.
(4aS,6R,7S,8aS)-N6,N7-dimethyleneoctahydrobenzo[b][1,4]dioxine-6,7-diamine (18d)

The title compound was synthesized through the condensation with formaldehyde (37%
in methanol) according to the general procedure for diimine synthesis. No crystals had formed.
Solution used as such according to the general procedure for diimine reduction.
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(4aS,6R,7S,8aS,N6E,N7E)-N6,N7-bis(2,4,6-trimethoxybenzylidene)octahydrobenzo[b][1,4]
dioxine-6,7-diamine (18e)

The title compound was synthesized through the condensation with 2,4,6trimethoxybenzaldehyde according to the general procedure for diimine synthesis. No crystals
had formed. Solution used as such according to the general procedure for diimine reduction.
(4aS,6R,7S,8aS,N6E,N7E)-N6,N7-bis(2,4,6-trimethylbenzylidene)octahydrobenzo[b][1,4]
dioxine-6,7-diamine (18f)

The title compound was synthesized through the condensation with 2,4,6trimethylbenzaldehyde according to the general procedure for diimine synthesis. No crystals
had formed. Solution used as such according to the general procedure for diimine reduction.
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(4aS,6R,7S,8aS,N6E,N7E)-N6,N7-bis(2,4-di-tert-butyl-6-methoxybenzylidene)octahydrobenzo[b]
[1,4]dioxine-6,7-diamine (18g)

The title compound was synthesized through the condensation with 3,5-di-tert-butyl-2methoxybenzaldehyde according to the general procedure for diimine synthesis. No crystals
had formed. Solution used as such according to the general procedure for diimine reduction.
(4aS,6R,7S,8aS,N6E,N7E)-N6,N7-bis(2-methoxybenzylidene)octahydrobenzo[b][1,4]dioxine-6,7diamine (18h)

The title compound was synthesized through the condensation with 2methoxybenzaldehyde according to the general procedure for diimine synthesis. No crystals
had formed. Solution used as such according to the general procedure for diimine reduction.
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2,2'-((1E,1'E)-(((4aS,6R,7S,8aS)-octahydrobenzo[b][1,4]dioxine-6,7-diyl)bis(azanylylidene))
bis(methanylylidene))bis(3,5-di-tert-butylphenol) (18i)

The title compound was synthesized through the condensation with 3,5-di-tert-butyl-2hydroxybenzaldehyde according to the general procedure for diimine synthesis. This resulted
in the isolation of yellow crystals (118 mg, 68%). 1H-NMR (600 MHz, CDCl3) δ 8.40 (s, 1H; N=CH-), 8.29 (s, 1H; -N=CH-), 7.35 (dd, J = 23.3, 2.0 Hz, 2H; CH, Ph), 7.06-7.03 (m, 2H; CH, Ph),
3.96-3.82 (m, 5H; H4a, -OCH2CH2O-), 3.75 (d, J = 12.0 Hz, 1H; H8a), 3.68 (s, 1H; H6), 3.52-3.49
(m, 1H; H7), 2.26 (q, J = 12.1 Hz, 1H; H5ax), 2.12 (dt, J = 13.1, 3.5 Hz, 1H; H5eq), 1.98-1.96 (m, 1H;
H2eq), 1.92-1.87 (m, 1H; H2ax), 1.47 (s, 9H; CH3, t-Bu), 1.30-1.26 (m, 27H; CH3, t-Bu).

13C-NMR

(151 MHz, CDCl3) δ 167.5 (-N=CH-), 165.4 (-N=CH-), 158.2 (COH, Ph), 158.1 (COH, Ph), 140.2 (C,
Ph), 137.0 (C, Ph), 136.7 (C, Ph), 127.4 (CH, Ph), 127.4 (CH, Ph), 126.4 (CH, Ph), 126.2 (CH, Ph),
117.8 (C, Ph), 117.8 (C, Ph), 78.5 (C7), 75.4 (C4a), 69.1 (H6), 67.6 (H8a), 67.5 (-OCH2CH2O-), 67.5
(-OCH2CH2O-), 35.4 (C5), 35.2 (C, t-Bu), 35.1 (C, t-Bu), 34.2 (C, t-Bu), 34.2 (C, t-Bu), 32.6 (C2),
31.6 (C5), 31.6 (CH3, t-Bu), 31.5 (CH3, t-Bu), 29.6 (CH3, t-Bu), 29.6 (CH3, t-Bu), 29.5 (CH3, t-Bu),
29.5 (CH3, t-Bu), 29.4 (CH3, t-Bu), HRMS: calculated for C38H57N2O4 [M+H]+ m/z 605.4318;
observed m/z 605.4193.
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2,2'-((1E,1'E)-(((4aS,6R,7S,8aS)-octahydrobenzo[b][1,4]dioxine-6,7-diyl)bis(azanylylidene))
bis(methanylylidene))diphenol (18j)

The title compound was synthesized through the condensation with 2hydroxybenzaldehyde according to the general procedure for diimine synthesis. No crystals
had formed. Solution used as such according to the general procedure for diimine reduction.
General Procedure for diamine synthesis through reduction of corresponding diimines

A solution of diimine 18 in ethanol (0.29 mmol ,726 µL) is diluted with ethanol (3.5 mL),
methanol (4.25 mL), and cooled to 0°C in an ice-bath. Next, sodium borohydride (0.885 mmol)
is added and the resulting solution is stirred at this temperature for 30 minutes. Next, the
mixture is allowed to reach room temperature and stirring is continued for 18 hours. The workup is conducted by evaporation of the solvents under reduced pressure, followed by partition
of the crude residue between ethyl acetate (5 mL) and water (2.5 mL). The layers are separated
and the water layer is extracted with ethyl acetate (3 x 2.5 mL). Next, the combined organic
layers are dried over Na2SO4 and concentrated under reduced pressure to give the crude
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diamine product. Purification using column chromatography is subsequently performed to
obtain pure diamines, with 19b being the only exception (see synthesis of 19b).
(4aS,6R,7S,8aS)-N6,N7-dibenzyloctahydrobenzo[b][1,4]dioxine-6,7-diamine (19a)

The title compound was synthesized through the reduction of diimine 18a according to
the general procedure for diamine synthesis. The crude product was purified using column
chromatography (SiO2, hexane/ethyl acetate/triethylamine 3:1:0.04  2:1:0.03) yielding the
product 19a as a white solid (76 mg, 74%). 1H-NMR (600 MHz, CD3OD) δ 7.34-7.27 (m, 6H; CH,
Ph), 7.25-7.21 (m, 4H; CH, Ph), 3.88 (d, J = 13.3 Hz, 1H; -NHCH-), 3.74-3.67 (m, 4H; -OCH2CH2O-),
3.64-3.60 (m, 1H) H8a), 3.58 (d, J = 13.2 Hz, 1H; -NHCH-), 3.49 (dd, J = 26.2, 13.3 Hz, 2H; NHCH2-), 3.21-3.17 (m, 1H; H4a), 2.97 (q, J = 3.1 Hz, 1H; H7), 2.74 (dt, J = 12.2, 3.9 Hz, 1H; H6),
2.10 (ddd, J = 13.6, 4.3, 3.2 Hz, 1H; H8eq), 1.78-1.74 (m, 1H; H4eq), 1.65 (q, J = 12.0 Hz, 1H; H4ax),
1.22-1.18 (m, 1H; H8ax).

13C-NMR

(151 MHz, CD3OD) δ 141.8 (C, Ph) , 141.2 (C, Ph), 129.7 (CH,

Ph), 129.4 (CH, Ph), 129.4, 129.2 (CH, Ph), 128.1 (CH, Ph), 128.0 (CH, Ph), 79.8 (C4a), 76.7(C8a),
68.4 (-OCCO-), 68.2 (-OCCO-), 57.9 (C6), 53.7 (C7), 52.2 (NHCH), 51.6(NHCH), 33.0 (C5), 31.5 (C8)
HRMS: calculated for C22H29N2O2 [M+H]+ m/z 353.2229; observed m/z 353.2055.
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(4aS,6R,7S,8aS)-N6,N7-bis(naphthalen-1-ylmethyl)octahydrobenzo[b][1,4]dioxine-6,7-diamine
(19b)

The title compound was synthesized through the reduction of diimine 18b according to
the general procedure for diamine synthesis. The pure product spontaneously precipitated
from the reaction mixture and required no further purification. Product 19b was obtained as a
white solid (123 mg, 94%). 1H-NMR (600 MHz, CD3OD) δ 8.11 (d, J = 8.3 Hz, 1H; CH, Ph), 7.80 (d,
J = 8.1 Hz, 1H; CH, Ph), 7.76-7.73 (m, 2H; CH, Ph), 7.71-7.69 (m, 2H; CH, Ph), 7.25-7.44 (7H; CH,
Ph), 7.04-7.15 (1H; CH, Ph), 4.37 (d, J = 13.2 Hz, 1H; -NHCH-), 3.84-3.58 (m, 8H; -NHCH-, NHCH2-, -OCH2CH2O-; H8a ), 3.25-3.21 (m, 1H; H4a), 3.07 (q, J = 3.1 Hz, 1H; H7), 2.85 (dt, J =
12.3, 4.0 Hz, 1H; H6), 2.26 (ddd, J = 13.5, 4.2, 3.1 Hz, 1H;), 1.78 (dt, J = 11.9, 4.1 Hz, 1H; H8eq),
1.64 (m, 2H; H5ax, H5eq), 1.33-1.28 (m, 1H; H8ax).

13C-NMR

(151 MHz, CDCl3) δ 136.4 (C, Ph),

135.8 (C, Ph), 134.0 (C, Ph), 133.9 (C, Ph), 132.0 (C, Ph), 131.7 (C, Ph), 128.8 (CH, Ph), 127.9 (CH,
Ph), 127.9 (CH, Ph), 126.5 (CH, Ph), 126.2 (CH, Ph), 125.8 (CH, Ph), 125.7 (CH, Ph), 125.7 (CH,
Ph), 125.5 (CH, Ph), 125.4 (CH, Ph), 124.0 (CH, Ph), 123.6 (CH, Ph), 78.6 (C4a), 75.7 (C8a), 67.6 (OCCO-), 67.3 (-OCCO), 58.2 (C6), 53.9 (C7), 49.6 (-NHCH-), 49.2 (-NHCH-), 32.7 (C5), 31.2 (C8).
HRMS: calculated for C30H33N2O2 [M+H]+ m/z 453.2542; observed m/z 453.2491.
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(4aS,6R,7S,8aS)-N6,N7-bis(3,5-di-tert-butylbenzyl)octahydrobenzo[b][1,4]dioxine-6,7-diamine
(19c)

The title compound was synthesized through the reduction of diimine 18c according to
the general procedure for diamine synthesis. The crude product was purified using column
chromatography (SiO2, hexane/ethyl acetate/triethylamine 4:1:0.05) yielding the product 19c as
a white solid (40 mg, 9%). 1H-NMR (600 MHz, CD3OD) δ 7.38 (s, 1H; CH, Ph), 7.34 (s, 1H; CH,
Ph), 7.21 (d, J = 1.5 Hz, 2H; CH, Ph), 7.12 (d, J = 1.3 Hz, 2H; CH, Ph), 3.89 (d, J = 13.2 Hz, 1H; NHCH-), 3.78-3.71 (m, 5H; -OCH2CH2O-, -NHCH- ), 3.59-3.52 (m, 2H; -NHCH2-), 3.23 (q, J = 7.2
Hz, 1H; H8a), 3.19-3.13 (m, 2H; H4a), 3.04 (d, J = 3.0 Hz, 1H; H7), 2.93 (dt, J = 12.3, 3.7 Hz, 1H;
H6), 2.08 (dt, J = 13.7, 3.5 Hz, 1H; H8eq), 2.01 (s, 1H; H8ax), 1.89-1.85 (m, 1H; H5eq), 1.67 (q, J =
12.1 Hz, 1H; H5ax), 1.26-1.31 (36H; CH3, t-Bu).

13C-NMR

(151 MHz, CD3OD) δ 152.0 (C, Ph), 140.6

(C, Ph), 123.8 (CH, Ph), 123.5 (CH, Ph), 122.4 (CH, Ph), 122.1 (CH, Ph), 79.7 (-OCCO-), 76.6 (OCCO-), 68.4 (C8a), 68.2 (C4a), 60.2 (NHCH), 57.5 (NHCH), 53.3 (C7), 52.8 (C6), 35.7 (C5), 35.6
(C, t-Bu), 32.8 (C8), 32.2 (CH3, t-Bu), 32.1 (CH3, t-Bu), 32.0 (CH3, t-Bu), 31.8 (CH3, t-Bu), 31.4 (CH3,
t-Bu). HRMS: calculated for C38H61N2O2 [M+H]+ m/z 577.4733; observed m/z 577.4727.
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(4aS,6R,7S,8aS)-N6,N7-dimethyloctahydrobenzo[b][1,4]dioxine-6,7-diamine (19d)

The title compound was synthesized through the reduction of diimine 18d according to
the general procedure for diamine synthesis. The crude product was purified using column
chromatography (SiO2, chloroform/methanol/conc. ammonia 10:0.5:0.05  10:1:0.1) yielding
the product 19d as a colorless oil (5 mg, 9%). 1H-NMR (600 MHz, CD3OD) δ 4.05 (d, J = 6.5 Hz,
1H; H7) 3.74-3.69 (m, 5H; -OCH2CH2O-), 3.46-3.42 (m, 1H; H4a), 3.41-3.37 (m, 1H; H8a), 3.203.14 (m, 2H; H6) 2.43 (t, J = 3.9 Hz, 1H; H5eq), 2.28 (s, 3H; CH3), 2.10 (dd, J = 14.4, 4.6 Hz, 1H;
H8eq), 1.88 (qd, J = 6.1, 4.1 Hz, 1H; H8ax), 1.59-1.52 (m, 2H; H5ax).

13C-NMR

(151 MHz, CD3OD) δ

78.3, 76.3 (C6), 71.6 (C7), 68.2 (-OCCO-), 68.1 (C8) 66.1 (C5), 57.5, 38.4 (CH3), 35.3, 29.5.
HRMS: calculated for C10H21N2O2 [M+H]+ m/z 201.1603; observed m/z 201.1593.
(4aS,6R,7S,8aS)-N6,N7-bis(2,4,6-trimethoxybenzyl)octahydrobenzo[b][1,4]dioxine-6,7-diamine
(19e)

The title compound was synthesized through the reduction of diimine 18e according to
the general procedure for diamine synthesis. The crude product was purified using column
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chromatography (SiO2, chloroform/methanol/conc. ammonia 10:0.5:0.05) yielding the product
19e as a colorless oil (93 mg, 60%). 1H-NMR (600 MHz, CD3OD) δ 6.23 (s, 2H; CH, Ph), 6.16 (s,
2H; CH, Ph), 3.82-3.70 (m, 24H; -OCH3, -OCH2CH2O-, -NHCH2-), 3.60-3.56 (m, 1H; H8a), 3.51 (d, J
= 13.7 Hz, 1H; -NHCH-), 3.42 (d, J = 13.6 Hz, 1H; -NHCH-), 3.10-3.06 (m, 1H; H4a), 2.85 (q, J = 3.2
Hz, 1H; H7), 2.48-2.45 (m, 1H; H6), 2.19 (ddd, J = 13.7, 4.3, 3.1 Hz, 1H; H8eq), 1.60-1.51 (m, 2H;
H5eq, H5ax), 1.11-1.06 (m, 1H; H8eq).

13C-NMR

(151 MHz, CD3OD) δ 161.0 (C, Ph), 160.9 (C, Ph),

159.6 (C, Ph), 159.4 (C, Ph), 107.4 (C, Ph), 107.3 (C, Ph), 90.1 (CH, Ph), 90.1 (CH, Ph), 78.6 (C4a),
75.4 (C8a), 67.1 (-OCCO-), 66.8 (-OCCO-), 54.8 (C6), 54.7 (-OCH3), 54.5 (-OCH3), 54.4 (-OCH3),
53.5 (-OCH3), 51.5 (C7), 37.7 (-NHCH-), 37.1 (-NHCH-), 31.6 (C5), 30.0 (C8). HRMS: calculated for
C28H41N2O8 [M+H]+ m/z 533.2863; observed m/z 533.2860.
(4aS,6R,7S,8aS)-N6,N7-bis(2,4,6-trimethylbenzyl)octahydrobenzo[b][1,4]dioxine-6,7-diamine
(19f)

The title compound was synthesized through the reduction of diimine 18f according to
the general procedure for diamine synthesis. The crude product was purified using column
chromatography (SiO2, hexane/ethyl acetate/triethylamine 3:1:0.04) yielding the product 19f as
a white foam (53 mg, 42%). 1H-NMR (600 MHz, CD3OD) δ 6.79 (s, 4H; CH, Ph), 3.83 (d, J = 11.9
Hz, 1H; -NHCH-), 3.77-3.71 (m, 4H, -OCH2CH2O-), 3.68-3.64 (m, 2H; -NHCH-,H8a), 3.60 (s, 1H; -
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NHCH-), 3.58 (s, 1H; -NHCH-), 3.27-3.22 (m, 1H; H4a), 3.06 (q, J = 2.9 Hz, 1H; H7), 2.86 (dt, J =
12.2, 3.9 Hz, 1H; H6), 2.32 (s, 6H; CH3, CH3), 2.24 (d, J = 6.5 Hz, 6H; CH3, CH3), 2.24-2.22 (m, 1H;
H8eq), 2.21 (d, J = 7.0 Hz, 6H; CH3, CH3), 1.79 (td, J = 7.9, 4.0 Hz, 1H; H5eq), 1.60 (q, J = 11.9 Hz,
1H; H5ax), 1.38-1.34 (m, 1H; H8ax).

13C-NMR

(151 MHz, CD3OD) δ 137.9 (C, Ph), 137.8 (C, Ph),

137.5 (C, Ph), 137.5 (C, Ph), 134.8 (C, Ph), 134.6 (C, Ph), 129.9 (CH, Ph), 79.9 (C4a), 77.0 (C8a),
68.5 (-OCCO-), 68.2 (-OCCO-), 59.9 (C6), 56.8 (C7), 46.4 (-NHCH-), 46.2 (-NHCH-), 32.6 (C5), 32.1
(C8), 21.0 (CH3), 21.0 (CH3), 20.0 (CH3), 19.8 (CH3). HRMS: calculated for C28H41N2O2 [M+H]+ m/z
437.3168; observed m/z 437.3149.
(4aS,6R,7S,8aS)-N6,N7-bis(2,4-di-tert-butyl-6-methoxybenzyl)octahydrobenzo[b][1,4]dioxine6,7-diamine (19g)

The title compound was synthesized through the reduction of diimine 18g according to
the general procedure for diamine synthesis. The crude product was purified using column
chromatography (SiO2, chloroform/methanol/conc. ammonia 10:0.2:0.02) yielding the product
19g as a colorless oil (53 mg, 42%). 1H-NMR (600 MHz, CD3OD) δ 7.25 (s, 1H; CH, Ph), 7.24 (d, J
= 2.3 Hz, 1H; CH, Ph), 7.19 (d, J = 2.3 Hz, 1H; CH, Ph), 3.96 (d, J = 13.7 Hz, 1H; -NHCH-), 3.78-3.57
(m, 14H; -OCH3, -OCH3, -OCH2CH2O-, -NHCH-, -NHCH2-, H8a), 3.17-3.13 (m, 1H; H4a), 2.94 (d, J =
2.8 Hz, 1H; H7), 2.67 (dt, J = 12.0, 3.8 Hz, 1H; H6), 2.09 (dt, J = 13.5, 3.5 Hz, 1H; H8eq), 1.75-1.72
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(m, 1H; H5eq), 1.67 (q, J = 11.9 Hz, 1H; H5ax), 1.36 (s, 18H; CH3, t-Bu), 1.27 (d, J = 6.0 Hz, 18H;
CH3, t-Bu), 1.19-1.15 (m, 1H; H8ax).

13C-NMR

(151 MHz, CD3OD) δ 157.5 (C, Ph), 157.2 (C, Ph),

147.0 (C, Ph), 142.9 (C, Ph), 142.7 (C, Ph), 134.0 (C, Ph), 127.0 (CH, Ph), 126.2(CH, Ph), 124.2
(CH, Ph), 124.0 (CH, Ph), 79.9 (H4a), 76.7 (H8a), 68.4 (-OCCO-), 68.2 (-OCCO-), 62.6 (OCH3), 62.5
(OCH3), 58.0 (C6), 54.4 (C7), 48.1 (-NHCH-), 47.2 (-NHCH-), 36.2 (C, t-Bu), 36.2 (C, t-Bu), 35.4 (C,
t-Bu), 35.3 (C, t-Bu), 32.9 (CH3, t-Bu), 32.0 (CH3, t-Bu), 32.0 (CH3, t-Bu), 31.7 (CH3, t-Bu), 31.7
(CH3, t-Bu), 31.6 (C5), 30.2 (C8). HRMS: calculated for C40H65N2O4 [M+H]+ m/z 637.4944;
observed m/z 637.4879.
(4aS,6R,7S,8aS)-N6,N7-bis(2-methoxybenzyl)octahydrobenzo[b][1,4]dioxine-6,7-diamine
(19h)

The title compound was synthesized through the reduction of diimine 18h according to
the general procedure for diamine synthesis. The crude product was purified using column
chromatography (SiO2, hexane/ethyl acetate/triethylamine 2:1:0.03  1:3:0.04) yielding the
product 19h as a light-yellow solid (45 mg, 38%). 1H-NMR (600 MHz, CD3OD) δ 7.27-7.21 (m,
3H; CH, Ph), 7.03 (dd, J = 7.4, 1.6 Hz, 1H; CH, Ph), 6.91 (dd, J = 8.2, 3.7 Hz, 3H; CH, Ph), 6.88-6.85
(m, 1H; CH, Ph), 3.94 (d, J = 13.3 Hz, 1H; -NHCH-), 3.75-3.66 (m, 10H, -OCH2CH2O-, -OCH3, OCH3), 3.62-3.58 (m, 2H; -NHCH-, H8a), 3.51 (d, J = 13.7 Hz, 1H; -NHCH-), 3.37 (d, J = 13.7 Hz,
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1H; -NHCH-), 3.18-3.14 (m, 1H; H4a), 2.94 (q, J = 3.2 Hz, 1H; H7), 2.66 (td, J = 8.0, 4.0 Hz, 1H;
H6), 2.14 (ddd, J = 13.7, 4.3, 3.1 Hz, 1H; H8eq), 1.70-1.67 (m, 1H; H5eq), 1.63 (q, J = 11.9 Hz, 1H;
H5ax), 1.18 (ddd, J = 14.5, 11.2, 2.5 Hz, 1H; H8ax).

13C-NMR

(151 MHz, CD3OD) δ 159.4 (C, Ph),

159.1 (C, Ph), 131.6 (CH, Ph), 130.6 (CH, Ph), 129.8 (CH, Ph), 129.5 (CH, Ph), 128.7 (CH, Ph),
128.6 (CH, Ph), 121.4 (CH, Ph), 121.3 (CH, Ph), 111.5 (CH, Ph), 111.4 (CH, Ph), 79.7 (C4a), 76.6
(C8a), 68.4 (-OCCO-), 68.2 (-OCCO-), 57.1 (C6), 55.7 (-OCH3), 55.7 (-OCH3), 53.0 (C7), 47.4 (NHCH-), 46.6 (-NHCH-), 33.1 (C5), 31.3 (C8). HRMS: calculated for C24H33N2O4 [M+H]+ m/z
413.2440; observed m/z 413.2479.
2,2'-((((4aS,6R,7S,8aS)-octahydrobenzo[b][1,4]dioxine-6,7-diyl)bis(azanediyl))bis(methylene))
bis(3,5-di-tert-butylphenol) (19i)

The title compound was synthesized through the reduction of diimine 18i according to
the general procedure for diamine synthesis. The crude product was purified using column
chromatography (SiO2, hexane/ethyl acetate/triethylamine 4:1:0.05) yielding the product 19i as
a white solid (113 mg, 64%). 1H-NMR (600 MHz, CDCl3) δ 7.25 (d, J = 11.7 Hz, 2H; CH, Ph), 6.92
(s, 1H; CH, Ph), 6.82 (s, 1H; CH, Ph), 4.10 (d, J = 12.6 Hz, 1H; -NHCH-), 3.96-3.77 (m, 7H; -NHCH2-,
-NHCH-, -OCH2CH2O-), 3.39 (s, 1H; H8a), 3.20 (m, 2H; H4a; H7), 2.87 (m, 1H; H6), 2.21 (d, J =
12.7 Hz, 1H; H8eq), 2.07 (d, J = 10.3 Hz, 1H; H5eq), 1.41-1.29 (m, 38H; CH3, t-Bu, H5ax, H8ax).

13C-
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NMR (151 MHz, CDCl3) δ 154.5 (C, Ph), 154.1 (C, Ph), 141.3 (C, Ph), 141.0 (C, Ph), 136.3 (CH, Ph),
123.7 (CH, Ph), 123.7 (CH, Ph), 123.7 (CH, Ph), 123.6 (CH, Ph), 123.5 (CH, Ph), 122.0 (CH, Ph),
121.6 (CH, Ph), 77.8 (C4a), 75.3 (C8a), 67.6 (-OCCO-), 67.2 (-OCCO-), 56.2 (C6), 54.3 (C7), 51.8 (NHCH-), 50.9 (-NHCH-), 35.1 (C, t-Bu), 35.1 (C, t-Bu), 34.3 (C, t-Bu), 34.3 (C, t-Bu), 31.8 (CH3, tBu), 31.8 (CH3, t-Bu), 30.7 (C5), 29.8 (C8). HRMS: calculated for C38H61N2O4 [M+H]+ m/z
609.4631; observed m/z 609.4529.
2,2'-((((4aS,6R,7S,8aS)-octahydrobenzo[b][1,4]dioxine-6,7-diyl)bis(azanediyl))bis(methylene))
diphenol (19j)

The title compound was synthesized through the reduction of diimine 18j according to
the general procedure for diamine synthesis. The crude product was purified using column
chromatography (SiO2, chloroform/methanol/conc. ammonia 10:0.2:0.02) yielding the product
19j as a white foam (88 mg, 79%). 1H-NMR (600 MHz, CD3OD) δ 7.13-7.07 (m, 3H; CH, Ph), 6.99
(d, J = 7.4 Hz, 1H; CH, Ph), 6.79-6.72 (m, 4H; CH, Ph), 3.98 (d, J = 13.5 Hz, 1H; -NHCH-), 3.79-3.66
(m, 7H; -NHCH-, -NHCH2-, -OCH2CH2O-), 3.53-3.49 (m, 1H; H8a), 3.20-3.15 (m, 1H; H4a), 3.06 (d,
J = 3.2 Hz, 1H; H7), 2.77 (dt, J = 12.4, 3.8 Hz, 1H; H6), 2.15-2.12 (m, 1H; H8eq), 1.81 (td, J = 8.1,
4.0 Hz, 1H; H5eq), 1.58 (q, J = 12.1 Hz, 1H; H5ax), 1.27-1.22 (m, 1H; H8ax).

13C-NMR

(151 MHz,

CD3OD) δ 130.6 (C, Ph), 130.5 (C, Ph), 129.6 (CH, Ph), 129.5 (CH, Ph), 126.0 (CH, Ph), 125.6 (CH,
Ph), 120.4 (CH, Ph), 120.3 (CH, Ph), 116.5 (CH, Ph), 116.5 (CH, Ph), 79.5 (C4a), 76.7 (C8a), 68.4 (-
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OCCO-), 68.2 (-OCCO-), 57.3 (C6), 54.5 (C7), 49.8 (-NHCH-), 49.6 (-NHCH-), 32.7 (C5), 31.5 (C8).
HRMS: calculated for C22H29N2O4 [M+H]+ m/z 385.2127; observed m/z 385.2166.
Synthesis of N,N'-((4aS,6R,7S,8aS)-octahydrobenzo[b][1,4]dioxine-6,7diyl)dimethanesulfonamide (20a)

To a stirred solution of octahydrobenzo[b][1,4]dioxine-6,7-diamine 9 (50 mg, 0.29
mmol) in anhydrous DCM (4 mL) was added diisopropylamine (122 µL, 0.87 mmol) under
stirring. The resulting solution was cooled to 0°C after which methanesulfonyl chloride was
added (58 µL. 0.75 mmol). The resulting mixture was stirred at this temperature for 30
minutes followed by continued stirring at room temperature for 18.5 hours. The subsequent
work-up was conducted by cooling the mixture to 0°C and adding 2M H2SO4 (aq.) (1.5 mL). The
entire mixture was subsequently transferred to a separatory funnel, the layers were separated,
and the water layer was extracted with DCM (3 x 2 mL). The combined organic layers were
dried over Na2SO4 and concentrated under reduced pressure yielding a crude yellow oil.
Purification using column chromatography (SiO2, dichloromethane/methanol 9:1) resulted in
the isolation of the pure product as a colorless oil (43 mg, 45%). 1H-NMR (600 MHz, CDCl3) δ
4.79 (d, J = 8.0 Hz, 1H; NH4a), 4.52 (d, J = 9.0 Hz, 1H; NH8a), 3.93-3.91 (m, 1H; H8a), 3.81-3.74
(m, 4H; -OCH2CH2O-), 3.63 (dq, J = 16.9, 4.1 Hz, 1H; H4a), 3.26-3.24 (m, 2H; H6, H7), 3.08 (s, 3H;
CH3), 3.02 (s, 3H; CH3), 2.18-2.14 (m, 1H; H8eq), 2.12-2.08 (m, 1H; H5eq), 1.72-1.67 (m, 1H; H8ax),
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1.49-1.45 (m, 1H; H5ax). HRMS: calculated for C10H21N2O6S2 [M+H]+ m/z 329.0841; observed
m/z 329.0880, [2M+H]+ m/z 657.1740.
Simultaneous synthesis of N,N'-((4aS,6R,7S,8aS)-octahydrobenzo[b][1,4]dioxine-6,7diyl)dibenzenesulfonamide (20b) and N-((4aS,6R,7S,8aS)-7-aminooctahydrobenzo[b]
[1,4]dioxin-6-yl)benzenesulfonamide (20c)

Octahydrobenzo[b][1,4]dioxine-6,7-diamine 9 (50 mg, 0.29 mmol) was placed in a
flame-dried 1 dram vial followed by DCM (1.16 mL). To this was added p-toluenesulfonyl
chloride (87.5 mg, 0.45 mmol) under stirring. The resulting solution was cooled to 0°C upon
which trimethylamine (202 µL, 1.45 mmol) was slowly added. After 5 minutes, the resulting
mixture was allowed to reach room temperature and was continuously stirred for 14 hours.
The mixture was then neutralized with 1M HCl (aq.), the layers were separated, and the
aqueous layer was extracted with ethyl acetate (3 x 1 mL). The organic layers were combined,
dried over Na2SO4, and concentrated under reduced pressure yielding the crude product as a
light-yellow foam. Purification using column chromatography (SiO2,
chloroform/methanol/conc. ammonia 10:0.7:0.07) resulted in the separate isolation of the
pure ditosylate 20b as a slightly yellow solid (96 mg, 92%) and the monotosylate 20c as a
colorless oil (42%, 20 mg). 20b: 1H-NMR (600 MHz, CD3OD) δ 7.72 (dd, J = 8.2, 2.9 Hz, 4H; oCH), 7.37 (d, J = 8.1 Hz, 4H; m-CH), 5.47-5.52 (s 1H; NH4a), 4.88-4.86 (s, 1H; NH8a), 3.67-3.57

196
(m, 4H; -OCH2CH2O-), 3.34 (d, J = 3.2 Hz, 1H; H8a), 3.31-3.27 (m 1H; H4a), 3.27-3.23 (m, 1H; H7),
3.04-3.00 (m, 1H; H6), 2.44 (s, 3H, CH3), 2.43 (s, 3H; CH3), 1.59-1.56 (m, 1H; H8eq), 1.54-1.50 (m,
2H; H5ax, H5eq), 1.28-1.24 (m, 1H; H8ax).

13C-NMR

(151 MHz, CD3OD) δ 145.0 (CSO2, Ph), 144.9

(CCH3, Ph), 139.4 (CCH3, Ph), 130.9 (CH, Ph), 130.8 (CH, Ph), 128.3 (CH, Ph), 128.1 (CH, Ph), 78.3
(C4a), 75.3 (C8a), 68.3 (-OCCO-), 68.0 (-OCCO-), 54.8 (C6), 54.7 (C7), 33.5 (C5), 33.2 (C8), 21.5
(CH3), 21.5 (CH3), HRMS: calculated for C22H29N2O6S2 [M+H]+ m/z 481.1467; observed m/z
481.1495. 20c: 1H-NMR (600 MHz, CD3OD) δ 7.77 (d, J = 8.2 Hz, 2H; (CH, Ph), 7.39 (d, J = 8.1 Hz,
2H; CH, Ph), 3.71-3.59 (m, 4H; -OCH2CH2O-), 3.42-3.38 (m, 1H; H8a), 3.26 (dt, J = 12.7, 3.9 Hz,
1H; H4a), 3.13 (d, J = 3.1 Hz, 1H; H7), 3.04-3.00 (m, 1H; H6), 2.43 (s, 3H; CH3), 1.82 (ddd, J =
13.5, 4.0, 3.2 Hz, 1H; H8eq), 1.63 (q, J = 12.3 Hz, 1H H5ax), 1.48-1.41 (m, 2H; H5eq, H8ax).

13C-

NMR (151 MHz, CD3OD) δ 144.9 (CSO2), 139.5 (CCH3), 130.9 (CH, Ph), 128.0 (CH, Ph), 79.0 (C4a),
75.3 (C8a), 68.3 (-OCCO-), 68.0(-OCCO-), 54.9 (C6), 51.4 (C7), 34.9 (C5), 31.2 (C8), 21.5 (CH3).
HRMS: calculated for C15H23N2O4S [M+H]+ m/z 327.1379; observed m/z 327.1371.
5.5 Asymmetric Synthesis
General Procedure for the Asymmetric Henry Reaction

To a flame-dried 1 dram vial equipped with stirrer bar is added ligand (0.01 mmol) and
Cu(OAc)2.H2O (0.01 mmol) followed by solvent (0.20 M with respect to aldehyde). The resulting
mixture is stirred at room temperature for 1 hour. Next, p-nitrobenzaldehyde (0.20 mmol) and
nitromethane (2.00 mmol) are added to the reaction mixture, followed by stirring at room
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temperature or 0°C for a certain amount of time (10-96 hours). The resulting mixtures are
filtered through a small plug of SiO2 in a Pasteur pipet, followed by elution with hexane/ethyl
acetate 3:1 (0.5 mL). The combined eluate is concentrated under reduced pressure to yield the
crude nitroalcohol which is either analyzed directly in terms of enantiomeric excess (HPLC) and
conversion (NMR), or purified using column chromatography.
Asymmetric synthesis of 2-nitro-1-(4-nitrophenyl)ethanol (21)

The title compound was synthesized according to the general procedure for the
asymmetric Henry reaction using p-nitrobenzaldehyde as the substrate, in combination with
various ligands, solvents and temperatures. Purification of the crude product using column
chromatography (SiO2, hexane/ethyl acetate 85:15  7:3) yielded the pure nitroalcohol 21 as a
yellow solid (various yields). 1H-NMR (600 MHz, CDCl3) δ 8.26 (d, J = 8.8 Hz, 2H; m-CH), 7.63 (d,
J = 8.8 Hz, 2H; o-CH), 5.62-5.59 (m, 1H; -CHOH), 4.62-4.55 (m, 2H; -CH2NO2), 3.20 (d, J = 4.1 Hz,
1H; OH).

13C-NMR

(151 MHz, CDCl3) δ 145.0 (C, Ph), 127.0 (CH, Ph), 124.3 (CH, Ph), 80.7 (-

CH2NO2), 70.1 (-CHOH). HRMS: calculated for C8H9N2O5 [M+H]+ m/z 213.0511; observed m/z
213.0486. HPLC (Astec Cellulose DMP, n-hexane/isopropanol 85:15, 0.8 mL/min, 262 nm, 25°C)
(R)-21 tr = 24.4 min; (S)-21 tr = 29.5 min.).
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Asymmetric synthesis of 2-nitro-1-(4-nitrophenyl)ethanol (22)

The title compound was synthesized according to the general procedure for the
asymmetric Henry reaction using benzaldehyde as the substrate, in combination with various
ligands, solvents and temperatures. Purification of the crude product using column
chromatography (SiO2, hexane/ethyl acetate 8:2) yielded the pure nitroalcohol 22 as a colorless
oil (various yields). 1H-NMR (600 MHz, CDCl3) δ 7.44-7.35 (m, 5H; CH. Ph)), 5.46 (dt, J = 9.7, 3.1
Hz, 1H; -CHOH), 4.60 (dd, J = 13.3, 9.6 Hz, 1H; -HCHNO2), 4.51 (dd, J = 13.4, 3.0 Hz, 1H; HCHNO2), 2.93 (d, J = 3.4 Hz, 1H; OH).

13C-NMR

(151 MHz, CDCl3) δ 138.2 (C, Ph), 129.5 (CH,

Ph), 129.3 (CH, Ph), 129.2 (CH, Ph), 129.1 (CH, Ph), 126.1 (CH, Ph), 81.4 (-CH2NO2), 71.1 (CHOH). HRMS: calculated for C8H10NO3 [M+H]+ m/z 168.0661; observed m/z 168.1250. HPLC
(Astec Cellulose DMP, n-hexane/isopropanol 9:1, 0.8 mL/min, 214 nm, 25°C) (R)-22 tr = 21.7
min; (S)-22 tr = 26.5 min.).
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Table 28
Evaluation of Ligand Selectivity for Henry Reaction Using i-PrOH at 0°C.
Entry
Ligand
Reaction time e.e. (%)a Configurationb
(h)
1
(4aS,6R,7S,8aS)-9
14
2
R
2
18a
14
-11
S
3
19a
20
72
R
4
19b
14
23
R
5
19c
14
42
R
6
19e
14
53
R
7
19f
14
53
R
8
19g
14
52
R
9
19h
14
75
R
10
18i
14
N/A
N/A
11
19i
14
1
R
12
19j
14
-46
S
13
20a
14
N/A
N/A
14
20b
14
0
N/A
15
20c
14
N/A
N/A

Conversion
(%)c
95
40
51
2
64
trace
trace
12
35
0
trace
60
0
2
0

a

Determination through chiral HPLC.
Assignment by correlating sign (polarimetry) for entry 1 and comparison to literature.
c
Calculated through integration of CH(OH) at 5.6 ppm for product 21 vs. aldehyde CHO at 10.2 ppm
b

General procedure for asymmetric transfer hydrogenation with isopropanol as the hydrogen
source

Acetophenone (0.50 mmol) is dissolved in i-propanol (0.5 mL) and added to a flamedried 1 dram vial. To this is added catalyst (0.005 mmol) in i-PrOH (0.5 mL), ligand (0.005
mmol) in i-PrOH, and base (0.01 mmol KOtBu or 0.015 mmol KOH) in i-PrOH. The resulting
mixture is heated to 40°C/80°C and stirred at this temperature for a certain amount of time (348 hours). The crude solution/suspension was subsequently filtered through a small plug of
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SiO2 in a Pasteur pipet, followed by elution with ethyl acetate (1.5 mL). The combined eluate is
concentrated under reduced pressure to yield the crude alcohol which is either analyzed
directly in terms of enantiomeric excess (HPLC) and conversion (NMR), or purified using column
chromatography (SiO2, hexane/ethyl acetate 95:5  85:15) to give the pure alcohol 23 as a
colorless oil (various yields). 1H-NMR (600 MHz, CDCl3) δ 7.38-7.33 (m, 4H; CH, Ph), 7.28-7.25
(m, 1H; CH, Ph), 4.90 (d, J = 6.2 Hz, 1H; OH), 4.04-4.00 (m, 1H; -CHOH) 1.50 (d, J = 6.3 Hz, 3H;
CH3).

13C-NMR

(151 MHz, CDCl3) δ 146.2 (C, Ph), 128.8 (CH, Ph), 127.9 (CH, Ph), 125.9 (CH, Ph),

70.7 (-CHOH), 25.5 (CH3). HRMS: calculated for C8H10NO3 [M+H]+ m/z 123.0810; observed m/z
123.0997. HPLC (Astec Cellulose DMP, n-hexane/isopropanol 9:1, 1.0 mL/min, 215 nm, 25°C)
(R)-23 tr = 10.9 min; (S)-23 tr = 12.5 min.).

Table 29
Evaluation of Ligand Selectivity for ATH Using i-PrOH as Hydrogen Source.
Ligand
Cat.
Base Temp. Time e.e. Configurationb Conversion
(°C)
(h) (%)a
(%)c
9
Mn(CO)5Br KOtBu
80
3
42
R
22
19a
Mn(CO)5Br KOtBu
80
3
N/A
N/A
0%
19b
Mn(CO)5Br KOtBu
80
3
N/A
N/A
0%
19d
Mn(CO)5Br KOtBu
80
3
N/A
N/A
0%
19j
Mn(CO)5Br KOtBu
80
3
N/A
N/A
0%
20a
Mn(CO)5Br KOtBu
80
3
N/A
N/A
0%
20a
[(Ph)RuCl2]2 KOH
40
48
2
R
Trace
20a
[(Cy)RuCl2]2
KOH
40
48
4
R
Trace
20b
[(Ph)RuCl2]2 KOH
40
48
1
R
10
20b
[(Cy)RuCl2]2
KOH
40
48
2
R
7
20c
[(Ph)RuCl2]2 KOH
40
48
14
R
87
20c
[(Cy)RuCl2]2
KOH
40
48
9
R
87
a

Determination through chiral HPLC.
Assignment by correlating HPLC data to literature.137
c
Calculated through integration of CH(OH) at 4.89 ppm for product 23 vs. aldehyde CH3 at 2.59 ppm.
b
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General procedure for asymmetric transfer hydrogenation with formic acid/triethylamine 5:2
azeotrope as the hydrogen source
The ruthenium catalyst (0.005 mmol) is dissolved in acetonitrile (0.25 mL) under
vigorous stirring, followed by the addition of triethylamine (0.01 mmol). After complete
dissolution, ligand (0.005 mmol) in acetonitrile (0.25 mL) is added to the solution followed by
stirring at room temperature for 30 minutes. Next, acetophenone (0.5 mmol) is dissolved in
formic acid/triethylamine 5:2 azeotrope (0.5 mL) and added to the catalyst-ligand complex
mixture followed by stirring at 40°C for 22-48 hours. Next, DCM (2 mL) and 1.1M HCl (1 mL) are
added to the mixture. The layers are separated and the organic phase is dried over Na2SO4, and
concentrated in vacuo to yield a crude oil, which is directly used for analysis in terms of
conversion (NMR) and enantiomeric excess using HPLC (Astec Cellulose DMP, nhexane/isopropanol 9:1, 1.0 mL/min, 215 nm, 25°C) (R)-23 tr = 10.9 min; (S)-23 tr = 12.5 min.).

Table 30
Evaluation of Ligand Selectivity for ATH Using a Ruthenium-based Catalyst with a Formic Acid
Hydrogen Source in Acetonitrile.
Entry Ligand
X=
Reaction time (h) e.e. (%)a Configurationb Conversion (%)c
1
20a
Benzene
22
3
R
5
2
20a
Cymene
22
0
R
7
3
20b
Benzene
48
19
R
4
4
20b
Cymene
48
14
R
6
5
20c
Benzene
48
9
R
39
6
20c
Cymene
48
-11
S
15
a

Determination through chiral HPLC.
Assignment by correlating HPLC data to literature.137
c
Calculated through integration of CH(OH) at 4.89 ppm for product 23 vs. aldehyde CH3 at 2.59 ppm
b
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5.6 Synthesis of Dicyclohexene-based Crown Ethers
Simultaneous synthesis of (1S,6S)-6-(2-(2-(((1R,6R)-6-hydroxycyclohex-3-en-1-yl)oxy)ethoxy)
ethoxy)cyclohex-3-enol (24) and (1S,6S)-6-(2-(2-(((1R,6R)-6-hydroxycyclohex-3-en-1yl)oxy)ethoxy) ethoxy)cyclohex-3-enol (25)

Diethylene glycol (5.58 g, 52.0 mmol) and 95% w/w sodium hydride (263 mg, 10.4
mmol) were stirred in an oven-dried round-bottomed flask under argon atmosphere for 0.5
hours at 60°C. Next, 7-oxa-bicyclo[4.1.0]hept-3-ene 2 (10.0 g, 104 mmol) was added to the
mixture followed by stirring at 60°C for 42h. After cooling to room temperature, the mixture
was diluted with water (10 mL) and the pH was adjusted to 7-8 using 1.1M HCl. The aqueous
mixture was extracted with DCM (1x50 mL, 2x30 mL). The combined organic extracts were
washed with brine (1x20 mL), dried over anhydrous Na2SO4, and concentrated in vacuo to yield
a dark red oil. The crude product was purified by column chromatography (SiO2, DCM/MeOH
39:1) yielding half-crowns 24 and 25 as a yellow oil (4.97 g, 32%). 1H-NMR (600 MHz, CDCl3) δ
5.47-5.54 (m, 4H; H3, H4, H3’, H4’), 5.09 (s, 1H; OH), 5.04 (s, 1H; OH’), 3.56-3.90 (m, 10H; H1,
H1’ (-OCH2CH2)2O-), 3.36-3.43 (m, 2H; H6, H6’), 2.47-2.52 (m, 4H; H21, H51, H21’, H51’), 1.972.11 (m, 4H; H22, H52, H22’, H52’).

13C-NMR

(151 MHz, CDCl3) δ 125.2 (C3), 125.1 (C4), 124.0

(C3’), 124.0 (C4’), 81.6 (C6), 81.1 (C6’), 70.9 (-OCH2CH2)2O-), 70.9 (-OCH2CH2)2O-), 70.6 (OCH2CH2)2O-), 70.4 (-OCH2CH2)2O-), 69.0 (C1), 68.5 (C1’), 33.3, 31.2, 31.1. HRMS: calculated for
C16H26O5 [M+H]+ m/z 299.1859; observed m/z 299.1820.
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Simultaneous synthesis of (4aR,11aS,15aS,22aR)1,4,4a,6,7,9,10,11a,12,15,15a,17,18,20,21,22a-hexadeca-hydrodibenzo[b,k][1,4,7,10,13,16]
hexaoxacyclooctadecine (26) and (4aR,11aR,15aR,22aR)-1,4,4a,6,7,9,10,11a,12,15, 15a,17,
18,20,21,22a-hexadecahydrodibenzo[b,k][1,4,7,10,13,16] hexaoxacyclooctadecine (27)

A mixture of half-crown 24 and 25 (3.50 g, 11.7 mmol) in DMSO (14 mL) is added to a
stirred suspension of 60% w/w NaH in mineral oil (1.41 g, 35.2 mmol) in DMSO (30 mL) under
argon atmosphere. After stirring for 0.5 hours, di(ethylene glycol) ditosylate (5.12 g, 11.7
mmol) is added to the mixture followed by stirring for 18 hours at room temperature, after
which full consumption of the starting material was observed on TLC. Brine (36 mL) was
subsequently added to break down excess NaH, followed by stirring for 5 minutes. Formed
solids were filtered off and the solution was extracted with diethyl ether (5x70 mL) The
combined organic extracts were washed with brine (1x35 mL), dried over anhydrous Na 2SO4,
and concentrated in vacuo yielding an orange colorless oil. Column chromatography with
gradient elution (SiO2, DCM/MeOH/ conc. NH3 (aq.) 15:1:.1  10:1:.1) was utilized to yield the
pure trans-syn-trans crown ether 26 (white solid, 743 mg, 17%) and pure trans-anti-trans crown
ether 27 (white solid, 1.09 g, 25%). 26: 1H-NMR (600 MHz, CDCl3) δ 5.52 (t, J = 1.2 Hz, 4H; H3,
H4, H3’, H4’), 3.83-3.76 (m, 16H; ((-OCH2CH2)2O-)2), 3.57-3.59 (m, 4H; H1, H6, H1’, H6’), 2.48
(dd, J = 19.5, 3.7 Hz, 4H; H21, H51, H21’, H51’), 2.06 (ddd, J = 15.5, 5.3, 3.2 Hz, 4H; H22, H52, H22’,
H52’).

13C-NMR

(151 MHz, CDCl3) δ 124.4 (C3, C4, C3’, C4’), 78.6 (C1, C6, C1’, C6’), 71.1 ((-

OCH2CH2)2O-)2), 69.5 ((-OCH2CH2)2O-)2), 31.3 (C2, C5, C2’, C5’). HRMS: calculated for C20H32O6
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[M+H]+ m/z 369.2277; observed m/z 369.2239. 27: 1H-NMR (600 MHz, CDCl3) δ 5.52 (t, J = 1.5
Hz, 4H; H3, H4, H3’, H4’), 3.95-3.73 (m, 16H; ((-OCH2CH2)2O-)2), 3.52-3.55 (m, 4H; H1, H6, H1’,
H6’), 2.47 (dd, J = 19.5, 3.7 Hz, 4H; H21, H51, H21’, H51’), 2.07 (ddd, J = 15.6, 5.5, 3.2 Hz, 4H; H22,
H52, H22’, H52’).

13C-NMR

(151 MHz, CDCl3) δ 124.5 (C3, C4, C3’, C4’), 79.3 (C1, C6, C1’, C6’),

71.3 ((-OCH2CH2)2O-)2), 70.4 ((-OCH2CH2)2O-)2), 31.7 (C2, C5, C2’, C5’). HRMS: calculated for
C20H32O6 [M+H]+ m/z 369.2277; observed m/z 369.2249.
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Crystallographic data for (4aR,11aS,15aS,22aR)-1,4,4a,6,7,9,10,11a,12,15,15a,17,18,20,21,
22a-hexadeca-hydrodibenzo[b,k][1,4,7,10,13,16] hexaoxacyclooctadecine (26)
The integration of the data using a triclinic unit cell yielded a total of 24237 reflections
to a maximum θ angle of 30.00° (0.71 Å resolution), of which 5706 were independent (average
redundancy 4.248, completeness = 99.9%, Rint = 4.79%, Rsig = 4.53%) and 3982 (69.79%) were
greater than 2σ(F2). The final cell constants of a = 9.5940(10) Å, b = 9.6038(10) Å, c =
11.6846(12) Å, α = 93.080(2)°, β = 91.317(2)°, γ = 114.457(2)°, volume = 977.38(18) Å3, are
based upon the refinement of the XYZ-centroids of 4339 reflections above 20 σ(I) with 4.67° <
2θ < 60.88°. The ratio of minimum to maximum apparent transmission was 0.845. The
calculated minimum and maximum transmission coefficients (based on crystal size) are 0.9780
and 0.9940. Space group P -1, with Z = 2 for the formula unit, C20H32O6. The final anisotropic
full-matrix least-squares refinement on F2 with 235 variables converged at R1 = 6.77%, for the
observed data and wR2 = 18.77% for all data.

Figure 56. ORTEP diagram for trans-syn-trans DCE18C6 26.
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Crystallographic data for (4aR,11aR,15aR,22aR)-1,4,4a,6,7,9,10,11a,12,15, 15a,17,
18,20,21,22a-hexadecahydrodibenzo[b,k][1,4,7,10,13,16] hexaoxacyclooctadecine (27)
The integration of the data using an orthorhombic unit cell yielded a total of 77561
reflections to a maximum θ angle of 30.00° (0.71 Å resolution), of which 5717 were
independent (average redundancy 13.567, completeness = 100.0%, Rint = 5.61%, Rsig = 2.45%)
and 4354 (76.16%) were greater than 2σ(F2). The final cell constants of a = 18.0762(12) Å, b =
8.4454(5) Å, c = 25.7443(16) Å, volume = 3930.1(4) Å3, are based upon the refinement of the
XYZ-centroids of 9992 reflections above 20 σ(I) with 4.508° < 2θ < 56.90°. The ratio of minimum
to maximum apparent transmission was 0.958. The calculated minimum and maximum
transmission coefficients (based on crystal size) are 0.7147 and 0.7461. Space group P b c a,
with Z = 8 for the formula unit, C20H32O6. The final anisotropic full-matrix least-squares
refinement on F2 with 235 variables converged at R1 = 4.00%, for the observed data and wR2 =
10.74% for all data.

Figure 57. ORTEP diagram for trans-anti-trans DCE18C6 27.
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Crystallographic data for (4aS,6S,7S,8aS)-7-azidooctahydrobenzo[b][1,4]dioxin-6-yl 4methylbenzenesulfonate (7)
The integration of the data using a monoclinic unit cell yielded a total of 25851
reflections to a maximum θ angle of 30.00° (0.71 Å resolution), of which 5286 were
independent (completeness = 100%, Rint = 4.79%). The final cell constants of a = 7.8917(2) Å, b
= 7.9681(2) Å, c = 13.1822(3) Å, α = 90.0°, β = 90.64°, γ = 90.0°, volume = 828.87(4) Å3, are
based upon the refinement of the XYZ-centroids of 5090 reflections above 20 σ(I). Space group
P 21, with Z = 2 for the formula unit, C15H20N3O5S.

Figure 58. ORTEP-diagram of (S,S,S,S)-7 obtained through single-crystal X-ray crystallography.
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Abstract
The number of applications found for crown ether-based materials continues to expand. Many
of such applications feature dibenzo- (DB18C6) and dicyclohexano-18-crown-6 (DC18C6)
structural backbones. The trans-syn-trans and trans-anti-trans isomers of dicyclohexeno-18crown-6 have been synthesized for the first time through a convenient three-step synthetic
procedure yielding both isomers simultaneously. A convenient chromatographic separation
resulted in the isolation of the pure isomers and single crystal X-ray crystallography confirmed
the solid-state structure of the crown ether compounds.

Keywords: Crown ether, dicyclohexeno-18-crown-6, dicyclohexano-18-crown-6, crown ether
functionalization
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Introduction
Ever since their first discovery by Pedersen,1 crown ethers have seen a tremendous increase in
their stand-alone applications,2-5 as well as their utility as fundamental building blocks comprising
higher order structures in the shape of cryptands and (pseudo)rotaxanes.6,7151,152 Their unique
suitability in host-guest chemistry has sparked the emergence of supramolecular chemistry and
molecular machinery.2,4,5,8 Additionally, crown ether-based compounds are used for the
selective binding of ions, in (phase-transfer) catalysis, membrane transport, and as antitumor
agents, either in solution or attached to a solid support.3,9-11 Evidently, the range of purposes
found for crown ether-based materials is both incredibly broad, and still expanding. Many
applications feature dibenzo- (DB18C6) and dicyclohexano-18-crown-6 (DC18C6),1,3,9-11 and both
their synthesis and physical properties are well described.1,12-16 Between these two similar
structures, DB18C6 can be further functionalized through incorporation of additional
substituents onto the catechol moiety. DC18C6, however, contains a relatively inert cyclohexane
ring that severely limits any potential for subsequent functionalization. To this extent, we sought
to develop a novel type of dicyclohexene-based crown ether that allows for additional
modification of the 6-membered ring, opening up new possibilities for use in a wide range of
applications. We envisioned the strategic incorporation of π-bonds that could further be
modified dependent on the final purpose of the target molecule. The well-defined
conformational behavior of cyclohexane-based compounds makes these molecules ideal
scaffolds for applications in supramolecular chemistry,4,5 where precise control over the shape
of the structure is highly desirable. Our goal was to design a quick and convenient synthesis,
without the use of any protecting-group strategies, to obtain two of the five possible isomers of
dicyclohexeno-18-crown-6 (DCE18C6) (Figure 1) containing a single separation of isomers in the
final step. To the best of our knowledge, the synthesis of this novel type of crown ether has not
been reported before.

Figure 1. Trans-syn-trans (1) and trans-anti-trans (2) isomers of dicyclohexene-18-crown-6.
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Results and Discussion
The synthesis of crown ethers 1 and 2 is based on a general strategy, as previously published for
the synthesis of DC18C6,15 shown in Scheme 1. Starting from the commercially available 1,4cyclohexadiene 3, epoxide 4 was obtained through reaction with meta-chloroperoxybenzoic acid
(mCPBA). In a first attempt, significant quantities of bis-epoxide 4a (cis/trans mixture) were
formed in addition to the desired product. The epoxidation of 4 to 4a appears minimally
hampered by increased steric hindrance in comparison to the diene 3. To this extent, we
conducted an optimization experiment by varying both temperature and the equivalents of
mCPBA used. We monitored the ratios between the products formed using gas chromatography
in an attempt to establish the optimal conditions for this reaction. This effort led to an increase
in yield from 50% to 70% of the pure epoxide 4 after vacuum distillation.

Scheme 1. Three-step simultaneous synthesis of trans-syn-trans (1) and trans-anti-trans (2)
isomers of DCE18C6. (i) mCPBA, DCM, rt, 12h, 70%. (ii) di(ethylene glycol), NaH, 60°C, 42h, 32%.
(iii) di(ethylene glycol) ditosylate, 60% NaH, DMSO, rt, 18h, 17% (1), 25% (2).
The residue consisted of crude bisepoxides 4a, in a 57:43 ratio favoring the cis isomer, in
accordance with the literature.17,18 The slight preference for the cis-isomer can possibly be
explained by a hydrogen-bonding-directing effect between mCPBA and the epoxide oxygen on 4.
Next, we evaluated several reaction conditions to construct the half-crown intermediates 5 and
6, and obtained our best results employing a modified solvent-free procedure based on the work
of Yamato et al.15 Two equivalents of epoxide 4 were reacted with diethylene glycol in the
presence of a catalytic amount of sodium hydride at 60°C. This resulted in a combined 32% yield
for the trans-syn-trans (5) and trans-anti-trans (6) diols after chromatography. Cyclization to the
desired dicyclohexeno-18-crown-6 was conducted following a procedure as described by Huber
and Dietz.13 The diols were transformed into their corresponding alkoxides using stoichiometric
quantities of sodium hydride, after which they were allowed to react with di(ethylenegylcol)
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ditosylate to give the trans-syn-trans (1) and trans-anti-trans (2) isomers of DCE18C6 (42% yield).
To our disappointment, attempts to separate the isomers through crystallization were
unsatisfactory, in contrast to what had been reported for the analogous DC18C6 isomers.15
Luckily, the products could be separated by chromatography on silica and, in contrast to the
literature,15 both compounds were obtained in pure form. The meso isomer 1 and racemic
isomer 2 were isolated in yields of 17% and 25%, respectively.
The relative stereochemistries of 1 and 2 were determined unequivocally by X-ray
crystallography. Suitable crystals of both samples were obtained through slow evaporation from
n-hexane. trans-syn-trans (1) DCE18C6 crystallizes in the triclinic space group P-1 with two halfmolecule fragments in the asymmetric unit straddling an inversion center.19 The two fragments
are nearly superimposable on each other with only slight deviations in the dihedral angles around
the ethylene linkages. Both fragments contain an identical trans-syn-trans stereochemistry
around the cyclohexene moieties. An ORTEP diagram for one of the molecules of DCE18C6, the
trans-syn-trans isomer (1) is shown on the left in Figure 2. The trans-anti-trans isomer, (2),
crystallizes in the orthorhombic space group Pbca with one complete molecule in the asymmetric
unit.19 The trans-anti-trans isomer’s relative stereochemistry is clearly displayed in the ORTEP
drawing shown on the right in Figure 2.

Figure 2. ORTEP diagram of trans-syn-trans DCE18C6 (1) and trans-anti-trans DCE18C6 (2).

Conclusions
We have developed the first synthesis of two isomers of dicyclohexeno-18-crown-6. A
convenient 3-step route combined with a chromatographic separation of the final products
resulted in the isolation of the pure crown ethers. Future work includes further functionalization
to more advanced materials, and optimization of the synthetic protocol.
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Experimental Section
General. Starting reagents were purchased from commercial sources (Sigma Aldrich, TCI, Alfa
Aesar) and used without additional purification. All solvents were dried/purified by conventional
techniques. The reactions were monitored by TLC on silica gel (8 x 2 cm) plates from Analtech
Inc. (visualization by UV light and/or staining with I2). Column chromatography was performed
on silica gel (40-75 μm, Sorbent Technologies). 1H NMR and 13C NMR spectra were acquired on
JEOL ECA-600 NMR-spectrometer (600 MHz for 1H and 151 MHz for 13C). High resolution mass
spectra (HRMS) were obtained on a JEOL AccuTOF time-of-flight mass spectrometer (Peabody,
MA) coupled with an Ionsense DART open-air ionization source (Saugus, MA). Crystallographic
data were collected at 150K using a Bruker Smart Apex II single crystal diffractometer with MoKα
(λ = 0.71073 Å) using omega and psi scans. Frames were integrated with the Bruker SAINT
software package using a narrow-frame algorithm. Data were corrected for absorption effects
using the Multi-Scan method (SADABS). The structures were solved and refined using the Bruker
SHELXTL Software Package.
Synthesis of 7-oxa-bicyclo[4.1.0]hept-3-ene (4)
To a stirred solution of 1,4-cyclohexadiene (20.0 mL, 205 mmol) in dichloromethane (1 L) at 0°C
was added mCPBA (55.4 g, 238 mmol) in a portion-wise fashion. The mixture was subsequently
stirred at 0°C for 1h, followed by stirring at RT for 16h. Next, 5% w/w Na2SO3 (aq.) (400 mL) was
added, followed by vigorous stirring for 1h at RT. The water layer was extracted with DCM (2x200
mL). The combined organic extracts were washed with saturated NaHCO3 (aq.) (2x250 mL) and
brine (1x100 mL), dried over anhydrous Na2SO4, and concentrated in vacuo. The residual yellow
oil was subjected to vacuum distillation (20 mbar, 47-49°C), yielding the pure epoxide 4 as a
colorless oil (13.73 g, 70%). 1H-NMR (600 MHz, CDCl3) δ 5.44 (dd, 2H), 3.24-3.25 (m, 2H), 2.582.60 (m, 1H), 2.54-2.56 (m, 1H), 2.46-2.47 (m, 1H), 2.43 (m, 1H). 13C-NMR (151 MHz, CDCl3) δ
121.67, 51.15, 25.11. HRMS: calculated for C6H8O [M+H]+ m/z 97.0653; observed m/z 97.0646.
Synthesis
of
(1S,6S)-6-(2-(2-(((1R,6R)-6-hydroxycyclohex-3-en-1-yl)oxy)ethoxy)ethoxy)
cyclohex-3-enol (5) and (1S,6S)-6-(2-(2-(((1R,6R)-6-hydroxycyclohex-3-en-1-yl)oxy)ethoxy)
ethoxy)cyclohex-3-enol (6)
Diethylene glycol (5.58 g, 52.0 mmol) and 95% w/w sodium hydride (263 mg, 10.4 mmol) were
stirred in an oven-dried vessel under argon atmosphere for 0.5h at 60°C. Next, 7-oxabicyclo[4.1.0]hept-3-ene 4 (10.0 g, 104 mmol) was added to the mixture followed by stirring at
60°C for 42h. After cooling to RT, the mixture was diluted with water (10 mL) and the pH was
adjusted to 7-8 using 1.1M HCl. The aqueous mixture was extracted with DCM (1x50 mL, 2x30
mL). The combined organic extracts were washed with brine (1x20 mL), dried over anhydrous
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Na2SO4, and concentrated in vacuo to yield a dark red oil. The crude product was purified by
column chromatography (SiO2, DCM/MeOH 39:1) yielding half-crowns 5 and 6 as a yellow oil
(4.97 g, 32%). 1H-NMR (600 MHz, CDCl3) δ 5.47-5.54 (m, 4H), 5.09 (s, 1H, OH), 5.04 (s, 1H, OH),
3.56-3.90 (m, 10H), 3.36-3.43 (m, 2H), 2.47-2.52 (m, 4H), 1.97-2.11 (m, 4H). 13C-NMR (151 MHz,
CDCl3) δ 125.15, 125.12, 124.04, 124.01, 81.56, 81.14, 70.92, 70.85, 70.61, 70.42, 68.99, 68.49,
33.28, 31.22, 31.06. HRMS: calculated for C16H26O5 [M+H]+ m/z 299.1859; observed m/z
299.1820.
Synthesis of (4aR,11aS,15aS,22aR)-1,4,4a,6,7,9,10,11a,12,15,15a,17,18,20,21,22a-hexadecahydrodibenzo[b,k][1,4,7,10,13,16]hexaoxacyclooctadecine (1) and (4aR,11aR,15aR,22aR)1,4,4a,6,7,9,10,11a,12,15,15a,17,18,20,21,22a-hexadecahydrodibenzo[b,k][1,4,7,10,13,16]
hexaoxacyclooctadecine (2)
A mixture of half-crown 5 and 6 (3.50 g, 11.7 mmol) in DMSO (14 mL) was added to a stirred
suspension of 60% w/w NaH in mineral oil (1.41 g, 35.2 mmol) in DMSO (30 mL) under argon
atmosphere. After stirring for 0.5h, di(ethylene glycol) ditosylate (5.12 g, 11.7 mmol) was added
to the mixture followed by stirring for 18h at RT, after which full consumption of the starting
material was observed on TLC. Brine (36 mL) was subsequently added to break down excess NaH,
followed by stirring for 5 minutes. Formed solids were filtered off and the solution was extracted
with diethyl ether (5x70 mL) The combined organic extracts were washed with brine (1x35 mL),
dried over anhydrous Na2SO4, and concentrated in vacuo yielding an orange colorless oil. Column
chromatography with gradient elution (SiO2, DCM/MeOH/ conc. NH3 (aq.) 15:1:.1  10:1:.1) was
utilized to yield the pure trans-syn-trans crown ether 1 (white solid, 743 mg, 17%) and pure transanti-trans crown ether 2 (white solid, 1.09 g, 25%). 1: 1H-NMR (600 MHz, CDCl3) δ 5.52 (t, J 1.2
Hz, 4H), 3.83-3.87 (m, 4H), 3.64-3.76 (m, 12H), 3.57-3.59 (m, 4H), 2.48 (dd, J 19.5, 3.7 Hz, 4H),
2.06 (ddd, J 15.5, 5.3, 3.2 Hz, 4H). 13C-NMR (151 MHz, CDCl3) δ 124.43, 78.59, 71.07, 69.48, 31.34.
HRMS: calculated for C20H32O6 [M+H]+ m/z 369.2277; observed m/z 369.2239. 2: 1H-NMR (600
MHz, CDCl3) δ 5.52 (t, J 1.5 Hz, 4H), 3.95-3.99 (m, 4H), 3.64-3.73 (m, 12H), 3.52-3.55 (m, 4H), 2.47
(dd, J 19.5, 3.7 Hz, 4H), 2.07 (ddd, J = 15.6, 5.5, 3.2 Hz, 4H). 13C-NMR (151 MHz, CDCl3) δ 124.50,
79.26, 71.26, 70.35, 31.66. HRMS: calculated for C20H32O6 [M+H]+ m/z 369.2277; observed m/z
369.2249.
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